syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187	100.0
OCULOFACIOCARDIODENTAL SYNDROME	2.0038318439999996	75.17605650262367
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0034246600000003	75.16078052650693
CHILDHOOD ABSENCE EPILEPSY	1.52074085	57.05234219516074
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	1.29241286	48.48635501975657
MYOCLONIC-ASTASTIC EPILEPSY	1.219235154	45.741009207701296
BEHR SYNDROME	1.20235462	45.10771655813182
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.78280343709462
260150 PALANT CLEFT PALATE SYNDROME	1.166667	43.76885444472777
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.15287269	43.25134503839722
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	1.0919960729999998	40.96748872930435
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	1.0355697729999997	38.850591181371186
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	1.021378854	38.31820253221259
JERVELL AND LANGE-NIELSEN SYNDROME	1.021374719	38.31804740293137
MOWAT-WILSON SYNDROME; MOWS	1.003080379	37.63171419506455
DUPLICATION OF THE PITUITARY GLAND	1.002819434	37.62192454324181
CHOREA, REMITTING, WITH NYSTAGMUS AND CATARACT	1.00178253	37.58302389699987
GOLDENHAR SYNDROME	1.00151745	37.5730791158959
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	1.001301984	37.564995661069645
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	1.00120482	37.56135044184834
INHERITED CREUTZFELDT-JAKOB DISEASE	1.000541419	37.53646219026713
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	1.000541419	37.53646219026713
IDIOPATHIC UVEAL EFFUSION SYNDROME	1.0	37.51615023372374
ANAPLASTIC THYROID CARCINOMA	1.0	37.51615023372374
OCULAR MOTOR APRAXIA	1.0	37.51615023372374
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.51615023372374
NYSTAGMUS 3, CONGENITAL, AUTOSOMAL DOMINANT; NYS3	1.0	37.51615023372374
DEHYDRATED HEREDITARY STOMATOCYTOSIS	1.0	37.51615023372374
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.05661993667499
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.833878554	31.283913108544315
OROFACIODIGITAL SYNDROME TYPE 3	0.833333	31.26344602271971
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.8272315589999999	31.0345434455215
%187370 ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10;;CONGENITAL PLANTAR CONTRACTURES;;TENDO CALCANEUS, SHORT	0.79684233	29.894456564870474
LAFORA DISEASE	0.7715289599999999	28.944796373028638
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706170999999999	28.910586896276513
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7485789639999999	28.083800875229276
BENIGN SCHWANNOMA	0.7357142999999999	27.601168207898898
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.7263814	27.251033729382577
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.722566614	27.10791764469707
PHEOCHROMOCYTOMA	0.70943396	26.61523102426556
EARLY MYOCLONIC ENCEPHALOPATHY	0.7087289139999999	26.58878041260787
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.7	26.261305163606618
15Q OVERGROWTH SYNDROME	0.6672074189999999	25.03105376825906
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.635819274	23.853491404881165
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.634205864	23.79296247293257
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59274141	22.23737578730924
ROLANDIC EPILEPSY	0.5906213	22.157837422037222
MUCOPOLYSACCHARIDOSIS TYPE 2	0.589348693	22.110094106636737
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.56408717	21.162379014636063
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.842307352786534
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5497264	20.62361820984411
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.532803654	19.98874192854096
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.772024109228724
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.5232558	19.630543203467308
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5231222799999999	19.625534047088095
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.516847064	19.39011210088303
WIEACKER-WOLFF SYNDROME	0.5161805030000001	19.36510529826709
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.51341463	19.261340391271688
ARTHROGRYPOSIS-LIKE HAND ANOMALY AND SENSORINEURAL DEAFNESS	0.508698	19.0843905915948
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.50704225	19.022273225845314
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.50704225	19.022273225845314
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.022273225845314
INHALATIONAL ANTHRAX	0.5035461	18.89111113720568
PAROXYSMAL HEMICRANIA	0.50342466	18.886555175921295
NON-DISTAL MONOSOMY 20Q	0.5028152990000001	18.863694297098725
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.5026044230000001	18.85578304140204
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.500545554	18.77854220268648
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.500541419	18.778387073405263
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.500541419	18.778387073405263
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.75807511686187
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.5	18.75807511686187
BRANCHIOOTORENAL SYNDROME 1	0.5	18.75807511686187
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.5	18.75807511686187
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.75807511686187
CREST SYNDROME	0.5	18.75807511686187
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.5	18.75807511686187
MYOPATHIC EHLERS-DANLOS SYNDROME	0.4700791	17.63555813733365
ULNAR HEMIMELIA	0.4455281	16.714499132945495
ANOCTAMIN-5-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R12	0.4383321	16.44453291586362
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.43830404999999995	16.44348058784956
WILLIAMS SYNDROME	0.43737571999999997	16.40865322010309
SPINOCEREBELLAR ATAXIA TYPE 42	0.43333299999999997	16.256985929230208
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.4322865699999999	16.21772790414113
SPINOCEREBELLAR ATAXIA TYPE 10	0.4321471	16.21249552666804
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42149728	15.812955279585921
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.415887734	15.602506709106938
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.398403219	14.946555017603142
CANAVAN DISEASE	0.37309227	13.99698565236102
CALPAIN-3-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R1	0.37166509999999997	13.943443728231959
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.36781579999999997	13.799032811137286
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752804
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769365
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769365
ACITRETIN/ETRETINATE EMBRYOPATHY	0.35492272999999996	13.315334460043369
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.307012252437023
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34973511999999995	13.120715303929401
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.3497264	13.120388163099364
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.3497264	13.120388163099364
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.34825196	13.065072850548754
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.34754957	13.038721881786087
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.345372854	12.957059877313936
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.345019934	12.943819677573448
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.34406480899999997	12.907987064581464
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841279
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.33894881	12.716054477501885
EMERY-NELSON SYNDROME	0.33814068999999997	12.685736926175007
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.337299079	12.654162921460655
COG4-CDG	0.33583980399999996	12.599416541328335
EPIDERMAL NEVUS SYNDROME	0.333878554	12.525837991682446
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.333874419	12.525682862401228
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.333333	12.505370905857834
PLACENTAL INSUFFICIENCY	0.333333	12.505370905857834
ALBINISM, OCULAR, TYPE I	0.333333	12.505370905857834
NEUROMYELITIS OPTICA	0.333333	12.505370905857834
FRASER-LIKE SYNDROME	0.333333	12.505370905857834
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.333333	12.505370905857834
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.31913092	11.972563538946472
JUVENILE HYALINE FIBROMATOSIS	0.311111	11.671687015364029
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.3098717	11.625193250379375
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.30521293	11.45041413515501
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	11.302918790252718
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.29420263	11.037350066236641
PALLISTER-HALL SYNDROME	0.294023854	11.030643078962454
SCHWARTZ-JAMPEL SYNDROME	0.28949509999999995	10.860741663526877
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.28689033999999997	10.763021096044083
SPINOCEREBELLAR ATAXIA TYPE 20	0.2732558	10.251505645036369
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.2732558	10.251505645036369
EPISODIC ATAXIA, TYPE 2	0.2732558	10.251505645036369
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.26767815400000006	10.042253839749844
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.267212554	10.024786320201018
SPINOCEREBELLAR ATAXIA TYPE 6	0.266667	10.004319234376409
STUVE-WIEDEMANN SYNDROME	0.26294890000000004	9.864830436192403
H SYNDROME	0.25866031	9.703939049461557
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.25758780400000003	9.663702753238987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.255941763	9.601949631792115
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.2545048	9.548040312003813
USHER SYNDROME	0.25449111	9.547526715907116
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.25449111	9.547526715907116
SCLERODERMA	0.254087519	9.532385535318136
INFANTILE MYOFIBROMATOSIS	0.2530914	9.49501498526347
AL KAISSI SYNDROME; ALKAS	0.25184340299999997	9.448194942320232
MUCOPOLYSACCHARIDOSIS TYPE 1	0.25150376	9.4354528445064
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.251301984	9.42788298577684
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.25129784899999996	9.427727856495622
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.25119335	9.42380745631235
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.251086973	9.419816600798937
MICROPHTHALMIA WITH LIMB ANOMALIES	0.25	9.379037558430936
CARNEY COMPLEX	0.25	9.379037558430936
%614826 NYSTAGMUS 7, CONGENITAL, AUTOSOMAL DOMINANT; NYS7	0.25	9.379037558430936
IDIOPATHIC BRONCHIECTASIS	0.25	9.379037558430936
METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	0.25	9.379037558430936
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.379037558430936
HYPERPARATHYROIDISM 2	0.25	9.379037558430936
EXTRAORAL HALITOSIS DUE TO METHANETHIOL OXIDASE DEFICIENCY; EHMTO	0.25	9.379037558430936
PARAGANGLIOMAS 4	0.25	9.379037558430936
DYSTONIA 6, TORSION	0.25	9.379037558430936
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.379037558430936
WILD TYPE ABETA2M AMYLOIDOSIS	0.25	9.379037558430936
PARAGANGLIOMAS 3	0.25	9.379037558430936
PRIMARY CILIARY DYSKINESIA	0.25	9.379037558430936
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.25	9.379037558430936
EXUDATIVE VITREORETINOPATHY 4	0.25	9.379037558430936
PLEURAL MESOTHELIOMA	0.25	9.379037558430936
HYPEREKPLEXIA 1; HKPX1	0.25	9.379037558430936
PARAGANGLIOMAS 1	0.25	9.379037558430936
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.249693714	9.36754688684045
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.24359010000000003	9.13856278704779
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.24304515400000004	9.118118511042525
JUVENILE MYOCLONIC EPILEPSY	0.2427134	9.105672378137884
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.24265660000000003	9.10354146080461
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.238637019	8.952742256131987
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.238039464	8.930324292979074
ARTHROGRYPOSIS, DISTAL, TYPE 1B	0.2371406	8.89660237611539
LENNOX-GASTAUT SYNDROME	0.23257131	8.725180206013937
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.22756148	8.53723067108852
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	8.475991933577506
POLYARTERITIS NODOSA	0.22425796	8.41329531846841
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.219107254	8.220060658362668
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.20962820000000001	7.864443044425089
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.20873440000000001	7.830911109346187
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.20757706	7.787492168034688
SARCOIDOSIS	0.20532863	7.7031397303646765
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.20492842	7.688125391879637
KUFOR-RAKEB SYNDROME	0.20475092	7.681466275213151
BETHLEM MYOPATHY 2; BTHLM2	0.20409836	7.656984736216634
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.20402425400000002	7.654204564387412
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.2035461	7.636266067088557
NON-FUNCTIONING PARAGANGLIOMA	0.2035461	7.636266067088557
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.2035461	7.636266067088557
FAMILIAL CERVICAL ARTERY DISSECTION	0.20342466	7.631710105804173
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.20342466	7.631710105804173
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.20308968000000002	7.61914294579888
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.20151745000000001	7.560158928916913
6P22 MICRODELETION SYNDROME	0.20151745000000001	7.560158928916913
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.20150376	7.559645332820213
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.20054555400000001	7.5236971325693585
WHIM SYNDROME	0.200541419	7.523542003288142
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.200541419	7.523542003288142
RIGID SPINE SYNDROME	0.20024095400000003	7.512269713208167
SALIVARY DUCT CALCULI	0.2	7.50323004674475
BETA-THALASSEMIA	0.2	7.50323004674475
RADIATION PROCTITIS	0.2	7.50323004674475
MALARIA	0.2	7.50323004674475
MYOFIBROMATOSIS, INFANTILE, 1; IMF1	0.2	7.50323004674475
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.2	7.50323004674475
MELIOIDOSIS	0.2	7.50323004674475
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	7.50323004674475
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.2	7.50323004674475
RAT-BITE FEVER	0.2	7.50323004674475
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.2	7.50323004674475
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.2	7.50323004674475
TRANSIENT NEONATAL DIABETES MELLITUS	0.192225754	7.2115702658548235
PERMANENT NEONATAL DIABETES MELLITUS	0.192225754	7.2115702658548235
ROBERTS SYNDROME	0.19055853399999997	7.149022589862152
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.1899228	7.125172297609468
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.18953489999999998	7.110619782933806
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.18953489999999998	7.110619782933806
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.18953489999999998	7.110619782933806
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.18953489999999998	7.110619782933806
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.18953489999999998	7.110619782933806
ZUNICH NEUROECTODERMAL SYNDROME	0.187009479	7.015875709294406
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.18458690000000003	6.924989871577342
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.184369054	6.916817128313525
SPINOCEREBELLAR ATAXIA TYPE 11	0.1830604	6.867721468245562
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.801145833266899
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.801145833266899
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.17932520000000002	6.727591143892557
DUPUYTREN CONTRACTUREDUPUYTREN CONTRACTURE 1, INCLUDED	0.17932520000000002	6.727591143892557
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.177944363	6.675787455552272
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.177885354	6.673573665043131
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.176133809	6.607862439682004
GRANULOMATOSIS WITH POLYANGIITIS	0.17568293899999998	6.590947533026123
PORPHYRIA	0.174179179	6.5345322469506595
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.17375885400000002	6.518763271103671
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.171984449	6.4521944265482
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17118598399999999	6.422239093651829
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.17076536	6.40645890047592
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.170754519	6.406052187891236
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.170462553	6.395098747572095
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.17045877399999998	6.394956974040363
PFAPA SYNDROME	0.1702131	6.385740231347843
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.16975151400000002	6.36842330162606
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.16894088000000002	6.338011434697495
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.16885877900000001	6.334931321247156
UNILATERAL POLYMICROGYRIA	0.16875812999999998	6.331155358242281
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.16818445	6.309633093176199
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.167964849	6.301394509068723
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.167212554	6.273171296828645
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.167212554	6.273171296828645
ENCEPHALITIS LETHARGICA	0.167208419	6.273016167547428
JUVENILE HUNTINGTON DISEASE	0.167208419	6.273016167547428
GM2 GANGLIOSIDOSIS, AB VARIANT	0.167208419	6.273016167547428
SANDIFER SYNDROME	0.166667	6.252704211004036
GRAFT VERSUS HOST DISEASE	0.166667	6.252704211004036
NYSTAGMUS, HEREDITARY VERTICAL	0.166667	6.252704211004036
FASCIAL DYSTROPHY, CONGENITAL	0.166667	6.252704211004036
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	6.252704211004036
CEREBROOCULONASAL SYNDROME	0.166667	6.252704211004036
PEYRONIE DISEASE	0.166667	6.252704211004036
SYNPOLYDACTYLY 1	0.166667	6.252704211004036
PITYRIASIS RUBRA PILARIS	0.166667	6.252704211004036
MUCOLIPIDOSIS TYPE II	0.166667	6.252704211004036
PEMPHIGUS VULGARIS	0.166667	6.252704211004036
DERMATOLEUKODYSTROPHY	0.166667	6.252704211004036
CRANIOACROFACIAL SYNDROME	0.166667	6.252704211004036
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	6.252704211004036
NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1	0.166126	6.23240797372759
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.16567356399999997	6.215434316780445
CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME	0.1625	6.096374412980109
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.15950570000000003	5.98403980433527
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.15950570000000003	5.98403980433527
OXOGLUTARIC ACIDURIA	0.15780365400000002	5.920185590894561
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.15699616	5.88989152467773
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15565328399999998	5.839511986916468
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.15549877299999998	5.833715329027704
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.152017284	5.703103264666649
TUBEROUS SCLEROSIS COMPLEX	0.15187796	5.697876364551486
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.6871294881555325
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.149905679	5.623883974252366
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.14880960000000001	5.582763309820337
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.14825734399999999	5.562044790756861
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.14632200999999997	5.4894385096604275
AMISH NEMALINE MYOPATHY	0.1458333	5.471103991879705
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.3594446739390715
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3594446739390715
PSEUDOXANTHOMA ELASTICUM; PXE	0.14188616	5.323022494646165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14089111	5.285692049356098
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.139785573	5.2442165571751564
YUNIS-VARON SYNDROME	0.13832833400000002	5.189546559924716
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.137843653	5.171363194713285
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	5.160973134422204
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.13754538400000002	5.160173290099223
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.13599260999999999	5.101919187436201
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.13545377299999997	5.081704097592712
BLAU SYNDROME	0.13501488	5.065238521868183
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.13500953899999998	5.065038148109784
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.134346419	5.040160438566798
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.970090811968418
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.13110385400000002	4.918511882884184
INSULIN-RESISTANCE SYNDROME TYPE B	0.1285461	4.822554799559276
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.128360853	4.815605045276929
DOORS SYNDROME	0.128062864	4.804425645184931
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.126843403	4.758676163104765
HEARING LOSS-FAMILIAL SALIVARY GLAND INSENSITIVITY TO ALDOSTERONE SYNDROME	0.12650376	4.745934065290932
LAMBOTTE SYNDROME	0.12575643	4.7178971207367635
VAN DER WOUDE SYNDROME	0.125	4.689518779215468
MARFANOID HYPERMOBILITY SYNDROME	0.125	4.689518779215468
KIMURA DISEASE	0.125	4.689518779215468
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.125	4.689518779215468
CHEILITIS GLANDULARIS	0.125	4.689518779215468
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.125	4.689518779215468
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.125	4.689518779215468
SEVERE HEMOPHILIA A	0.125	4.689518779215468
ANTERIOR SEGMENT DYSGENESIS 1; ASGD1	0.125	4.689518779215468
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.12480361400000001	4.682151132535668
FRONTOMETAPHYSEAL DYSPLASIA	0.12396775000000002	4.650792733136707
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.121353463	4.552714749290635
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.120915814	4.536295843656997
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.1208448	4.533631671764299
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.1208333	4.5332002360366115
ROBERTS SYNDROME; RBS	0.12019526	4.509263431541486
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.432655077602719
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.11795960000000003	4.42539007510996
SAY-BARBER-MILLER SYNDROME	0.11706438400000002	4.391805017162327
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.11667834399999999	4.377322282526099
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.11520935999999998	4.322211658091162
TAKAYASU ARTERITIS	0.11519851899999999	4.321804945506479
SYSTEMIC SCLEROSIS	0.11519851899999999	4.321804945506479
22Q11.2 DELETION SYNDROME	0.11473693299999999	4.304488015784695
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.11465709999999998	4.301492988963086
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.11465709999999998	4.301492988963086
NEUROLEPTIC MALIGNANT SYNDROME	0.11465709999999998	4.301492988963086
SCHINZEL-GIEDION SYNDROME	0.11428576000000001	4.2875617417352965
FG SYNDROME TYPE 1	0.11370173299999999	4.265651297062744
BILATERAL POLYMICROGYRIA	0.11335876400000001	4.252784420533235
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.11231581999999998	4.213657176743873
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.11207652000000001	4.204679561992944
CAREY-FINEMAN-ZITER SYNDROME	0.11186742999999999	4.196835310140574
ACUTE INTERMITTENT PORPHYRIA	0.11165241899999999	4.188768925162671
TERMINAL OSSEOUS DYSPLASIA; TOD	0.11139679000000001	4.179178709194575
HYALINE FIBROMATOSIS SYNDROME; HFS	0.11111099999999999	4.168456968619278
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.10908715	4.092529907968757
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.108689483	4.077610973053763
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.10818720000000001	4.058767248565918
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.10815050000000001	4.05739040585234
BLAU SYNDROME	0.10743062	4.030383279622087
AICARDI SYNDROME; AIC	0.10743048000000001	4.0303780273610545
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000001	4.005181580605681
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.105694673	3.9652572311723047
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.105694673	3.9652572311723047
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.1046077	3.9244781888043034
ALSTRÃ–M SYNDROME	0.10407432300000001	3.904467937141091
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.1035461	3.884651043716182
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.10310420000000001	3.8680726569279
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.1017026	3.8154900207603126
SPINOCEREBELLAR ATAXIA 31	0.10150376000000001	3.8080303094478394
TRISOMY 8P	0.10147674900000002	3.8070169607138764
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.10088861400000002	3.7849523996961647
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.10066773400000001	3.77666583243254
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.10056594000000002	3.7728469134356484
VASCULAR EHLERS-DANLOS SYNDROME	0.10054555400000001	3.7720821091969836
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.10054555400000001	3.7720821091969836
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.100541419	3.771926979915767
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.10001712399999999	3.752257449928976
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.1	3.751615023372375
CAMPTOBRACHYDACTYLY	0.1	3.751615023372375
SPINOCEREBELLAR ATAXIA 15	0.1	3.751615023372375
UROCANIC ACIDURIA	0.1	3.751615023372375
GRANGE SYNDROME; GRNG	0.1	3.751615023372375
9Q31.1Q31.3 MICRODELETION SYNDROME	0.1	3.751615023372375
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.1	3.751615023372375
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.1	3.751615023372375
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.1	3.751615023372375
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.099946743	3.7496170257593766
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.099150284	3.719736950260376
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.099150284	3.719736950260376
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.7123395157572903
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.09879724400000002	3.706492248581862
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.681154065810906
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.681154065810906
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.09722055000000002	3.6473407596052514
PIERPONT SYNDROME	0.096667153	3.626579434614359
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.09653291900000002	3.621543491703886
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.09599150000000001	3.601231535160493
ALLAN-HERNDON-DUDLEY SYNDROME	0.09576389	3.592692484205795
PELIZAEUS-MERZBACHER DISEASE	0.095474773	3.581845927398671
JUVENILE ABSENCE EPILEPSY	0.09540435	3.579203927550761
OCULODENTODIGITAL DYSPLASIA; ODDD	0.09398947900000001	3.5261234145534233
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.09397259	3.5254898042921248
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.09389645	3.52263332461333
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.093875834	3.521859891660112
OTOONYCHOPERONEAL SYNDROME	0.09320629999999999	3.4967415535295245
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.09315583899999999	3.4948484510725812
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.093138154	3.494184977955698
TRICHOTHIODYSTROPHY	0.093066864	3.491510451605536
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.09275250300000001	3.479716837101913
MARDEN-WALKER SYNDROME	0.09252750900000001	3.471275928396226
WT LIMB-BLOOD SYNDROME	0.09241286000000001	3.4669747392880796
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.091771079	3.4428975868749303
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.09166553000000001	3.438937794733911
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.09166553000000001	3.438937794733911
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.09145465400000001	3.431026539037224
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.09119704400000002	3.421362003575515
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.0909091	3.410559453212615
NYSTAGMUS, CONGENITAL MOTOR, AUTOSOMAL RECESSIVE	0.0909091	3.410559453212615
APLASIA CUTIS-MYOPIA SYNDROME	0.0909091	3.410559453212615
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.0909091	3.410559453212615
HERMANSKY-PUDLAK SYNDROME 9	0.0909091	3.410559453212615
APLASIA CUTIS CONGENITA, HIGH MYOPIA, AND CONE-ROD DYSFUNCTION	0.0909091	3.410559453212615
SENIOR-LOKEN SYNDROME 4; SLSN4	0.0909091	3.410559453212615
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.0902778	3.3868755075700654
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.090100804	3.380235299043297
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.08998439300000001	3.375868006478439
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.0896686	3.364020668847681
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.089135949	3.344037653909538
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.08897280900000001	3.3379172691604087
3Q29 MICRODUPLICATION SYNDROME	0.08847668300000001	3.319304531609552
CAMPTODACTYLY-TAURINURIA SYNDROME	0.08814099000000002	3.3067106225891427
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.08788528300000002	3.2971174803613277
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.08704935900000002	3.265756829993353
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.08618236000000001	3.2332303652568646
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.08567275400000002	3.2141119100008573
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.08489203	3.184822151125783
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.08463114900000002	3.1750349003366596
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.08456377300000001	3.1725072121985116
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.08442027300000002	3.1671236446399726
MONOSOMY 22	0.08408973000000002	3.154722943793267
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.08387885400000002	3.1468116880965806
8P INVERTED DUPLICATION/DELETION SYNDROME	0.08387471900000001	3.146656558815364
MANDIBULOACRAL DYSPLASIA	0.08333330000000001	3.1263446022719714
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0825032	3.0952024459629564
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.08022308	3.0096611214920386
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904281	2.9653819348556816
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.07899125000000001	2.963447602149631
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07898196900000001	2.963099414759312
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.07862284000000001	2.9496262772420248
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.07845034000000001	2.9431547413267074
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.07822094900000001	2.9345488741084433
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.07775374000000002	2.917020991073896
WHITE-SUTTON SYNDROME; WHSUS	0.077690884	2.9146628759348046
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.9063256618683644
ETHYLMALONIC ENCEPHALOPATHY	0.07746451900000001	2.9061705325871476
DDOST-CDG	0.07746451900000001	2.9061705325871476
TRICHOHEPATOENTERIC SYNDROME 1	0.07692310000000001	2.885858576043755
CONGENITAL ENTEROVIRUS INFECTION	0.07692310000000001	2.885858576043755
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.07692310000000001	2.885858576043755
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.885858576043755
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.885858576043755
BECKWITH-WIEDEMANN SYNDROME	0.07692310000000001	2.885858576043755
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.8628236598002488
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.07627505400000001	2.861546384949391
URBAN-ROGERS-MEYER SYNDROME	0.07623629000000001	2.8600921089017315
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.07610066	2.855003793445531
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07561588	2.8368167141352263
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.07552696	2.833480778056444
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.075054533	2.8157571357499767
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.07487236900000002	2.808923043758801
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.07458247	2.7980471493221937
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.07418566	2.7831603657479502
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.0737813	2.7679903352394413
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07370248000000001	2.76503331227802
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.07286200300000001	2.7335018508780307
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.07272644900000001	2.7284163866492483
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.07198275400000001	2.700515813301179
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.700193174409169
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.07197415400000001	2.700193174409169
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.07197415400000001	2.700193174409169
LOCALIZED SCLERODERMA	0.07142860000000001	2.67972608858456
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.07142860000000001	2.67972608858456
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.07142860000000001	2.67972608858456
LETHAL CONGENITAL CONTRACTURE SYNDROME 6; LCCS6	0.07142860000000001	2.67972608858456
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.07098874000000001	2.663224234742754
YOU-HOOVER-FONG SYNDROME; YHFS	0.07079183400000001	2.655837079664833
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07077939999999999	2.655370603852826
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.07073001300000001	2.6535177937412335
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.07021279999999999	2.634113953130398
BETHLEM MYOPATHY 1	0.07003308999999999	2.6273719257718953
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.069718639	2.6155749348147515
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.06965405	2.613151804187305
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.06965405	2.613151804187305
MICROHYDRANENCEPHALY; MHAC	0.06898579	2.588081261632117
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.0688549	2.583170772728025
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5771231693103487
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.068517954	2.570529855971373
AUTOIMMUNE HYPOPARATHYROIDISM	0.06844923	2.56795159606271
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.068417074	2.5667452267357946
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067964549	2.549768230851279
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.06776525	2.5422912996258478
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.06742313	2.5294562743078863
LETHAL CONGENITAL CONTRACTURE SYNDROME 4; LCCS4	0.0667341	2.503606521312344
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.5010779327865906
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.5010779327865906
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.5010779327865906
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.5010779327865906
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.5010779327865906
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.065901773	2.472380816536759
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4316017741687577
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.4316017741687577
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.06470255000000001	2.4273905863050227
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.06454336399999999	2.4214185404139164
CHROMOSOME 17Q12 DELETION SYNDROME	0.0642537	2.410551462272615
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.063898499	2.3972256881934464
SLC39A8-CDG	0.06383128900000001	2.3947042277362383
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.06327884	2.3739784680557676
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.06229758	2.3371653704774236
PEHO SYNDROME	0.062030924	2.3271614639207
LOEYS-DIETZ SYNDROME 3; LDS3	0.06155699	2.3093812847758297
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0611888	2.295568213421275
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.061062322999999995	2.2908232832881645
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.06079233	2.280694185338111
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.06060603	2.273704926549568
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.060125484	2.255676690619353
BLUE CONE MONOCHROMACY; BCM	0.06002832	2.252031471398044
FETAL HYDANTOIN SYNDROME	0.059743584	2.241349272845094
BLEPHAROCHALASIS AND DOUBLE LIP	0.0592948	2.224512624878603
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.05910170000000001	2.2172682562684707
CONGENITAL ISOLATED ACTH DEFICIENCY	0.05910170000000001	2.2172682562684707
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.05905026900000001	2.2153387631458004
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.0588235	2.2068312632734486
CATARACT 48; CTRCT48	0.0588235	2.2068312632734486
ACHROMATOPSIA	0.0588235	2.2068312632734486
LEBER CONGENITAL AMAUROSIS 4; LCA4	0.0588235	2.2068312632734486
BETHLEM MYOPATHY	0.05836648999999999	2.1896860074551343
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.057777909999999995	2.167604751750569
AMISH INFANTILE EPILEPSY SYNDROME	0.05771586000000001	2.1652768746285673
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.057439290000000004	2.154901032958426
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.05734132000000001	2.1512255757200283
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0573294	2.150778383209242
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.057305974	2.149899529873867
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.084232235924663
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.084232235924663
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.084232235924663
GITELMAN SYNDROME	0.055555600000000004	2.084232235924663
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.084232235924663
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.084232235924663
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.084232235924663
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.05548023	2.0814046436815468
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0553161	2.075247117943686
RAMOS-ARROYO SYNDROME	0.0553161	2.075247117943686
DISTAL MONOSOMY 12Q	0.055163783999999993	2.0695328080046855
ISOLATED CEREBELLAR AGENESIS	0.054832549	2.0571061459820186
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.05459812	2.048311272398877
COG2-CDG	0.05426045399999999	2.035643344014056
SHEEHAN SYNDROME	0.05413536	2.0309502987167187
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.052905669	1.9848170264196612
JEJUNAL NEUROENDOCRINE TUMOR	0.0526316	1.9745350126412546
ILEAL NEUROENDOCRINE TUMOR	0.0526316	1.9745350126412546
LARYNGEAL NEUROENDOCRINE TUMOR	0.0526316	1.9745350126412546
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.0526316	1.9745350126412546
GALLBLADDER NEUROENDOCRINE TUMOR	0.0526316	1.9745350126412546
VIPOMA	0.0526316	1.9745350126412546
FAMILIAL PANCREATIC CARCINOMA	0.0526316	1.9745350126412546
144120 HYPERIMMUNOGLOBULIN G1(A1) SYNDROMEIMMUNOGLOBULIN HEAVY CHAIN REGULATOR, INCLUDED; IGHR	0.0526316	1.9745350126412546
ADENOCARCINOMA OF THE ANAL CANAL	0.0526316	1.9745350126412546
GLUCAGONOMA	0.0526316	1.9745350126412546
AUTOIMMUNE HEPATITIS	0.0526316	1.9745350126412546
JUVENILE POLYPOSIS SYNDROME	0.0526316	1.9745350126412546
MARFAN SYNDROME	0.0526316	1.9745350126412546
SOMATOSTATINOMA	0.0526316	1.9745350126412546
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.052037643999999994	1.9522520701130326
HYPEREKPLEXIA 4; HKPX4	0.051708133	1.9398900859333685
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.051471769	1.9310226185995247
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.05126819	1.9233851182510933
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340927
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.05081072300000001	1.9062227175521227
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.05067254	1.9010386233643757
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.049954319000000004	1.8740937364273607
ERYTHERMALGIA, PRIMARY	0.0494995	1.8570306784942086
CORNELIA DE LANGE SYNDROME 3	0.049135423000000004	1.8433719110655653
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076854	1.841174627662526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.048849473000000004	1.832644167906232
MENTAL RETARDATION, X-LINKED 98; MRX98	0.048814133	1.831318347156972
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.048734823	1.8283429412819352
GERMAN SYNDROME	0.048261784	1.8105963390915247
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.047617973	1.786443028893401
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.04757886	1.7849756597093092
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.046876744	1.758634970371808
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.04680156	1.7558143561326358
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.0466779	1.7511751089947336
CHRISTIANSON SYNDROME	0.04619249	1.732964394509782
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.045662999	1.7130999306063772
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.0454475	1.70501523774716
3P25.3 MICRODELETION SYNDROME	0.04538887	1.7028156658589564
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6854321824866583
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.04469101	1.6766346452568501
16P13.11 MICRODELETION SYNDROME	0.044650434	1.6751123899449667
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.044596313000000005	1.6730819783781672
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.04456062	1.671742914427875
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297954	1.6618886973105835
PYRIDOXINE-DEPENDENT EPILEPSY	0.044297953999999994	1.6618886973105835
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.044260310000000004	1.6604764393511857
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.04423473000000001	1.6595167762282068
GENITOPATELLAR SYNDROME	0.044046592999999995	1.6524586002716846
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0435606	1.6342260138711464
PREPAPILLARY VASCULAR LOOPS	0.0435606	1.6342260138711464
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.043531344	1.6331284413799088
GABRIELE-DE VRIES SYNDROME	0.043478300000000004	1.6311384347069111
CHROMOSOME 1P36 DELETION SYNDROME	0.043400303	1.6282122875371314
INCONTINENTIA PIGMENTI	0.043391493	1.6278817702535722
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.04324875399999999	1.6225267524853604
MERRF	0.043021119999999996	1.613986801143057
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.0429612	1.6117388334210523
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.604061153275721
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.604061153275721
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.042253623000000004	1.585193268387125
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.042218459	1.5838740504803062
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.04152505	1.5578600142628902
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.041524623999999996	1.5578440323828904
ZELLWEGER SYNDROME	0.04150325900000001	1.5570424998331474
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.04111050900000001	1.5423080318288525
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.041110509	1.542308031828852
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.04073417	1.5281892413660427
FIBROCHONDROGENESIS	0.04052199000000001	1.5202290646094514
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.039968699999999996	1.499471753846634
ATYPICAL RETT SYNDROME	0.03988108900000001	1.4961849264085079
SLC35A2-CDG	0.039871534	1.4958264595930242
SARCOSINEMIA	0.039845903999999994	1.4948649206625335
INSULINOMA	0.039801819	1.4932110211794802
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.039760144000000004	1.4916475356184897
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.03970287900000001	1.489499173275356
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0397012	1.489436183659113
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.0396492	1.4874853438469595
WAGR SYNDROME	0.039458080000000006	1.4803152572142904
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.474397834837925
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.03929049	1.4740279255966204
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938224
MUCOLIPIDOSIS TYPE III	0.0392604	1.4728990646360878
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.03913896000000001	1.4683431033517045
ALKAPTONURIA	0.03913896000000001	1.4683431033517045
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.03907515300000001	1.4659493103537413
PEROXISOME BIOGENESIS DISORDER 11B	0.039014280000000005	1.4636655897405637
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.03899825	1.463064205852317
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4451708779983423
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.4429274122143658
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	1.4429274122143658
CYCLIC NEUTROPENIA	0.0384615	1.4429274122143658
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.4429274122143658
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.4429274122143658
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.4429274122143658
ACROCEPHALOPOLYDACTYLY	0.0384615	1.4429274122143658
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.4429274122143658
BAZEX SYNDROME; BZX	0.0384615	1.4429274122143658
ABLEPHARON-MACROSTOMIA SYNDROME	0.0384615	1.4429274122143658
MAL DE MELEDA	0.0384615	1.4429274122143658
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	1.4429274122143658
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.4429274122143658
SHPRINTZEN OMPHALOCELE SYNDROME	0.0384615	1.4429274122143658
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.4429274122143658
LIP, HAMARTOMATOUS	0.0384615	1.4429274122143658
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.038416580000000006	1.4412421867458671
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.038363639000000005	1.4392560442363433
LISSENCEPHALY 2; LIS2	0.038338984	1.4383310835523309
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	1.4284161653039615
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.038011569	1.4260477332235562
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4212340735032172
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.03779343	1.417863997727722
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.03771556399999999	1.4149427651736224
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.037513903999999994	1.40737725831749
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.037511	1.4072683114172113
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.037499954	1.4068539080217297
HARLEQUIN ICHTHYOSIS	0.03749683	1.4067367075683994
OLIVER SYNDROME	0.03745967	1.4053426074257143
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.037416454	1.4037213094772139
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.0372267	1.3966024699057638
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.037218060000000004	1.3962783303677444
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.037073533	1.390856233722915
MCLEOD SYNDROME; MCLDS	0.037037	1.3894856562064262
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.3894856562064262
MYOCLONUS AND ATAXIA	0.037037	1.3894856562064262
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3894856562064262
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.037016284	1.3887084716381846
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.037016284	1.3887084716381846
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.03701214900000001	1.3885533423569683
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.03701214900000001	1.3885533423569683
PAPILLARY TUMOR OF THE PINEAL REGION	0.03691912000000001	1.3850632524168751
PINEOCYTOMA	0.03691912000000001	1.3850632524168751
DE BARSY SYNDROME	0.036859984	1.3828446973566535
WOLF-HIRSCHHORN SYNDROME	0.036823773	1.3814862000405401
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.03668001300000001	1.3760928782829405
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.036541669	1.3709027439950057
LEPRECHAUNISM	0.03647073000000001	1.3682413858135758
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.03647073000000001	1.3682413858135758
NIJMEGEN BREAKAGE SYNDROME	0.03647073000000001	1.3682413858135758
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.036326203	1.3628192891687463
GENITOPATELLAR SYNDROME; GTPTS	0.036310934	1.3622464550708275
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.036259854	1.3603301301168889
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.036255719000000006	1.3601750008356726
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.036255719000000006	1.3601750008356726
LISSENCEPHALY, X-LINKED, 2	0.036255719000000006	1.3601750008356726
STURGE-WEBER SYNDROME	0.036255719000000006	1.3601750008356726
ALPERS-HUTTENLOCHER SYNDROME	0.036122034	1.355159654291677
THUMBS, CONGENITAL CLASPED	0.0361093	1.3546819236346006
MYOPATHY AND DIABETES MELLITUS	0.03598656	1.3500771913549137
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.035819623999999994	1.3438143952994963
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.035804199999999994	1.3432357461982913
CROSSED POLYSYNDACTYLY	0.035714300000000004	1.33986304429228
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.035714300000000004	1.33986304429228
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.035714300000000004	1.33986304429228
MCCUNE-ALBRIGHT SYNDROME	0.035714300000000004	1.33986304429228
ROWLEY-ROSENBERG SYNDROME	0.03568276	1.3386797849139083
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.03568276	1.3386797849139083
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3380603932735493
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3380603932735493
HYDRANENCEPHALY	0.035569773	1.3344409476474504
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.035551614	1.3337596918753563
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.035483850000000004	1.3312174474709184
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.035306323	1.324557317868376
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.03527403	1.3233458088288783
RESTRICTIVE DERMOPATHY	0.03525773	1.3227342955800687
FETAL AKINESIA DEFORMATION SEQUENCE	0.03525773	1.3227342955800687
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.03523923	1.3220402468007448
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.035028354	1.314128991104058
JAWAD SYNDROME	0.035028354	1.314128991104058
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.035028354	1.314128991104058
COSTELLO SYNDROME; CSTLO	0.035028354	1.314128991104058
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.035024219	1.3139738618228416
PRIMROSE SYNDROME; PRIMS	0.03500895	1.3134010277249226
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.03500895	1.3134010277249226
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.03496668	1.3118152200545434
ACRORENAL-MANDIBULAR SYNDROME	0.0349224	1.310154004922194
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457726
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.3063142269457726
SILVER-RUSSELL SYNDROME	0.0347755	1.30464288245286
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03469632	1.3016723536773538
FLYNN-AIRD SYNDROME	0.034582049	1.2973853456739959
GRISCELLI SYNDROME TYPE 1	0.034549893	1.2961789763470801
MYOTILINOPATHY	0.0344828	1.2936619052794491
MYOPATHY, SCAPULOHUMEROPERONEAL	0.0344828	1.2936619052794491
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.0344828	1.2936619052794491
ALPHA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R3	0.0344828	1.2936619052794491
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.0344828	1.2936619052794491
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.0344828	1.2936619052794491
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.0344828	1.2936619052794491
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.0344828	1.2936619052794491
RECOMBINANT CHROMOSOME 8 SYNDROME	0.034453683000000006	1.292569547533094
HYDROXYKYNURENINURIA	0.034321104	1.287595693851257
SANDHOFF DISEASE	0.034316969	1.2874405645700404
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.034247929999999996	1.2848504870740542
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.03421949	1.2837835277614074
AICARDI SYNDROME	0.03421935	1.2837782755003746
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.034072884	1.2782834350402419
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.2781471013502925
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2781471013502925
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.034040629999999995	1.2770733891306034
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.034032919	1.2767841020961512
LEIGH SYNDROME	0.034004339	1.2757118905224714
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.033560084	1.2590451532003883
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.033560084	1.2590451532003883
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.033555949	1.258890023919172
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.0334915	1.2564721455527588
SPINOCEREBELLAR ATAXIA TYPE 34	0.03346292	1.255399933979079
DIENCEPHALIC SYNDROME	0.03346292	1.255399933979079
ALG13-CDG	0.03346292	1.255399933979079
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.03346292	1.255399933979079
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.03346292	1.255399933979079
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.0330284	1.2390984163795213
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.032803653999999995	1.2306668116790926
NETHERTON SYNDROME; NETH	0.032803653999999995	1.2306668116790926
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.032799519	1.2305116823978763
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.032799519	1.2305116823978763
NEURONAL CEROID LIPOFUSCINOSIS	0.032799519	1.2305116823978763
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978763
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2305116823978763
PROGRESSIVE HEMIFACIAL ATROPHY	0.032799519	1.2305116823978763
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978763
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.032394814	1.2153287088175373
AYMÃ‰-GRIPP SYNDROME	0.032324734	1.212699577009158
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	1.2101997258544839
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	1.2101997258544839
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	1.2101997258544839
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	1.2101997258544839
LESCH-NYHAN SYNDROME	0.0322581	1.2101997258544839
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	1.2101997258544839
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	1.2101997258544839
WEST SYNDROME	0.0322581	1.2101997258544839
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	1.2101997258544839
HSD10 DISEASE, ATYPICAL TYPE	0.0322581	1.2101997258544839
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	1.2101997258544839
DESMOID TUMOR	0.0322581	1.2101997258544839
HUNTINGTON DISEASE	0.0322581	1.2101997258544839
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	1.2101997258544839
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	1.2101997258544839
ATTENUATED CHÃ‰DIAK-HIGASHI SYNDROME	0.0322581	1.2101997258544839
THROMBOCYTOPENIA 1	0.0322581	1.2101997258544839
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	1.2101997258544839
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	1.2101997258544839
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.2101997258544839
19P13.3 MICRODUPLICATION SYNDROME	0.031393984	1.1777814201791195
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.031389972999999995	1.1776309429005318
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.031389972999999995	1.1776309429005318
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.031255202999999995	1.1725748913335328
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1715134468949702
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.031178973000000002	1.1697150352012164
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.031114519	1.1672969692540518
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.030932133	1.160454548677524
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.030848553999999997	1.1573189863571394
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.030616619999999997	1.148617715568831
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.030467403	1.1430196681794056
LETHAL CONGENITAL CONTRACTURE SYNDROME 3; LCCS3	0.03045004	1.1423682752628974
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.030302999999999997	1.1368519005325306
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.030302999999999997	1.1368519005325306
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Y; LGMD2Y	0.030302999999999997	1.1368519005325306
DISTAL NEBULIN MYOPATHY	0.030302999999999997	1.1368519005325306
KLHL9-RELATED EARLY-ONSET DISTAL MYOPATHY	0.030302999999999997	1.1368519005325306
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.030284604	1.136161753432831
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.030267259999999997	1.1355110733231772
VELOCARDIOFACIAL SYNDROME	0.030168229999999997	1.1317958489655315
ROSSELLI-GULIENETTI SYNDROME	0.029957354	1.1238845932688448
STÃœVE-WIEDEMANN SYNDROME	0.02966099	1.1127661569209777
15Q13.3 MICRODELETION SYNDROME	0.029621203000000002	1.1112735018516287
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.02947992	1.1059731075981574
EAR WITHOUT HELIX	0.0294118	1.1034175074442358
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	1.1034175074442358
ALKAPTONURIA	0.0294118	1.1034175074442358
FRYNS MICROPHTHALMIA SYNDROME	0.0294118	1.1034175074442358
AREDYLD	0.0294118	1.1034175074442358
DARWINIAN TUBERCLE OF PINNA	0.0294118	1.1034175074442358
OSTEOMA OF MIDDLE EAR	0.0294118	1.1034175074442358
OSSIFIED EAR CARTILAGES	0.0294118	1.1034175074442358
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.0294118	1.1034175074442358
EAR WAX, WET/DRY	0.0294118	1.1034175074442358
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0294118	1.1034175074442358
HAIRY EARS, Y-LINKED	0.0294118	1.1034175074442358
MUSICAL PERFECT PITCH	0.0294118	1.1034175074442358
EAR MALFORMATION	0.0294118	1.1034175074442358
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0294118	1.1034175074442358
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0294118	1.1034175074442358
DARWINIAN POINT OF PINNA	0.0294118	1.1034175074442358
EAR FOLDING	0.0294118	1.1034175074442358
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	1.1034175074442358
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.0294118	1.1034175074442358
WAARDENBURG SYNDROME, TYPE IIB	0.02928156	1.0985314040377958
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.029189684	1.0950845702189222
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.029079784	1.090961545308236
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.029079784	1.090961545308236
MENKES DISEASE	0.029075649000000002	1.0908064160270197
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.028987154000000005	1.0874864243120863
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.028960879000000002	1.086500687464695
BRUCK SYNDROME 2	0.02895166	1.0861548260756904
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.02881992	1.0812124484438996
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901084
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901084
GAUCHER DISEASE	0.0285593	1.0714349893699864
15Q24 RECURRENT MICRODELETION SYNDROME	0.02853423	1.0704944594836272
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.02853423	1.0704944594836272
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.02853423	1.0704944594836272
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.028341363999999997	1.0632588696526497
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341363999999997	1.0632588696526497
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.028323354000000002	1.0625832037869403
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.02831885	1.0624142310462876
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.02818422	1.0573634317403213
AASE-SMITH SYNDROME	0.02806349	1.052834106922604
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.027872539	1.0456703605193243
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.0421161179623315
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.0421161179623315
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.0421161179623315
DIMPLES, FACIAL	0.027777800000000002	1.0421161179623315
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.0421161179623315
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.0421161179623315
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.0421161179623315
DWARFISM, LEVI TYPE	0.027777800000000002	1.0421161179623315
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	1.0421161179623315
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.0421161179623315
MENINGIOMA	0.027777800000000002	1.0421161179623315
CLEFT CHIN	0.027777800000000002	1.0421161179623315
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.0421161179623315
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	1.0421161179623315
GANGLIOCYTOMA	0.027777800000000002	1.0421161179623315
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.0421161179623315
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.0421161179623315
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623315
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.0421161179623315
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623315
NASAL BONES, ABSENCE OF	0.027777800000000002	1.0421161179623315
OROFACIAL CLEFT 3	0.027777800000000002	1.0421161179623315
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.0421161179623315
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0421161179623315
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.0421161179623315
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.027751730000000002	1.0411380719257382
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0344160781914604
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.027519154	1.0324127157689797
LOWE OCULOCEREBRORENAL SYNDROME	0.027441269	1.0294907704080263
OROFACIODIGITAL SYNDROME TYPE 4	0.027386274	1.0274275697259223
WARBURG MICRO SYNDROME 3; WARBM3	0.027326759000000003	1.0251947960447625
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.02711349	1.0171937642005664
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668517
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668517
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668517
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668517
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.026734499999999998	1.0029755184234874
KEPPEN-LUBINSKY SYNDROME	0.026672809	1.0006611095994187
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.026635830000000003	0.999273799879926
COWDEN SYNDROME 5; CWS5	0.026568699	0.9967553031985859
COWDEN SYNDROME 6; CWS6	0.026568699	0.9967553031985859
XQ21 MICRODELETION SYNDROME	0.026549753	0.9960445222162576
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.026532200000000002	0.9953860012312052
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.026494883999999996	0.9939860485690833
AICARDI-GOUTIÃˆRES SYNDROME	0.026304023	0.9868256786193247
PMM2-CDG	0.026125303000000002	0.9801207922495537
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.026125303000000002	0.9801207922495537
POTOCKI-LUPSKI SYNDROME	0.026088153	0.9787270672683708
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.025940273	0.9731791789718077
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.025842273	0.9695025962489027
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.02579476	0.9677200914028479
WRINKLY SKIN SYNDROME	0.025738453999999997	0.9656077070477878
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.025738453999999997	0.9656077070477878
PEHO-LIKE SYNDROME; PEHOL	0.025738453999999997	0.9656077070477878
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.025605504	0.9606199348742142
WARBURG MICRO SYNDROME 2; WARBM2	0.025580520000000002	0.9596826313767749
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.025528424	0.9577281900141988
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.025417439	0.9535644600805089
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.025398854000000002	0.9528672224284153
CHROMOSOME 17P13.1 DELETION SYNDROME	0.025398854000000002	0.9528672224284153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.025292874	0.9488912608266451
MELAS	0.02524997	0.9472816679170175
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.025242679	0.9470081376656635
EMANUEL SYNDROME	0.025099203	0.9416254704947298
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.024853300000000002	0.9324001366038063
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.024853300000000002	0.9324001366038063
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.02475956	0.928883372680897
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730213999999997	0.9277824237361381
HUNTER-MACDONALD SYNDROME	0.02472948	0.9277548868818666
CEDNIK SYNDROME	0.024623763	0.9237887920276081
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.024570703	0.9217981850962067
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.024557784	0.9213135139513372
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.02446062	0.9176682947300276
SPINOCEREBELLAR ATAXIA 1	0.02446062	0.9176682947300276
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.02446062	0.9176682947300276
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.02443564	0.9167311412971894
RENPENNING SYNDROME 1; RENS1	0.024398889	0.9153523852599497
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.024362069	0.913971040608344
GAUCHER DISEASE, TYPE I	0.02425796	0.9100652717236611
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.024088054	0.9036910527020502
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.02401223	0.9008464281267283
ANE SYNDROME	0.02401223	0.9008464281267283
WYBURN-MASON SYNDROME	0.023881023	0.8959240466030121
KAGAMI-OGATA SYNDROME	0.023814273	0.893419843574911
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.023801354	0.8929351724300415
SPINOCEREBELLAR ATAXIA 5; SCA5	0.023801354	0.8929351724300415
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.023797219	0.8927800431488251
EPISODIC ATAXIA TYPE 6	0.023797219	0.8927800431488251
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.023718023999999997	0.8898089516310652
OCULOSKELETODENTAL SYNDROME; OCSKD	0.023692064	0.8888350323709979
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0235425	0.8832239668774413
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0235425	0.8832239668774413
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.023445883	0.8795992689903096
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.023432192999999997	0.8790856728936097
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.023339604	0.8756120900596196
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.023321779	0.8749433646817035
SILVER-RUSSELL SYNDROME; SRS	0.023272854	0.8731078870315184
HYPOADRENOCORTICISM, FAMILIAL	0.023268719	0.8729527577503022
MILLER-DIEKER SYNDROME	0.023268719	0.8729527577503022
EPISODIC ATAXIA, TYPE 4	0.0232558	0.8724680866054326
SPINOCEREBELLAR ATAXIA 30; SCA30	0.0232558	0.8724680866054326
MACHADO-JOSEPH DISEASE TYPE 1	0.0232558	0.8724680866054326
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0232558	0.8724680866054326
EPISODIC ATAXIA, TYPE 5	0.0232558	0.8724680866054326
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.0232558	0.8724680866054326
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.0232558	0.8724680866054326
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.0232558	0.8724680866054326
DISTAL MYOTILINOPATHY	0.0232558	0.8724680866054326
MACHADO-JOSEPH DISEASE TYPE 3	0.0232558	0.8724680866054326
CENTRAL CORE DISEASE	0.0232558	0.8724680866054326
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.0232558	0.8724680866054326
SPINOCEREBELLAR ATAXIA TYPE 27	0.0232558	0.8724680866054326
SPINOCEREBELLAR ATAXIA TYPE 14	0.0232558	0.8724680866054326
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.0232558	0.8724680866054326
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.0232558	0.8724680866054326
SPINOCEREBELLAR ATAXIA 2; SCA2	0.0232558	0.8724680866054326
BATHING SUIT ICHTHYOSIS	0.0232558	0.8724680866054326
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.0232558	0.8724680866054326
SPINOCEREBELLAR ATAXIA TYPE 30	0.0232558	0.8724680866054326
MULTIPLE SYSTEM ATROPHY	0.0232558	0.8724680866054326
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.0232558	0.8724680866054326
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.0232558	0.8724680866054326
EPISODIC ATAXIA TYPE 4	0.0232558	0.8724680866054326
MACHADO-JOSEPH DISEASE; MJD	0.0232558	0.8724680866054326
SPINOCEREBELLAR ATAXIA 27; SCA27	0.0232558	0.8724680866054326
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.0232558	0.8724680866054326
CLASSIC MULTIMINICORE MYOPATHY	0.0232558	0.8724680866054326
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.0232558	0.8724680866054326
EPISODIC ATAXIA TYPE 5	0.0232558	0.8724680866054326
MACHADO-JOSEPH DISEASE TYPE 2	0.0232558	0.8724680866054326
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.023157248999999998	0.8687708324837489
PYRUVATE DEHYDROGENASE DEFICIENCY	0.023120003	0.8673735059521437
AICARDI-GOUTIERES SYNDROME 7	0.023120003	0.8673735059521437
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.023120003	0.8673735059521437
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.023120003	0.8673735059521437
X-LINKED RETINOSCHISIS	0.02305913	0.8650897853389662
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.022904464	0.859287312446917
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.022896304	0.8589811806610099
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.022794549999999997	0.8551637623101275
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.02278036	0.854631408138311
SUSAC SYNDROME	0.02278036	0.854631408138311
WATSON SYNDROME	0.0227273	0.8526408012069097
THUMB DEFORMITY	0.0227273	0.8526408012069097
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	0.8526408012069097
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	0.8526408012069097
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	0.8526408012069097
SIRENOMELIA	0.0227273	0.8526408012069097
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	0.8526408012069097
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	0.8526408012069097
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0227273	0.8526408012069097
CONGENITAL ATRANSFERRINEMIA	0.0227273	0.8526408012069097
COCAINE EMBRYOFETOPATHY	0.0227273	0.8526408012069097
LARSEN SYNDROME	0.0227273	0.8526408012069097
AMYLOIDOSIS	0.0227273	0.8526408012069097
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	0.8526408012069097
ATROPHODERMA VERMICULATA; AVA	0.0227273	0.8526408012069097
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	0.8526408012069097
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0227273	0.8526408012069097
MUSCULAR HYPERTONIA, LETHAL	0.0227273	0.8526408012069097
ARTERIES, ANOMALIES OF	0.0227273	0.8526408012069097
FATCO SYNDROME	0.0227273	0.8526408012069097
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.0227273	0.8526408012069097
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0227273	0.8526408012069097
RHOMBENCEPHALOSYNAPSIS	0.0227273	0.8526408012069097
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	0.8526408012069097
DISTAL TRISOMY 17Q	0.022676703	0.8507425965535338
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.022676703	0.8507425965535338
MICROPHTHALMIA, SYNDROMIC 1	0.022616359	0.8484787219838301
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.022606804	0.8481202551683468
DYSTONIA 28, CHILDHOOD-ONSET	0.022578584	0.8470615494087511
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.022513204	0.8446087435064703
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8446087435064703
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8446087435064703
JOUBERT SYNDROME 30; JBTS30	0.022363573	0.838995164430848
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.022363573	0.838995164430848
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.022363573	0.838995164430848
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.022363573	0.838995164430848
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.02233706	0.8380004987397013
CRANDALL SYNDROME	0.02233706	0.8380004987397013
STICKLER SYNDROME, TYPE III	0.02233706	0.8380004987397013
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.022335163	0.837929330602708
THROMBOCYTHEMIA, ESSENTIAL	0.02229256	0.8363310300543005
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.022173119999999998	0.8318501010703845
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.022170223	0.8317414167831575
ROIFMAN SYNDROME; RFMN	0.022135283999999998	0.8304306400101413
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.022125009	0.83004516156649
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.022117899	0.829778421738328
MEIER-GORLIN SYNDROME 1; MGORS1	0.02207494	0.8281667654404375
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.022055544	0.8274391021905043
MOSAIC TRISOMY 15	0.02204909	0.8271969729568958
3MC SYNDROME 1	0.02203303	0.8265944635841422
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8241416576818613
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.021920273	0.8223642550322383
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.021846239	0.8195867843658347
JOUBERT SYNDROME 23; JBTS23	0.021822154	0.8186832078874554
HUNTINGTON DISEASE; HD	0.021818019	0.818528078606239
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.021818019	0.818528078606239
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.021695843000000003	0.8139445054352836
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.02162906	0.8114390643742247
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.021589729999999998	0.8099635541855323
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.021589729999999998	0.8099635541855323
ISOTRETINOIN-LIKE SYNDROME	0.021589729999999998	0.8099635541855323
ROIFMAN SYNDROME	0.021589729999999998	0.8099635541855323
FRONTONASAL DYSPLASIA 1; FND1	0.021583590000000003	0.8097332050230976
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.021378854	0.8020522984888457
MEDULLOBLASTOMA	0.021378854	0.8020522984888457
N SYNDROME	0.021378854	0.8020522984888457
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.021374719	0.8018971692076293
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.021374719	0.8018971692076293
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.021374719	0.8018971692076293
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.021374719	0.8018971692076293
DILATED CARDIOMYOPATHY WITH ATAXIA	0.021374719	0.8018971692076293
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.021374719	0.8018971692076293
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.021355984	0.8011943041330006
SALT-AND-PEPPER SYNDROME	0.021342293999999998	0.8006807080363008
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.798583930399738
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0212766	0.7982161220628465
RAVINE SYNDROME	0.0212766	0.7982161220628465
NEUROFERRITINOPATHY	0.0212766	0.7982161220628465
SPINOCEREBELLAR ATAXIA 12	0.0212766	0.7982161220628465
KURU, SUSCEPTIBILITY TO	0.0212766	0.7982161220628465
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.0212766	0.7982161220628465
LEBER OPTIC ATROPHY AND DYSTONIA	0.0212766	0.7982161220628465
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.0212766	0.7982161220628465
PRIMARY BASILAR INVAGINATION	0.0212766	0.7982161220628465
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.0212766	0.7982161220628465
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.021103044	0.7917049690928826
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.02100588	0.788059749871573
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.020992814000000002	0.7875695638526192
WEAVER SYNDROME	0.020888033	0.7836385841149793
611961 STEVENSON-CAREY SYNDROME	0.020888033	0.7836385841149793
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.02084172	0.7819010986492049
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.7815852126642369
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.7815852126642369
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.7815852126642369
PUPIL, EGG-SHAPED	0.0208333	0.7815852126642369
DEAFNESS, AUTOSOMAL DOMINANT 20	0.0208333	0.7815852126642369
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.7815852126642369
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.7815852126642369
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 11	0.0208333	0.7815852126642369
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.7815852126642369
PROTRUSIO ACETABULI	0.0208333	0.7815852126642369
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.7815852126642369
DERMOIDS OF CORNEA	0.0208333	0.7815852126642369
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.7815852126642369
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.0208333	0.7815852126642369
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0208333	0.7815852126642369
UNIQUE GREEN PHENOMENON	0.0208333	0.7815852126642369
WOODHOUSE-SAKATI SYNDROME	0.0208333	0.7815852126642369
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.7815852126642369
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	0.7815852126642369
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.0208333	0.7815852126642369
DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37	0.0208333	0.7815852126642369
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.7815852126642369
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.7815852126642369
DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101	0.0208333	0.7815852126642369
TIETZ SYNDROME	0.0208333	0.7815852126642369
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0208333	0.7815852126642369
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.7815852126642369
IMINOGLYCINURIA	0.0208333	0.7815852126642369
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.0208333	0.7815852126642369
DEAFNESS, AUTOSOMAL RECESSIVE 94; DFNB94	0.0208333	0.7815852126642369
MYOPATHY, CENTRONUCLEAR, 5	0.0208333	0.7815852126642369
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.7815852126642369
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.7815852126642369
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.0208333	0.7815852126642369
DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77	0.0208333	0.7815852126642369
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.7815852126642369
DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	0.0208333	0.7815852126642369
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.0208333	0.7815852126642369
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.7815852126642369
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.7815852126642369
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.7815852126642369
611426 TENTED EYEBROWS	0.0208333	0.7815852126642369
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.0208333	0.7815852126642369
HYPERCALCEMIA, INFANTILE, 1	0.0208333	0.7815852126642369
OSTEOGENESIS IMPERFECTA, TYPE V	0.0208333	0.7815852126642369
DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY	0.0208333	0.7815852126642369
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0207875	0.7798669729835324
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751291
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751291
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.020711303	0.7770083548841733
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.02055749	0.7712378832682736
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.02055749	0.7712378832682736
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.020392434000000004	0.7650456175752962
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.020387693	0.7648677535070378
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.02038535	0.7647798531670403
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.020346614000000002	0.7633266275715869
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.020346614000000002	0.7633266275715869
FRYNS SYNDROME; FRNS	0.020342479	0.7631714982903703
311450 PALLISTER W SYNDROME;;W SYNDROME	0.020342479	0.7631714982903703
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.020329413	0.7626813122714166
AYME-GRIPP SYNDROME; AYGRP	0.020139449	0.7555545943084174
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.020088752999999997	0.7536526755561684
PALLISTER-KILLIAN SYNDROME	0.019987959000000003	0.7498712727095107
BAND HETEROTOPIA; BH	0.019954873	0.7486300133628777
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.01989336	0.7463222824135505
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.019879379	0.7457977691171329
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.019852440000000002	0.7447871215459867
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.019801060000000002	0.742859541746978
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.019801060000000002	0.742859541746978
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.019801060000000002	0.742859541746978
FIBROCHONDROGENESIS 1; FBCG1	0.019801060000000002	0.742859541746978
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.019801060000000002	0.742859541746978
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.019801060000000002	0.742859541746978
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.019801060000000002	0.742859541746978
201020 ACROCEPHALOPOLYSYNDACTYLY TYPE IV;;ACPS IV;;GOODMAN SYNDROME	0.019801060000000002	0.742859541746978
ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	0.019801060000000002	0.742859541746978
BRACHYDACTYLY, TYPE B1	0.019801060000000002	0.742859541746978
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.019801060000000002	0.742859541746978
KAPUR-TORIELLO SYNDROME	0.019789839000000004	0.7424385730252053
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.01974137	0.7406202027395269
SCHAAF-YANG SYNDROME; SHFYNG	0.019522433000000002	0.7324065293558062
BRANCHIOOCULOFACIAL SYNDROME	0.019501508999999997	0.7316215414283156
HHHH SYNDROME	0.019409319	0.7281629275382687
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	0.7281629275382687
OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY; ODRMD	0.019380750000000002	0.7270911286422415
ATELOSTEOGENESIS TYPE II	0.01933796	0.7254858125737405
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.019208699000000003	0.7206364374783791
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.7158870804395407
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.019017054	0.713446654866837
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.018883933	0.7084524674315734
CARPAL DISPLACEMENT	0.0188679	0.7078509709948763
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.7078509709948763
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.7078509709948763
NEPHROSIALIDOSIS	0.0188679	0.7078509709948763
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.7078509709948763
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.7078509709948763
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.7078509709948763
VAN DEN BOSCH SYNDROME	0.0188679	0.7078509709948763
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.7078509709948763
MONOPHALANGY OF GREAT TOE	0.0188679	0.7078509709948763
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.7078509709948763
KNUCKLE PADS	0.0188679	0.7078509709948763
SPINAL ARACHNOIDITIS	0.0188679	0.7078509709948763
MEGAEPIPHYSEAL DWARFISM	0.0188679	0.7078509709948763
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.7078509709948763
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.7078509709948763
LETTERER-SIWE DISEASE	0.0188679	0.7078509709948763
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.7078509709948763
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.7078509709948763
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.7078509709948763
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.7078509709948763
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.7078509709948763
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.7078509709948763
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.7078509709948763
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.7078509709948763
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.7078509709948763
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.7078509709948763
TRACHEOBRONCHOMEGALY	0.0188679	0.7078509709948763
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.7078509709948763
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.7078509709948763
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.7078509709948763
PUBIC BONE DYSPLASIA	0.0188679	0.7078509709948763
VESICOURETERAL REFLUX 1	0.0188679	0.7078509709948763
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.7078509709948763
RAYNAUD DISEASE	0.0188679	0.7078509709948763
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.7078509709948763
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.7078509709948763
TOE, MISSHAPEN	0.0188679	0.7078509709948763
THROMBOCYTOPENIA 3	0.0188679	0.7078509709948763
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.018843613999999998	0.7069398537703
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.01875885	0.7037598348118888
COCKAYNE SYNDROME	0.018749138999999998	0.7033955154769689
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.018553389999999996	0.6960517665848676
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.018438353	0.6917360212104309
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.018438353	0.6917360212104309
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.018262760000000003	0.6851484478424408
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.018193223999999997	0.6825397248197883
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.018099463999999996	0.6790222105738742
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.017897160000000002	0.6714325433169913
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.017897160000000002	0.6714325433169913
SPINOCEREBELLAR ATAXIA TYPE 37	0.017897160000000002	0.6714325433169913
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.017695384	0.6638626845874314
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.01759822	0.6602174653661219
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.017507843	0.6568268682564485
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.017494153	0.6563132721597489
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.017480373000000004	0.6557962996095283
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.017480373000000004	0.6557962996095283
SYNDACTYLY, TYPE V	0.01746589	0.6552529532056932
FIBROSCLEROSIS, MULTIFOCAL	0.01746589	0.6552529532056932
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.01746589	0.6552529532056932
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.01740912	0.6531231613569247
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6468309526397246
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397246
TRANSSEXUALITY	0.0172414	0.6468309526397246
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397246
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397246
DIASTEMATOMYELIA	0.0172414	0.6468309526397246
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397246
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397246
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397246
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397246
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397246
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397246
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6468309526397246
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6468309526397246
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397246
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397246
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397246
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397246
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397246
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397246
CERVICAL RIB	0.0172414	0.6468309526397246
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397246
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397246
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397246
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397246
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397246
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6468309526397246
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397246
RHEUMATOID ARTHRITIS	0.0172414	0.6468309526397246
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397246
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397246
PALMOMENTAL REFLEX	0.0172414	0.6468309526397246
MOTION SICKNESS	0.0172414	0.6468309526397246
SICKLE CELL ANEMIA	0.0172414	0.6468309526397246
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6468309526397246
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397246
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6468309526397246
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397246
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397246
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397246
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397246
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6468309526397246
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397246
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6468309526397246
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397246
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.017206603	0.6455255031600416
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.01714983	0.6433955987628225
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.01714983	0.6433955987628225
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.01714983	0.6433955987628225
MICROCEPHALY, AUTOSOMAL DOMINANT	0.01714983	0.6433955987628225
MOSAIC TRISOMY 1	0.01700279	0.6378792240324558
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.016948598999999998	0.6358461863351399
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.016938954000000003	0.6354843430661358
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.016938954000000003	0.6354843430661358
GAUCHER DISEASE, TYPE IIIC	0.016934819000000004	0.6353292137849194
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.016894643999999997	0.6338220024492793
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.01675656	0.6286416223604059
HYPERMANGANESEMIA WITH DYSTONIA 2	0.016692114	0.6262238565424434
HAREL-YOON SYNDROME; HAYOS	0.016675773999999997	0.6256108426476242
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.016675773999999997	0.6256108426476242
COFS SYNDROME	0.016586069	0.622245456390908
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.016393400000000002	0.6150172572415269
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.016393400000000002	0.6150172572415269
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.016393400000000002	0.6150172572415269
CRANIOFACIOFRONTODIGITAL SYNDROME	0.016393400000000002	0.6150172572415269
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.016393400000000002	0.6150172572415269
RETINAL CONE DYSTROPHY 3B	0.016393400000000002	0.6150172572415269
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.016393400000000002	0.6150172572415269
HERMANSKY-PUDLAK SYNDROME 4; HPS4	0.016393400000000002	0.6150172572415269
SPINOCEREBELLAR ATAXIA 42	0.016393400000000002	0.6150172572415269
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.016393400000000002	0.6150172572415269
OPTIC ATROPHY 1; OPA1	0.016393400000000002	0.6150172572415269
FOCAL FACIAL DERMAL DYSPLASIA TYPE II	0.016393400000000002	0.6150172572415269
VAN DEN BOSCH SYNDROME	0.016393400000000002	0.6150172572415269
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.016393400000000002	0.6150172572415269
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.016393400000000002	0.6150172572415269
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.016393400000000002	0.6150172572415269
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.016393400000000002	0.6150172572415269
WERNICKE-KORSAKOFF SYNDROME	0.016393400000000002	0.6150172572415269
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.016333929	0.6127861342709771
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6115698981965498
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965498
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965498
CORNELIA DE LANGE SYNDROME 1	0.016201529	0.607818995980032
NIEMANN-PICK DISEASE TYPE B	0.016130219999999997	0.6051437568230152
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.016059972999999998	0.602508359817547
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.016040634	0.6017828349881771
MARINESCO-SJOGREN SYNDROME; MSS	0.016039124000000002	0.6017261856013242
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.015990393	0.5998979860842845
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.015990393	0.5998979860842845
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.015990393	0.5998979860842845
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.015990393	0.5998979860842845
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.015875909000000004	0.595602987140927
MEIER-GORLIN SYNDROME 7	0.015761604	0.591314703588461
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.015757469	0.5911595743072446
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.015747914	0.5908011074917613
MYHRE SYNDROME	0.015710903000000002	0.5894125972554611
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.015542002999999999	0.583076119480985
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.015477634	0.5806612424065906
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5804106345230292
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5804106345230292
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.015470953999999999	0.5804106345230292
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.015025733	0.5637076565998206
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.015000583999999999	0.5627641629375927
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.015000583999999999	0.5627641629375927
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.015000583999999999	0.5627641629375927
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.014996448999999999	0.5626090336563762
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.014996448999999999	0.5626090336563762
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984203
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984203
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5599435486984203
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5599435486984203
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.014918959999999998	0.5597019446909152
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.014903419999999999	0.5591189437162831
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.014903419999999999	0.5591189437162831
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.014834304000000001	0.556525977476729
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.014785572999999998	0.5546977779596893
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.014785572999999998	0.5546977779596893
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.014785572999999998	0.5546977779596893
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.014785572999999998	0.5546977779596893
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.014785572999999998	0.5546977779596893
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.014785572999999998	0.5546977779596893
PEHO SYNDROME; PEHO	0.014785572999999998	0.5546977779596893
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.014785572999999998	0.5546977779596893
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.014785572999999998	0.5546977779596893
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.014785572999999998	0.5546977779596893
W SYNDROME	0.014730664000000001	0.552637803666506
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.014652623000000002	0.549710005786116
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.014638933000000002	0.5491964096894163
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.014578814	0.546940976253515
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.014578814	0.546940976253515
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.014501603000000002	0.5440443167778191
ALPORT SYNDROME, X-LINKED; ATS	0.01436238	0.5388212057938292
ANGELMAN SYNDROME	0.014339993000000002	0.5379813317385469
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.014339993000000002	0.5379813317385469
NATIVE AMERICAN MYOPATHY	0.0143371	0.5378727975159207
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.0143371	0.5378727975159207
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.0143371	0.5378727975159207
MOEBIUS SYNDROME; MBS	0.0143371	0.5378727975159207
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.014313734	0.5369961951495594
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.014313734	0.5369961951495594
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.014244153999999998	0.534385821416297
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.014244153999999998	0.534385821416297
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.014244153999999998	0.534385821416297
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.014244153999999998	0.534385821416297
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.534385821416297
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.534385821416297
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2	0.01424165	0.5342918809761117
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.014240018999999998	0.5342306921350805
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.014240018999999998	0.5342306921350805
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.014240018999999998	0.5342306921350805
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.014240018999999998	0.5342306921350805
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.014240018999999998	0.5342306921350805
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.014240018999999998	0.5342306921350805
RETT SYNDROME, CONGENITAL VARIANT	0.014240018999999998	0.5342306921350805
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.014240018999999998	0.5342306921350805
COG8-CDG	0.014240018999999998	0.5342306921350805
HALLERMANN-STREIFF SYNDROME; HSS	0.014210690000000002	0.5331303809648756
SENGERS SYNDROME	0.01418488	0.5321620891273433
TIBIAL HEMIMELIA	0.014175650000000001	0.531815815060686
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.014161960000000001	0.5313022189639863
BARAITSER-WINTER SYNDROME 2; BRWS2	0.014107069000000002	0.5292429199615071
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.014001104	0.5252675211019905
VICI SYNDROME; VICIS	0.013985943	0.524698738748297
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.013960184000000002	0.5237323602344265
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.013863020000000002	0.5200871410131169
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.013845333	0.519423592863933
CODAS SYNDROME	0.013807223	0.5179938523785258
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.013798574000000003	0.5176693751951544
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.013794439000000002	0.517514245913938
PELVISCAPULAR DYSPLASIA	0.01371255	0.5144420858874486
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.013698599999999998	0.513918735591688
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.513918735591688
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.513918735591688
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.513918735591688
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.513918735591688
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.513918735591688
COG1-CDG	0.013698599999999998	0.513918735591688
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.013698599999999998	0.513918735591688
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.513918735591688
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.513918735591688
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.013565650000000002	0.5089309634181145
MOSAIC TRISOMY 8	0.013519380000000001	0.5071950911468002
SECKEL SYNDROME 1; SCKL1	0.013492949	0.5062035017799725
DESMOSTEROLOSIS	0.01345555	0.5048004352773815
ROTHMUND-THOMSON SYNDROME	0.013424644000000001	0.5036409611382581
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.013399920000000001	0.5027134118398795
GAUCHER DISEASE TYPE 2	0.01335762	0.5011264786849929
MARDEN-WALKER SYNDROME	0.013303914000000002	0.4991116363205406
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.013244674	0.4968891795806948
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.013135173000000002	0.4927811236139518
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.013135173000000002	0.4927811236139518
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.013135173000000002	0.4927811236139518
WEBB-DATTANI SYNDROME; WEDAS	0.013135173000000002	0.4927811236139518
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.013135173000000002	0.4927811236139518
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.013135173000000002	0.4927811236139518
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.013135173000000002	0.4927811236139518
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.013135173000000002	0.4927811236139518
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.013135173000000002	0.4927811236139518
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.013135173000000002	0.4927811236139518
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.013135173000000002	0.4927811236139518
LISSENCEPHALY 1; LIS1	0.013135173000000002	0.4927811236139518
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.013135173000000002	0.4927811236139518
8Q24.3 MICRODELETION SYNDROME	0.013135173000000002	0.4927811236139518
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.013135173000000002	0.4927811236139518
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.013135173000000002	0.4927811236139518
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.012951530000000001	0.4858915452365801
ATYPICAL WERNER SYNDROME	0.01285862	0.4824059197183647
SCALP-EAR-NIPPLE SYNDROME; SENS	0.01285862	0.4824059197183647
GAUCHER DISEASE TYPE 3	0.01280536	0.4804078095569167
FUMARASE DEFICIENCY; FMRD	0.012796284	0.48006731297739536
RING CHROMOSOME 14 SYNDROME	0.012796284	0.48006731297739536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012796284	0.48006731297739536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.012796284	0.48006731297739536
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.012796284	0.48006731297739536
BETA-UREIDOPROPIONASE DEFICIENCY	0.012796284	0.48006731297739536
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.012758360000000002	0.4786445504959317
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 62	0.012658200000000001	0.47488693288852196
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.012658200000000001	0.47488693288852196
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.012658200000000001	0.47488693288852196
FINNISH UPPER LIMB-ONSET DISTAL MYOPATHY	0.012658200000000001	0.47488693288852196
OTOONYCHOPERONEAL SYNDROME	0.012658200000000001	0.47488693288852196
CONGENITAL PATELLA DISLOCATION	0.012658200000000001	0.47488693288852196
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.012658200000000001	0.47488693288852196
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.012658200000000001	0.47488693288852196
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.012658200000000001	0.47488693288852196
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.012658200000000001	0.47488693288852196
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.012658200000000001	0.47488693288852196
MYOPATHY, DISTAL 3	0.012658200000000001	0.47488693288852196
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.012658200000000001	0.47488693288852196
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.012606423	0.47294445917787037
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.012593754000000002	0.4724691670705594
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.012589619000000002	0.4723140377893429
MENTAL RETARDATION, X-LINKED 1	0.012589619000000002	0.4723140377893429
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.012589619000000002	0.4723140377893429
RETT SYNDROME; RTT	0.012589619000000002	0.4723140377893429
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.012589619000000002	0.4723140377893429
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.012589619000000002	0.4723140377893429
HYPERPROLINEMIA, TYPE I	0.012581272999999999	0.4720009279994922
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.012410923	0.46561005180717735
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.01225073	0.4596002271527865
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01225073	0.4596002271527865
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.0121951	0.4575132037152844
RUIJS-AALFS SYNDROME; RJALS	0.0121951	0.4575132037152844
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.0121951	0.4575132037152844
RARE CIRCULATORY SYSTEM DISEASE	0.0121951	0.4575132037152844
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0121951	0.4575132037152844
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.012048200000000002	0.4520020812459505
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.012048200000000002	0.4520020812459505
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012039854	0.45168897145609965
PERLMAN SYNDROME	0.012039854	0.45168897145609965
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.45168897145609965
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.45168897145609965
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.012001930000000001	0.4502662089746361
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.012001930000000001	0.4502662089746361
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.012001930000000001	0.4502662089746361
CROME SYNDROME	0.011936629	0.4478163668482236
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.011786774	0.44219438415494894
19P13.12 MICRODELETION SYNDROME	0.011746223000000002	0.4406730667468213
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.011708533000000002	0.4392590830445122
DUANE RETRACTION SYNDROME	0.011694843000000002	0.43874548694781257
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.011529813	0.4325541966747411
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.011494299999999999	0.4312218856314908
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.4312218856314908
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.4312218856314908
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.011492829	0.431166699374497
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.011395210000000001	0.42750441030483116
HALLERMANN-STREIFF SYNDROME	0.011395210000000001	0.42750441030483116
BIOTINIDASE DEFICIENCY	0.011322264	0.4247677572098819
KRABBE DISEASE	0.011308574	0.4242541611131822
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.011304439	0.4240990318319658
METATROPIC DYSPLASIA	0.0112926	0.4236548781293487
NEMALINE MYOPATHY 2; NEM2	0.0112926	0.4236548781293487
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.011277363	0.42308324454823754
ADAMS-OLIVER SYNDROME 2; AOS2	0.011277363	0.42308324454823754
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.01124122	0.42172729833034
CATARACT 15, MULTIPLE TYPES; CTRCT15	0.011216489999999999	0.42079952393506
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.011184334	0.4195931546081444
KNOBLOCH SYNDROME 1; KNO1	0.011180199	0.419438025326928
1P36 DELETION SYNDROME	0.011142203000000002	0.41801256168264744
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.011012464	0.41314525386747425
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.011009634	0.4130390831623129
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.010989793000000001	0.41229472522552557
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.010974704	0.41172864403464887
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.010938413000000001	0.41036714542651687
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.01093772	0.41034114673440486
FABRY DISEASE	0.010798469	0.40511698529820855
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.01077671	0.40430067138527304
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.01076302	0.40378707528857327
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.010735944	0.402771288004845
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.010735944	0.402771288004845
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.010731809	0.4026161587236286
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.01063878	0.39912606878353546
PEROXISOME BIOGENESIS DISORDER 14B	0.01063878	0.39912606878353546
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.01063878	0.39912606878353546
CATARACT 17, MULTIPLE TYPES	0.01063878	0.39912606878353546
NANCE-HORAN SYNDROME	0.01063878	0.39912606878353546
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.01063878	0.39912606878353546
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.01063878	0.39912606878353546
MICROPHTHALMIA, LENZ TYPE	0.010610339000000002	0.39805907195473816
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.010561244000000001	0.39621721655901354
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.010561244000000001	0.39621721655901354
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.010561244000000001	0.39621721655901354
RFT1-CDG	0.010555093000000002	0.39598645471892585
PHACE ASSOCIATION	0.010520933	0.39470490302694183
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.010520933	0.39470490302694183
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.010503713000000001	0.39405887491991715
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.010444239000000001	0.39182763940091664
CONGENITAL MYASTHENIC SYNDROME	0.010444239000000001	0.39182763940091664
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.010392859	0.38990005960190793
HURLER SYNDROME	0.010295354	0.38624204737336865
ALPORT SYNDROME	0.01025705	0.3848050287548161
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.01019039	0.38230420218023614
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.01019039	0.38230420218023614
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.01019039	0.38230420218023614
WARBURG MICRO SYNDROME 1	0.01019039	0.38230420218023614
1Q21.1 MICRODUPLICATION SYNDROME	0.010063743	0.37755289430158573
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01001569	0.3757501307344046
PAINE SYNDROME	0.01001569	0.3757501307344046
XQ12-Q13.3 DUPLICATION SYNDROME	0.01001569	0.3757501307344046
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01001569	0.3757501307344046
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.010012363	0.3756253145025769
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.009979514	0.37439294648354937
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.009975379	0.3742378172023329
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.009975379	0.3742378172023329
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.009861683999999999	0.3699724185015097
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.009804814	0.36783887503771784
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.36783887503771784
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.36783887503771784
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.36783887503771784
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.36783887503771784
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009804814	0.36783887503771784
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.36783887503771784
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.36783887503771784
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.36768374575650137
NEU-LAXOVA SYNDROME	0.009733200000000001	0.3651521934548799
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.009696909000000002	0.3637906948467479
HENNEKAM-BEEMER SYNDROME	0.009651639	0.3620923387256672
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.009586024	0.35963071652808143
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00958121	0.3594501137808563
COHEN-GIBSON SYNDROME; COGIS	0.009470944	0.3553133579591845
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.009466809	0.355158228677968
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.00943396	0.35392586065894044
%614422 CATARACT, CONGENITAL, CERULEAN TYPE, 5; CCA5	0.00943396	0.35392586065894044
CATARACT 45	0.00943396	0.35392586065894044
CATARACT, POSTERIOR POLAR, 1 CTPA CATARACT, CONGENITAL TOTAL, INCLUDED	0.00943396	0.35392586065894044
FECHTNER SYNDROME	0.00943396	0.35392586065894044
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.00943396	0.35392586065894044
CONGENITAL FIBRINOGEN DEFICIENCY	0.00943396	0.35392586065894044
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00943396	0.35392586065894044
CATARACT 13 WITH ADULT I PHENOTYPE	0.00943396	0.35392586065894044
HYDROCEPHALUS, ENDOCARDIAL FIBROELASTOSIS, AND CATARACTS	0.00943396	0.35392586065894044
49,XYYYY SYNDROME	0.00943396	0.35392586065894044
SUPERNUMERARY NOSTRIL	0.00943396	0.35392586065894044
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00943396	0.35392586065894044
CATARACT 44; CTRCT44	0.00943396	0.35392586065894044
RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT	0.00943396	0.35392586065894044
CATARACT, CONGENITAL OR JUVENILECATARACT, JUVENILE, HUTTERITE TYPE, INCLUDED	0.00943396	0.35392586065894044
INSULINOMATOSIS AND DIABETES MELLITUS; INSDM	0.00943396	0.35392586065894044
CATARACT, NUCLEAR TOTAL	0.00943396	0.35392586065894044
CATARACT 22, MULTIPLE TYPES; CTRCT22	0.00943396	0.35392586065894044
MUSCULAR HYPERTROPHY-HEPATOMEGALY-POLYHYDRAMNIOS SYNDROME	0.00943396	0.35392586065894044
CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES 1	0.00943396	0.35392586065894044
CATARACT, CRYSTALLINE ACULEIFORM	0.00943396	0.35392586065894044
%115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	0.00943396	0.35392586065894044
HEC SYNDROME	0.00943396	0.35392586065894044
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00943396	0.35392586065894044
CATARACT 7; CTRCT7	0.00943396	0.35392586065894044
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 25	0.00943396	0.35392586065894044
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00943396	0.35392586065894044
CATARACT 3, MULTIPLE TYPES; CTRCT3	0.00943396	0.35392586065894044
EDICT SYNDROME	0.00943396	0.35392586065894044
PUPILLARY MEMBRANE, PERSISTENCE OF	0.00943396	0.35392586065894044
CATARACT 1, MULTIPLE TYPES	0.00943396	0.35392586065894044
15Q24 MICRODELETION SYNDROME	0.009373363000000001	0.3516524945032275
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.3473717892131089
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.3473717892131089
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3473717892131089
GLYCINE ENCEPHALOPATHY	0.00925926	0.3473717892131089
HYDROXYLYSINURIA	0.00925926	0.3473717892131089
CARNOSINASE DEFICIENCY	0.00925926	0.3473717892131089
CARNOSINEMIA	0.00925926	0.3473717892131089
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3473717892131089
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3473717892131089
COCKAYNE SYNDROME A; CSA	0.009213619000000001	0.3456595146002916
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.009205864000000001	0.34536857685522904
20Q11.2 MICRODELETION SYNDROME	0.009205864000000001	0.34536857685522904
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.009205864000000001	0.34536857685522904
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.009124183000000001	0.34230422018798823
BUSCHKE-OLLENDORFF SYNDROME	0.00904047	0.3391636307034725
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.009037643	0.3390575725467617
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.009037643	0.3390575725467617
WILLIAMS-BEUREN SYNDROME; WBS	0.00902678	0.3386500346067728
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.0090035	0.3377766586293317
GLASS SYNDROME	0.008986263000000001	0.33712999274775307
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.008986263000000001	0.33712999274775307
BOHRING-OPITZ SYNDROME	0.008986263000000001	0.33712999274775307
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.008929113	0.33498594476189575
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.008929113	0.33498594476189575
CUSHING SYNDROME	0.00875329	0.3283897426793517
CUSHING DISEASE	0.00875329	0.3283897426793517
MOEBIUS SYNDROME	0.008711690000000001	0.32682907082962886
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.008711690000000001	0.32682907082962886
TRISOMY 17P	0.008700324	0.3264026622660723
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.008696189	0.32624753298485587
16P13.2 MICRODELETION SYNDROME	0.008664033000000002	0.3250411636579403
13Q12.3 MICRODELETION SYNDROME	0.008660310000000001	0.3249014910306201
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.008660310000000001	0.3249014910306201
OTOPALATODIGITAL SYNDROME TYPE 2	0.008653224000000001	0.3246356515900639
BRITTLE CORNEA SYNDROME	0.00864662	0.3243878949339204
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00864662	0.3243878949339204
RAINE SYNDROME	0.008496224	0.31874561600336926
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.008496224	0.31874561600336926
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.008496224	0.31874561600336926
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.008496224	0.31874561600336926
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.008496224	0.31874561600336926
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.008496224	0.31874561600336926
RETT SYNDROME	0.008492089000000001	0.3185904867221529
GAUCHER DISEASE, PERINATAL LETHAL	0.008492089000000001	0.3185904867221529
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.008492089000000001	0.3185904867221529
BARDET-BIEDL SYNDROME 1; BBS1	0.008475014	0.31794989845691196
OROFACIODIGITAL SYNDROME IX; OFD9	0.008444844	0.31681803620436055
CEREBROFACIOARTICULAR SYNDROME	0.008444844	0.31681803620436055
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.008444844	0.31681803620436055
21Q22.11Q22.12 MICRODELETION SYNDROME	0.008440709000000001	0.31666290692314414
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00840089	0.3151690513369874
1Q44 MICRODELETION SYNDROME	0.008344233999999999	0.31304353632934556
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.008344233999999999	0.31304353632934556
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.008340594	0.31290697754249486
OCULODENTODIGITAL DYSPLASIA	0.008336459000000001	0.31275184826127844
CATEL-MANZKE SYNDROME; CATMANS	0.008229833	0.30875165122645737
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.008229833	0.30875165122645737
LYNCH SYNDROME	0.008185879	0.3071026663590843
FAMILIAL COLORECTAL CANCER TYPE X	0.008185879	0.3071026663590843
BOHRING-OPITZ SYNDROME	0.008168543	0.3064522863786325
6Q25 MICRODELETION SYNDROME	0.008154853	0.30593869028193277
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.008154853	0.30593869028193277
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00814108	0.3054219803447637
XERODERMA PIGMENTOSUM	0.008130239000000001	0.3050152677600799
8Q21.11 MICRODELETION SYNDROME	0.00810767	0.30416856576545503
ADDUCTED THUMBS SYNDROME	0.00795067	0.2982785301787604
MECKEL SYNDROME 12; MKS12	0.00795067	0.2982785301787604
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.00795067	0.2982785301787604
VON HIPPEL-LINDAU DISEASE	0.007915769999999999	0.2969692165356033
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00789929	0.2963509503797516
GERODERMA OSTEODYSPLASTICUM; GO	0.00789929	0.2963509503797516
TEEBI-SHALTOUT SYNDROME; TBSH	0.00789929	0.2963509503797516
MEIER-GORLIN SYNDROME 2; MGORS2	0.00789929	0.2963509503797516
TRISOMY 18	0.007892204	0.2960851109391955
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00784214	0.29420690239389424
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00779868	0.2925764505047367
AMISH LETHAL MICROCEPHALY	0.00779868	0.2925764505047367
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.007739794	0.2903672744820736
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.007739794	0.2903672744820736
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.007739794	0.2903672744820736
NOONAN SYNDROME 2; NS2	0.007739794	0.2903672744820736
FETAL GAUCHER DISEASE	0.007735659000000001	0.2902121452008572
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.007724293	0.2897857366373007
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.007688414	0.2884396946830649
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.007688414	0.2884396946830649
RAHMAN SYNDROME	0.007688414	0.2884396946830649
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.007688414	0.2884396946830649
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.007688414	0.2884396946830649
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.007688414	0.2884396946830649
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.007688414	0.2884396946830649
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.007688414	0.2884396946830649
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.0076771930000000006	0.2880187259612923
EAR-PATELLA-SHORT STATURE SYNDROME	0.007627124	0.28614032983523996
2P15P16.1 MICRODELETION SYNDROME	0.007627124	0.28614032983523996
COG5-CDG	0.007609298999999999	0.28547160445732384
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.28466519480804997
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.28466519480804997
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.28466519480804997
OROFACIODIGITAL SYNDROME TYPE 2	0.007587804	0.28466519480804997
X SMALL RINGS	0.007587804	0.28466519480804997
PELGER-HUET ANOMALY; PHA	0.007587804	0.28466519480804997
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.28466519480804997
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.007587804	0.28466519480804997
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2845100655268335
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2845100655268335
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00752302	0.28223474853130837
ARTERIAL TORTUOSITY SYNDROME	0.00752302	0.28223474853130837
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00752302	0.28223474853130837
ARTERIAL TORTUOSITY SYNDROME	0.007516314	0.281983165227841
TSH-SECRETING PITUITARY ADENOMA	0.007512179	0.2818280359466246
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.007459213	0.2798409555333452
RECOMBINANT 8 SYNDROME	0.007412113	0.2780739448573368
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00739834	0.2775572349201677
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00739834	0.2775572349201677
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0073874990000000005	0.27715052233548393
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.007362049	0.27619573631203564
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.007362049	0.27619573631203564
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.007341653	0.27543055691186863
MOWAT-WILSON SYNDROME	0.007310358999999999	0.27425652650645443
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.007310358999999999	0.27425652650645443
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.007310358999999999	0.27425652650645443
CONGENITAL HYPOTHYROIDISM	0.007270194000000001	0.272749690332317
NEUROFIBROMATOSIS TYPE 1	0.007266059	0.2725945610511005
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00719424	0.2699001886574647
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00719424	0.2699001886574647
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.00719424	0.2699001886574647
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00719424	0.2699001886574647
NAKAJO-NISHIMURA SYNDROME	0.00719424	0.2699001886574647
INIENCEPHALY	0.00719424	0.2699001886574647
NEMALINE MYOPATHY 10	0.00719424	0.2699001886574647
GERMAN SYNDROME	0.00719424	0.2699001886574647
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00719424	0.2699001886574647
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00719424	0.2699001886574647
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00719424	0.2699001886574647
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00719424	0.2699001886574647
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00719424	0.2699001886574647
TYPICAL NEMALINE MYOPATHY	0.00719424	0.2699001886574647
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00719424	0.2699001886574647
INTERMEDIATE NEMALINE MYOPATHY	0.00719424	0.2699001886574647
LETHAL CONGENITAL CONTRACTURE SYNDROME 2	0.00719424	0.2699001886574647
POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA	0.00719424	0.2699001886574647
SPONDYLOSPINAL THORACIC DYSOSTOSIS	0.00719424	0.2699001886574647
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.00719424	0.2699001886574647
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.00719424	0.2699001886574647
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.00719424	0.2699001886574647
CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	0.00719424	0.2699001886574647
NEMALINE MYOPATHY 3; NEM3	0.00719424	0.2699001886574647
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00719424	0.2699001886574647
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00719424	0.2699001886574647
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00719424	0.2699001886574647
MULTIMINICORE MYOPATHY	0.00719424	0.2699001886574647
PELVIC DYSPLASIA - ARTHROGRYPOSIS OF LOWER LIMBS	0.00719424	0.2699001886574647
ARTHROGRYPOSIS - HYPERKERATOSIS, LETHAL FORM	0.00719424	0.2699001886574647
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.00719424	0.2699001886574647
GLYCOGEN STORAGE DISEASE IV	0.00719424	0.2699001886574647
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00719424	0.2699001886574647
NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	0.00719424	0.2699001886574647
BRUCK SYNDROME	0.00719424	0.2699001886574647
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.007182874	0.2694737800939082
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.007146583	0.26811228148577615
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.007146583	0.26811228148577615
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.007146583	0.26811228148577615
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.007146583	0.26811228148577615
CAMPTOSYNPOLYDACTYLY, COMPLEX	0.00714286	0.267972608858456
PSEUDODIASTROPHIC DYSPLASIA	0.00714286	0.267972608858456
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00714286	0.267972608858456
WAHAB SYNDROME	0.00714286	0.267972608858456
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00714286	0.267972608858456
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00714286	0.267972608858456
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00714286	0.267972608858456
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00714286	0.267972608858456
SILLENCE SYNDROME	0.00714286	0.267972608858456
MEESTER-LOEYS SYNDROME; MRLS	0.00714286	0.267972608858456
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.00714286	0.267972608858456
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00714286	0.267972608858456
2Q24 MICRODELETION SYNDROME	0.007131639	0.26755164013668337
WAARDENBURG SYNDROME TYPE 3	0.00708157	0.265673244010631
CHOREOACANTHOCYTOSIS	0.007074869	0.2654218482879149
CRANIOFRONTONASAL DYSPLASIA	0.0070678799999999995	0.2651596479139313
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00704225	0.26419810898344104
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26419810898344104
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.26419810898344104
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26419810898344104
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26419810898344104
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26419810898344104
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26419810898344104
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26419810898344104
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26419810898344104
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.26419810898344104
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.26419810898344104
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26419810898344104
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26419810898344104
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.26419810898344104
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26419810898344104
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.0069707599999999995	0.26151607940323207
LIDDLE SYNDROME	0.0069707599999999995	0.26151607940323207
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.0069707599999999995	0.26151607940323207
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.0069707599999999995	0.26151607940323207
SOMATOMAMMOTROPINOMA	0.0069707599999999995	0.26151607940323207
POLYCYTHEMIA VERA	0.0069707599999999995	0.26151607940323207
ACTH-INDEPENDENT CUSHING SYNDROME	0.0069707599999999995	0.26151607940323207
PITUITARY APOPLEXY	0.0069707599999999995	0.26151607940323207
POSTORGASMIC ILLNESS SYNDROME	0.0069707599999999995	0.26151607940323207
HEMORRHAGIC FEVER-RENAL SYNDROME	0.0069707599999999995	0.26151607940323207
AL AMYLOIDOSIS	0.0069707599999999995	0.26151607940323207
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.0069707599999999995	0.26151607940323207
PERIPARTUM CARDIOMYOPATHY	0.0069707599999999995	0.26151607940323207
ACROMEGALY	0.0069707599999999995	0.26151607940323207
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.0069707599999999995	0.26151607940323207
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.0069707599999999995	0.26151607940323207
CLASSICAL EHLERS-DANLOS SYNDROME	0.0069707599999999995	0.26151607940323207
CARNEY TRIAD	0.0069707599999999995	0.26151607940323207
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.0069707599999999995	0.26151607940323207
ACTH-DEPENDENT CUSHING SYNDROME	0.0069707599999999995	0.26151607940323207
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.006913659	0.25937386970873627
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.006870694	0.2577619883139443
16P11.2P12.2 MICRODELETION SYNDROME	0.006870694	0.2577619883139443
ABLEPHARON MACROSTOMIA SYNDROME	0.006870694	0.2577619883139443
HYPERTRYPTOPHANEMIA; HYPTRP	0.006857004	0.25724839221724466
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.006796099	0.2549634710872597
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.0067246400000000005	0.25228260450770806
NAIL-PATELLA SYNDROME	0.0067246400000000005	0.25228260450770806
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00671095	0.25176900841100835
SIALIDOSIS TYPE 2	0.006702783	0.25146261401204956
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.006702783	0.25146261401204956
CANAVAN DISEASE	0.006702783	0.25146261401204956
PETTIGREW SYNDROME	0.006689093	0.25094901791534985
MACDERMOT-WINTER SYNDROME	0.006651093	0.24952340420646835
2Q31.1 MICRODELETION SYNDROME	0.006651092999999999	0.24952340420646832
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.006651092999999999	0.24952340420646832
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.006651092999999999	0.24952340420646832
GALLOWAY-MOWAT SYNDROME	0.006651092999999999	0.24952340420646832
HEART AND BRAIN MALFORMATION SYNDROME	0.006651092999999999	0.24952340420646832
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.006651092999999999	0.24952340420646832
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.006651092999999999	0.24952340420646832
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0066373199999999995	0.24900669426929928
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.006605163999999999	0.2478003249423836
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.006605163999999999	0.2478003249423836
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.006601029	0.2476451956611672
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00659022	0.24723968359329088
METATROPIC DYSPLASIA	0.00659022	0.24723968359329088
FRONTORHINY	0.00659022	0.24723968359329088
GM1 GANGLIOSIDOSIS	0.006553928999999999	0.24587818498515876
HERMANSKY-PUDLAK SYNDROME	0.00653345	0.24510989174452236
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.006422308999999999	0.2409403092913961
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.006415603000000001	0.24068872598792876
ISOLATED ECTOPIA LENTIS	0.006412009999999999	0.24055393046013895
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.006390152999999999	0.23973393996448042
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.006390152999999999	0.23973393996448042
COFFIN-SIRIS SYNDROME	0.006348203	0.2381601374621758
PETERS-PLUS SYNDROME; PTRPLS	0.006348202999999999	0.23816013746217574
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.006334513	0.23764654136547608
SMITH-LEMLI-OPITZ SYNDROME	0.006334512999999999	0.23764654136547606
CAMPTODACTYLY-TALL STATURE-SCOLIOSIS-HEARING LOSS SYNDROME	0.00632514	0.23729490248933538
FREEMAN-SHELDON SYNDROME	0.00632514	0.23729490248933538
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00632514	0.23729490248933538
DIASTROPHIC DWARFISM	0.00632514	0.23729490248933538
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00632514	0.23729490248933538
FOCAL DERMAL HYPOPLASIA	0.00632514	0.23729490248933538
GORDON SYNDROME	0.00632514	0.23729490248933538
HEREDITARY ACROKERATOTIC POIKILODERMA	0.00632514	0.23729490248933538
FRONTOMETAPHYSEAL DYSPLASIA	0.00631145	0.23678130639263573
PROXIMAL SYMPHALANGISM	0.00631145	0.23678130639263573
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.00631145	0.23678130639263573
15Q26 OVERGROWTH SYNDROME	0.00631145	0.23678130639263573
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.00631145	0.23678130639263573
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.006294163	0.23613276470354533
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.006244094	0.23425436857749302
OROFACIODIGITAL SYNDROME I; OFD1	0.006239959	0.23409923929627657
HURLER SYNDROME	0.006161364	0.23115065746865704
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.006161364	0.23115065746865704
MUCOPOLYSACCHARIDOSIS, TYPE II	0.006157229	0.2309955281874406
BARDET-BIEDL SYNDROME	0.00614693	0.23060914935618348
MOSAIC TRISOMY 9	0.006109674	0.22921144766307588
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.006109674	0.22921144766307588
8Q22.1 MICRODELETION SYNDROME	0.006109674	0.22921144766307588
PENTASOMY X	0.006109674	0.22921144766307588
BOWEN-CONRADI SYNDROME	0.006105539	0.22905631838185941
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.006105538999999999	0.2290563183818594
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.006105538999999999	0.2290563183818594
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.006105538999999999	0.2290563183818594
DISTAL TRISOMY 15Q	0.006105538999999999	0.2290563183818594
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.005941763	0.22291207336118107
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.005941763	0.22291207336118107
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.005941763	0.22291207336118107
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.005941763	0.22291207336118107
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.005941763	0.22291207336118107
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.005941762999999999	0.22291207336118105
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.005941762999999999	0.22291207336118105
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.005941762999999999	0.22291207336118105
MOSAIC TRISOMY 14	0.005894663	0.2211450626851727
SIMPSON-GOLABI-BEHMEL SYNDROME	0.005894663	0.2211450626851727
MARFAN SYNDROME; MFS	0.00588089	0.2206283527480036
MALIGNANT ATROPHIC PAPULOSIS	0.0058700490000000004	0.22022164016331983
BEHÃ‡ET DISEASE	0.0058700490000000004	0.22022164016331983
CRONKHITE-CANADA SYNDROME	0.0058700490000000004	0.22022164016331983
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.0058487339999999995	0.21942198342108798
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0058487339999999995	0.21942198342108798
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.0058487339999999995	0.21942198342108798
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.0058487339999999995	0.21942198342108798
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.005844599	0.21926685413987154
TETRASOMY 9P	0.005837893	0.21901527083640424
FANCONI ANEMIA	0.005806784	0.2178481809187833
DUBOWITZ SYNDROME	0.005802649	0.21769305163756686
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.005802648999999999	0.2176930516375668
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.0057930939999999995	0.21733458482208362
CONGENITAL RUBELLA SYNDROME	0.005788959	0.21717945554086715
NORRIE DISEASE	0.005788959	0.21717945554086715
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.005788959	0.21717945554086715
CORNELIA DE LANGE SYNDROME	0.005788958999999999	0.21717945554086712
SENIOR-LOKEN SYNDROME	0.005752744000000001	0.2158208081601529
CLASSIC HOMOCYSTINURIA	0.005748609	0.2156656788789364
POTOCKI-SHAFFER SYNDROME	0.005716453	0.21445930955202078
COACH SYNDROME	0.005716453	0.21445930955202078
XFE PROGEROID SYNDROME; XFEPS	0.005698539999999999	0.21378728275288408
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00561581	0.2106835716440481
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.00561581	0.2106835716440481
LASSA FEVER	0.005604969	0.2102768590593643
VIRAL HEMORRHAGIC FEVER	0.005604969	0.2102768590593643
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.0056021199999999995	0.21016997554734845
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.0056021199999999995	0.21016997554734845
CINCA SYNDROME	0.005595414	0.20991839224388112
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.005591773	0.20978179594088012
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.005591773	0.20978179594088012
LEBER CONGENITAL AMAUROSIS	0.0055917729999999995	0.20978179594088012
INFANTILE REFSUM DISEASE	0.005578083	0.20926819984418044
VICI SYNDROME	0.005578083	0.20926819984418044
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00556412	0.20874436183846695
FAMILIAL VISCERAL MYOPATHY	0.00556412	0.20874436183846695
TRISOMY 4P	0.00556412	0.20874436183846695
2P15-16.1 MICRODELETION SYNDROME	0.00556412	0.20874436183846695
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00556412	0.20874436183846695
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00556412	0.20874436183846695
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00556412	0.20874436183846695
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00556412	0.20874436183846695
SHPRINTZEN-GOLDBERG SYNDROME	0.00556412	0.20874436183846695
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00556412	0.20874436183846695
KEUTEL SYNDROME; KTLS	0.005483529	0.2057208977749809
OROFACIODIGITAL SYNDROME TYPE 1	0.005483529	0.2057208977749809
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.005469839000000001	0.20520730167828127
CADASIL	0.005469839	0.20520730167828122
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.005400344	0.2026001168177886
AICARDI-GOUTIERES SYNDROME 5	0.005400344	0.2026001168177886
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.005396209	0.20244498753657214
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.005396209	0.20244498753657214
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.005396208999999999	0.2024449875365721
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.005389503	0.20219340423310483
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.0053895029999999995	0.20219340423310478
WEAVER SYNDROME	0.005353244	0.2008331061417802
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.005353244	0.2008331061417802
FLOATING-HARBOR SYNDROME	0.005353244	0.2008331061417802
DISTAL TRISOMY 18Q	0.005353244	0.2008331061417802
AARSKOG-SCOTT SYNDROME	0.005353244	0.2008331061417802
TRISOMY 8Q	0.005353244	0.2008331061417802
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.0053491089999999995	0.20067797686056377
INTELLECTUAL DISABILITY, WOLFF TYPE	0.0053491089999999995	0.20067797686056377
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.0053491089999999995	0.20067797686056377
CRISPONI SYNDROME	0.0053491089999999995	0.20067797686056377
ACROCARDIOFACIAL SYNDROME	0.0053491089999999995	0.20067797686056377
HENNEKAM SYNDROME	0.0053491089999999995	0.20067797686056377
HEMOCHROMATOSIS, TYPE 4; HFE4	0.00532863	0.19990968361992736
GENETIC HYPERFERRITINEMIA WITHOUT IRON OVERLOAD	0.00532863	0.19990968361992736
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.005303179999999999	0.19895489759647905
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.005303179999999999	0.19895489759647905
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.005303179999999999	0.19895489759647905
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.005303179999999999	0.19895489759647905
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.005303179999999999	0.19895489759647905
ADAMS-OLIVER SYNDROME 1; AOS1	0.005268063	0.1976374429487214
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.005247539999999999	0.1968674989974747
SCALP-EAR-NIPPLE SYNDROME	0.00520719	0.19535372233554396
CARDIOMYOPATHY-CATARACT-HIP SPINE DISEASE SYNDROME	0.00520719	0.19535372233554396
WERNER SYNDROME	0.00520719	0.19535372233554396
ZTTK SYNDROME; ZTTKS	0.005185333	0.19453373183988545
KAGAMI-OGATA SYNDROME	0.005185333	0.19453373183988545
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.005185333	0.19453373183988545
PRADER-WILLI-LIKE SYNDROME	0.005185333	0.19453373183988545
JOUBERT SYNDROME 14	0.005175034	0.19414735300862832
ALSTROM SYNDROME; ALMS	0.005175034	0.19414735300862832
ALEXANDER DISEASE	0.005170899	0.19399222372741184
LATHOSTEROLOSIS	0.0051433830000000005	0.19295992933758074
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.0051433830000000005	0.19295992933758074
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.0051433830000000005	0.19295992933758074
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.005143383	0.19295992933758072
1Q21.1 MICRODELETION SYNDROME	0.005129693	0.19244633324088106
MULTIPLE SULFATASE DEFICIENCY	0.005129693	0.19244633324088106
WALDENSTRÃ–M MACROGLOBULINEMIA	0.00506355	0.18996490251597184
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.00506355	0.18996490251597184
ARACHNOIDITIS	0.00506355	0.18996490251597184
PLAGUE	0.00506355	0.18996490251597184
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00504986	0.18945130641927216
FAMILIAL COLD URTICARIA	0.00504986	0.18945130641927216
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00504986	0.18945130641927216
X-LINKED AGAMMAGLOBULINEMIA	0.00504986	0.18945130641927216
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.005046219	0.1893147101162712
CODAS SYNDROME	0.005036664	0.18895624330078795
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.005036664	0.18895624330078795
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.005032529	0.1888011140195715
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.005032529	0.1888011140195715
NEURAMINIDASE DEFICIENCY	0.005032529	0.1888011140195715
SIALIDOSIS TYPE 1	0.005032529	0.1888011140195715
NEONATAL ADRENOLEUKODYSTROPHY	0.005032529	0.1888011140195715
TURNER SYNDROME	0.0049421099999999996	0.18540894123158844
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.0049421099999999996	0.18540894123158844
JUVENILE PAGET DISEASE	0.0049421099999999996	0.18540894123158844
MARSHALL-SMITH SYNDROME; MRSHSS	0.0049421099999999996	0.18540894123158844
MONOSOMY X	0.0049421099999999996	0.18540894123158844
MOSAIC MONOSOMY X	0.0049421099999999996	0.18540894123158844
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00492842	0.18489534513488878
APERT SYNDROME	0.00492842	0.18489534513488878
STIFF SKIN SYNDROME	0.00492842	0.18489534513488878
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00492842	0.18489534513488878
JACOBSEN SYNDROME	0.0048547899999999995	0.18213303099317968
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.0048547899999999995	0.18213303099317968
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.0048547899999999995	0.18213303099317968
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.0048547899999999995	0.18213303099317968
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.0048547899999999995	0.18213303099317968
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.0048547899999999995	0.18213303099317968
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.0048547899999999995	0.18213303099317968
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.0048547899999999995	0.18213303099317968
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.0048547899999999995	0.18213303099317968
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.0048547899999999995	0.18213303099317968
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.004843949	0.1817263184084959
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.004843948999999999	0.18172631840849585
MENKES DISEASE	0.004843948999999999	0.18172631840849585
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.004830753	0.18123125529001166
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.004830753	0.18123125529001166
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.004830753	0.18123125529001166
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.004830753	0.18123125529001166
MESOMELIC LIMB SHORTENING AND BOWING	0.00480769	0.1803660203171713
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00480769	0.1803660203171713
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00480769	0.1803660203171713
LOEYS-DIETZ SYNDROME	0.00480769	0.1803660203171713
ABSENCE OF FINGERPRINTS-CONGENITAL MILIA SYNDROME	0.00480769	0.1803660203171713
SYNDACTYLY TYPE 5	0.00480769	0.1803660203171713
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.00480769	0.1803660203171713
SPONDYLOCAMPTODACTYLY SYNDROME	0.00480769	0.1803660203171713
ENG-STROM SYNDROME	0.00480769	0.1803660203171713
ANTLEY-BIXLER SYNDROME	0.00480769	0.1803660203171713
PHAVER SYNDROME	0.00480769	0.1803660203171713
CAMPTOBRACHYDACTYLY	0.00480769	0.1803660203171713
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00480769	0.1803660203171713
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00480769	0.1803660203171713
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	0.00480769	0.1803660203171713
HYPOPLASTIC TIBIAE-POSTAXIAL POLYDACTYLY SYNDROME	0.00480769	0.1803660203171713
FRONTONASAL DYSPLASIA	0.00480769	0.1803660203171713
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.00480769	0.1803660203171713
MASA SYNDROME	0.00480769	0.1803660203171713
SPONDYLOCAMPTODACTYLY	0.00480769	0.1803660203171713
ECTRODACTYLY-POLYDACTYLY SYNDROME	0.00480769	0.1803660203171713
MICROPHTHALMIA-MICROTIA-FETAL AKINESIA SYNDROME	0.00480769	0.1803660203171713
PELVIS-SHOULDER DYSPLASIA	0.00480769	0.1803660203171713
ULNAR-MAMMARY SYNDROME	0.00480769	0.1803660203171713
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.00480769	0.1803660203171713
MESOMELIC DWARFISM-CLEFT PALATE-CAMPTODACTYLY SYNDROME	0.00480769	0.1803660203171713
TRISOMY 1Q	0.00480769	0.1803660203171713
TRISOMY 20P	0.00480769	0.1803660203171713
OPHTHALMOMANDIBULOMELIC DYSPLASIA	0.00480769	0.1803660203171713
MUCKLE-WELLS SYNDROME	0.00480769	0.1803660203171713
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00480769	0.1803660203171713
THORACO-ABDOMINAL ENTERIC DUPLICATION	0.00480769	0.1803660203171713
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.00480769	0.1803660203171713
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00480769	0.1803660203171713
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00480769	0.1803660203171713
CAMPTODACTYLY 1; CAMPD1	0.00480769	0.1803660203171713
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.00480769	0.1803660203171713
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00480769	0.1803660203171713
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00480769	0.1803660203171713
ALLAN-HERNDON-DUDLEY SYNDROME	0.00480769	0.1803660203171713
DIGITOTALAR DYSMORPHISM	0.00480769	0.1803660203171713
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00480769	0.1803660203171713
ACROPECTOROVERTEBRAL DYSPLASIA	0.00480769	0.1803660203171713
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.00480769	0.1803660203171713
LERI PLEONOSTEOSIS	0.00480769	0.1803660203171713
COOPER-JABS SYNDROME	0.00480769	0.1803660203171713
SUMMITT SYNDROME	0.00480769	0.1803660203171713
DISTAL SYMPHALANGISM	0.00480769	0.1803660203171713
DIGITAL EXTENSOR MUSCLE APLASIA-POLYNEUROPATHY	0.00480769	0.1803660203171713
SYNDACTYLY TYPE 4	0.00480769	0.1803660203171713
DESBUQUOIS SYNDROME	0.00480769	0.1803660203171713
KINDLER SYNDROME	0.00480769	0.1803660203171713
EXTENSOR TENDONS OF FINGER ANOMALIES	0.00480769	0.1803660203171713
CATEL-MANZKE SYNDROME	0.00480769	0.1803660203171713
SYNDACTYLY TYPE 2	0.00480769	0.1803660203171713
SYNDACTYLY TYPE 3	0.00480769	0.1803660203171713
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00480769	0.1803660203171713
DIGITOTALAR DYSMORPHISM	0.00480769	0.1803660203171713
INFANTILE SYSTEMIC HYALINOSIS	0.00480769	0.1803660203171713
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.00480769	0.1803660203171713
FRANK-TER HAAR SYNDROME	0.00480769	0.1803660203171713
RICHARDS-RUNDLE SYNDROME; RRNS	0.004771584	0.17901146219683248
GIANT CELL ARTERITIS	0.00475092	0.17823622846840279
ERDHEIM-CHESTER DISEASE	0.00475092	0.17823622846840279
PEDIATRIC-ONSET GRAVES DISEASE	0.0047266439999999995	0.1773254864053289
MONOSOMY 18P	0.0047266439999999995	0.1773254864053289
MECKEL SYNDROME 13; MKS13	0.004643914	0.17422177529649296
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.004643914	0.17422177529649296
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.004643914	0.17422177529649296
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.004643914	0.17422177529649296
DUCHENNE MUSCULAR DYSTROPHY	0.004643914	0.17422177529649296
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.004643914	0.17422177529649296
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.004639779	0.17406664601527652
GLUTAMINE DEFICIENCY, CONGENITAL	0.004639779	0.17406664601527652
HUNTINGTON DISEASE-LIKE 3	0.004639779	0.17406664601527652
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.004639779	0.17406664601527652
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.004639779	0.17406664601527652
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.004633073	0.17381506271180916
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.004633073	0.17381506271180916
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.004601964	0.17264797279418825
COFFIN-LOWRY SYNDROME	0.004584139	0.17197924741627213
RENPENNING SYNDROME	0.004584139	0.17197924741627213
WITTEVEEN-KOLK SYNDROME	0.004565673	0.1712864741860562
COFFIN-SIRIS SYNDROME 1; CSS1	0.004565673	0.1712864741860562
HSD10 DISEASE	0.004565673	0.1712864741860562
CONGENITAL TOXOPLASMOSIS	0.004565673	0.1712864741860562
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.004551983	0.1707728780893565
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.004551983	0.1707728780893565
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.004551983	0.1707728780893565
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.004551983	0.1707728780893565
COHEN SYNDROME	0.004551983	0.1707728780893565
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0045048	0.1690027535728787
CENANI-LENZ SYNDROME	0.0045048	0.1690027535728787
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.0045048	0.1690027535728787
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.0045048	0.1690027535728787
REFSUM DISEASE	0.0044911099999999995	0.168489157476179
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.0044911099999999995	0.168489157476179
RETINITIS PIGMENTOSA	0.0044911099999999995	0.168489157476179
LEBER CONGENITAL AMAUROSIS, TYPE I	0.0044911099999999995	0.168489157476179
ACRO-RENAL-OCULAR SYNDROME	0.0044911099999999995	0.168489157476179
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.0044911099999999995	0.168489157476179
LAURENCE-MOON SYNDROME	0.0044911099999999995	0.168489157476179
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.0044911099999999995	0.168489157476179
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.0044911099999999995	0.168489157476179
MARSHALL SYNDROME	0.0044911099999999995	0.168489157476179
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.0044911099999999995	0.168489157476179
SPONDYLOOCULAR SYNDROME; SOS	0.0044911099999999995	0.168489157476179
REFSUM DISEASE	0.0044911099999999995	0.168489157476179
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.0044911099999999995	0.168489157476179
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.0044911099999999995	0.168489157476179
USHER SYNDROME TYPE 2	0.0044911099999999995	0.168489157476179
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.004386953000000001	0.1645815878162851
COWDEN SYNDROME	0.004386953000000001	0.1645815878162851
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.004386953000000001	0.1645815878162851
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.004386953000000001	0.1645815878162851
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.004319059	0.16203446631231663
MEVALONIC ACIDURIA; MEVA	0.004289334	0.1609192987466192
PETERS PLUS SYNDROME	0.004289334	0.1609192987466192
MARINESCO-SJÃ–GREN SYNDROME	0.004289334	0.1609192987466192
MIETENS SYNDROME	0.004289334	0.1609192987466192
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.004285199	0.16076416946540273
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.004285199	0.16076416946540273
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.004285199	0.16076416946540273
PRIMARY CUTIS VERTICIS GYRATA	0.004285199	0.16076416946540273
SECKEL SYNDROME 10; SCKL10	0.00418109	0.15685840058072
DESANTO-SHINAWI SYNDROME	0.0041081830000000005	0.15412321061562992
MUENKE SYNDROME	0.0041081830000000005	0.15412321061562992
ORAL SUBMUCOUS FIBROSIS	0.00409836	0.15375468947188403
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00409836	0.15375468947188403
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00409836	0.15375468947188403
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00409836	0.15375468947188403
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.00409836	0.15375468947188403
CHST3-RELATED SKELETAL DYSPLASIA	0.00409836	0.15375468947188403
NEONATAL MARFAN SYNDROME	0.00409836	0.15375468947188403
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B	0.00409836	0.15375468947188403
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00409836	0.15375468947188403
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00409836	0.15375468947188403
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.00409836	0.15375468947188403
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00409836	0.15375468947188403
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.00409836	0.15375468947188403
ICHTHYOSIS HYSTRIX OF CURTH-MACKLIN	0.00409836	0.15375468947188403
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00409836	0.15375468947188403
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00409836	0.15375468947188403
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.00409836	0.15375468947188403
ADULT-ONSET NEMALINE MYOPATHY	0.00409836	0.15375468947188403
HYPERKALEMIC PERIODIC PARALYSIS	0.00409836	0.15375468947188403
268650 RUDIGER SYNDROME	0.00409836	0.15375468947188403
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00409836	0.15375468947188403
CZECH DYSPLASIA, METATARSAL TYPE	0.00409836	0.15375468947188403
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00409836	0.15375468947188403
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.00409836	0.15375468947188403
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00409836	0.15375468947188403
NEMALINE MYOPATHY 1; NEM1	0.00409836	0.15375468947188403
NEMALINE MYOPATHY 4	0.00409836	0.15375468947188403
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.00409836	0.15375468947188403
MAJEED SYNDROME	0.00409836	0.15375468947188403
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00409836	0.15375468947188403
AASE-SMITH SYNDROME I	0.00409836	0.15375468947188403
DRACUNCULIASIS	0.00409836	0.15375468947188403
BUSCHKE-OLLENDORFF SYNDROME; BOS	0.00409836	0.15375468947188403
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00409836	0.15375468947188403
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.00409836	0.15375468947188403
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.00409836	0.15375468947188403
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1	0.00409836	0.15375468947188403
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00409836	0.15375468947188403
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00409836	0.15375468947188403
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00409836	0.15375468947188403
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00409836	0.15375468947188403
SALIH MYOPATHY; SALMY	0.00409836	0.15375468947188403
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00409836	0.15375468947188403
MAJEED SYNDROME	0.00409836	0.15375468947188403
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.00409836	0.15375468947188403
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.00409836	0.15375468947188403
POTASSIUM-AGGRAVATED MYOTONIA	0.00409836	0.15375468947188403
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.00409836	0.15375468947188403
GROWTH FACTORS, COMBINED DEFECT OF	0.00409836	0.15375468947188403
BASAN SYNDROME	0.00409836	0.15375468947188403
CUTIS LAXA-MARFANOID SYNDROME	0.00409836	0.15375468947188403
TEMPLE SYNDROME	0.00409836	0.15375468947188403
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.00409836	0.15375468947188403
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00409836	0.15375468947188403
ANAUXETIC DYSPLASIA 2; ANXD2	0.00409836	0.15375468947188403
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00409836	0.15375468947188403
STIFF SKIN SYNDROME	0.00409836	0.15375468947188403
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00409836	0.15375468947188403
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.00409836	0.15375468947188403
CHRONIC GRAFT VERSUS HOST DISEASE	0.00409836	0.15375468947188403
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00409836	0.15375468947188403
RESTRICTIVE DERMOPATHY, LETHAL	0.00409836	0.15375468947188403
FAMILIAL THYROID DYSHORMONOGENESIS	0.004091654	0.1535031061684167
PERIPHERAL HYPOTHYROIDISM	0.004091654	0.1535031061684167
THYROID HYPOPLASIA	0.004091654	0.1535031061684167
THYROID HEMIAGENESIS	0.004091654	0.1535031061684167
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.004091654	0.1535031061684167
ATHYREOSIS	0.004091654	0.1535031061684167
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.004091654	0.1535031061684167
PROLACTINOMA	0.0040875189999999995	0.15334797688720023
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.0040875189999999995	0.15334797688720023
ADDISON DISEASE	0.0040875189999999995	0.15334797688720023
LYMPHANGIOLEIOMYOMATOSIS	0.0040875189999999995	0.15334797688720023
NOCARDIOSIS	0.0040875189999999995	0.15334797688720023
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.0040875189999999995	0.15334797688720023
EBOLA HEMORRHAGIC FEVER	0.0040875189999999995	0.15334797688720023
SPONTANEOUS PERIODIC HYPOTHERMIA	0.0040875189999999995	0.15334797688720023
NON-FUNCTIONING PITUITARY ADENOMA	0.0040875189999999995	0.15334797688720023
LUJO HEMORRHAGIC FEVER	0.0040875189999999995	0.15334797688720023
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.0040875189999999995	0.15334797688720023
BENIGN FAMILIAL INFANTILE EPILEPSY	0.0040875189999999995	0.15334797688720023
RIFT VALLEY FEVER	0.0040875189999999995	0.15334797688720023
MIXED CONNECTIVE TISSUE DISEASE	0.0040875189999999995	0.15334797688720023
GLIOBLASTOMA	0.0040875189999999995	0.15334797688720023
GITELMAN SYNDROME	0.0040875189999999995	0.15334797688720023
NIPAH VIRUS DISEASE	0.0040875189999999995	0.15334797688720023
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.0040875189999999995	0.15334797688720023
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.0040875189999999995	0.15334797688720023
ACUTE ADRENAL INSUFFICIENCY	0.0040875189999999995	0.15334797688720023
ADIPOSIS DOLOROSA	0.0040875189999999995	0.15334797688720023
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.0040875189999999995	0.15334797688720023
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.0040875189999999995	0.15334797688720023
ATYPICAL JUVENILE PARKINSONISM	0.0040875189999999995	0.15334797688720023
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.0040875189999999995	0.15334797688720023
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.0040875189999999995	0.15334797688720023
WHIPPLE DISEASE	0.0040875189999999995	0.15334797688720023
ACQUIRED METHEMOGLOBINEMIA	0.0040875189999999995	0.15334797688720023
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.004074323	0.15285291376871604
SRD5A3-CDG	0.004074323	0.15285291376871604
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.0040743229999999995	0.15285291376871601
YUNIS-VARON SYNDROME	0.00405641	0.15218088696957932
CRI-DU-CHAT SYNDROME	0.00405641	0.15218088696957932
19Q13.11 MICRODELETION SYNDROME	0.00405641	0.15218088696957932
ERYTHROKERATODERMIA VARIABILIS	0.00405641	0.15218088696957932
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00404272	0.15166729087287964
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00404272	0.15166729087287964
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00404272	0.15166729087287964
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.004024254	0.1509745176426637
CHARGE SYNDROME	0.004024254	0.1509745176426637
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.004024254	0.1509745176426637
PELIZAEUS-MERZBACHER DISEASE	0.004020119	0.15081938836144726
ISOLATED COMPLEX I DEFICIENCY	0.0040105639999999994	0.150460921545964
KABUKI SYNDROME	0.004006429	0.15030579226474758
CHROMOSOME 18Q DELETION SYNDROME	0.004006429	0.15030579226474758
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.003970214	0.14894714488403327
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.003970214	0.14894714488403327
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.003970214	0.14894714488403327
POPOV-CHANG SYNDROME; POPCHAS	0.003970214	0.14894714488403327
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.003970214	0.14894714488403327
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.003966079	0.14879201560281682
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.003966079	0.14879201560281682
NEUROFIBROMATOSIS, TYPE I	0.003966079	0.14879201560281682
PREECLAMPSIA/ECLAMPSIA 1	0.003966079	0.14879201560281682
SNEDDON SYNDROME	0.003966079	0.14879201560281682
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.003966079	0.14879201560281682
PRADER-WILLI SYNDROME	0.003966079	0.14879201560281682
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.003966079	0.14879201560281682
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.003966079	0.14879201560281682
SNEDDON SYNDROME	0.003966079	0.14879201560281682
MERCURY POISONING	0.003966079	0.14879201560281682
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.003966079	0.14879201560281682
FAMILIAL DYSAUTONOMIA	0.003966079	0.14879201560281682
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.003966079	0.14879201560281682
BETA-KETOTHIOLASE DEFICIENCY	0.003966079	0.14879201560281682
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.003966079	0.14879201560281682
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.0038455340000000003	0.1442696312728926
CHOPS SYNDROME; CHOPS	0.0038455340000000003	0.1442696312728926
TRANSKETOLASE DEFICIENCY	0.0038455340000000003	0.1442696312728926
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.0038455340000000003	0.1442696312728926
ALPHA-MANNOSIDOSIS	0.0038455340000000003	0.1442696312728926
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.0038455340000000003	0.1442696312728926
DYSKERATOSIS CONGENITA	0.0038455340000000003	0.1442696312728926
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.0038455340000000003	0.1442696312728926
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.003841399	0.14411450199167616
ZIMMERMANN-LABAND SYNDROME 1	0.003841399	0.14411450199167616
MUCOPOLYSACCHARIDOSIS TYPE 3	0.003841399	0.14411450199167616
LISSENCEPHALY 5; LIS5	0.003841399	0.14411450199167616
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.003831844	0.14375603517619293
USHER SYNDROME TYPE 1	0.003831844	0.14375603517619293
PAPILLORENAL SYNDROME	0.0038277090000000003	0.14360090589497648
ZIMMERMANN-LABAND SYNDROME	0.0038277090000000003	0.14360090589497648
TRISOMY 13	0.0038277090000000003	0.14360090589497648
SPINOCEREBELLAR ATAXIA TYPE 13	0.0038092430000000004	0.14290813266476055
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.0038092430000000004	0.14290813266476055
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.0038092430000000004	0.14290813266476055
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0038092430000000004	0.14290813266476055
NARP SYNDROME	0.0038092430000000004	0.14290813266476055
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.0038092430000000004	0.14290813266476055
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.0038092430000000004	0.14290813266476055
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0038092430000000004	0.14290813266476055
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.003809243	0.14290813266476052
PONTINE TEGMENTAL CAP DYSPLASIA	0.003795553	0.14239453656806086
LEIGH SYNDROME; LS	0.003795553	0.14239453656806086
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.003795553	0.14239453656806086
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.003795553	0.14239453656806086
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.003795553	0.14239453656806086
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0037955529999999997	0.14239453656806084
JABERI-ELAHI SYNDROME; JABELS	0.0036259330000000005	0.13603104716541664
KOOLEN-DE VRIES SYNDROME; KDVS	0.0036259330000000005	0.13603104716541664
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0036259330000000005	0.13603104716541664
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0036259330000000005	0.13603104716541664
MICRO SYNDROME	0.0036259330000000005	0.13603104716541664
PHACE SYNDROME	0.0036259330000000005	0.13603104716541664
WALKER-WARBURG SYNDROME	0.0036259330000000005	0.13603104716541664
LISSENCEPHALY 8; LIS8	0.0036259330000000005	0.13603104716541664
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.0036259330000000005	0.13603104716541664
CLASSIC PHENYLKETONURIA	0.0036259330000000005	0.13603104716541664
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.0036259330000000005	0.13603104716541664
KOOLEN-DE VRIES SYNDROME	0.0036259330000000005	0.13603104716541664
GALACTOSEMIA	0.0036259330000000005	0.13603104716541664
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.003625933	0.1360310471654166
MEVALONIC ACIDURIA	0.003625933	0.1360310471654166
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.003625933	0.1360310471654166
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.003625933	0.1360310471654166
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.003625933	0.1360310471654166
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.003625933	0.1360310471654166
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.0035626290000000003	0.13365612479102099
POST-TRAUMATIC PITUITARY DEFICIENCY	0.0035461	0.13303602034380776
HELLP SYNDROME	0.0035461	0.13303602034380776
PITUICYTOMA	0.0035461	0.13303602034380776
UNCLASSIFIED MYELODYSPLASTIC SYNDROME	0.0035461	0.13303602034380776
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.0035461	0.13303602034380776
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.0035461	0.13303602034380776
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.0035461	0.13303602034380776
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.0035461	0.13303602034380776
DUBIN-JOHNSON SYNDROME	0.0035461	0.13303602034380776
KAWASAKI DISEASE	0.0035461	0.13303602034380776
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.0035461	0.13303602034380776
GASTROINTESTINAL STROMAL TUMOR	0.0035461	0.13303602034380776
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.0035461	0.13303602034380776
THYMIC CARCINOMA	0.0035461	0.13303602034380776
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.0035461	0.13303602034380776
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.0035461	0.13303602034380776
WISKOTT-ALDRICH SYNDROME	0.0035461	0.13303602034380776
EISENMENGER SYNDROME	0.0035461	0.13303602034380776
RHEUMATIC FEVER	0.0035461	0.13303602034380776
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.0035461	0.13303602034380776
EOSINOPHILIC FASCIITIS	0.0035461	0.13303602034380776
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.0035461	0.13303602034380776
POSTPOLIOMYELITIS SYNDROME	0.0035461	0.13303602034380776
HODGKIN LYMPHOMA	0.0035461	0.13303602034380776
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.0035461	0.13303602034380776
MULTIPLE MYELOMA	0.0035461	0.13303602034380776
POEMS SYNDROME	0.0035461	0.13303602034380776
AUTOIMMUNE HEMOLYTIC ANEMIA	0.0035461	0.13303602034380776
AUTOSOMAL AGAMMAGLOBULINEMIA	0.0035461	0.13303602034380776
KAPOSI SARCOMA	0.0035461	0.13303602034380776
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.0035461	0.13303602034380776
REFRACTORY ANEMIA	0.0035461	0.13303602034380776
TUBERCULOSIS	0.0035461	0.13303602034380776
THYMIC EPITHELIAL NEOPLASM	0.0035461	0.13303602034380776
PRIMARY FAMILIAL POLYCYTHEMIA	0.0035461	0.13303602034380776
CYCLIC NEUTROPENIA	0.0035461	0.13303602034380776
STEVENS-JOHNSON SYNDROME	0.0035461	0.13303602034380776
HEPATOCELLULAR CARCINOMA	0.0035461	0.13303602034380776
SCHNITZLER SYNDROME	0.0035461	0.13303602034380776
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.0035461	0.13303602034380776
CLASSIC HODGKIN LYMPHOMA	0.0035461	0.13303602034380776
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.0035461	0.13303602034380776
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.0035461	0.13303602034380776
IATROGENIC BOTULISM	0.0035461	0.13303602034380776
INHALATIONAL BOTULISM	0.0035461	0.13303602034380776
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.0035461	0.13303602034380776
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.0035461	0.13303602034380776
RARE HEREDITARY HEMOCHROMATOSIS	0.0035461	0.13303602034380776
PANHYPOPITUITARISM	0.0035461	0.13303602034380776
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.0035461	0.13303602034380776
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.0035461	0.13303602034380776
CHOLANGIOCARCINOMA	0.0035461	0.13303602034380776
PYOGENIC ARTHRITIS-PYODERMA GANGRENOSUM-ACNE SYNDROME	0.0035461	0.13303602034380776
LIPOSARCOMA	0.0035461	0.13303602034380776
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.0035461	0.13303602034380776
PONTIAC FEVER	0.0035461	0.13303602034380776
PARATHYROID CARCINOMA	0.0035461	0.13303602034380776
MAST CELL SARCOMA	0.0035461	0.13303602034380776
CUTANEOUS MASTOCYTOSIS	0.0035461	0.13303602034380776
TYPHOID	0.0035461	0.13303602034380776
FUNCTIONING GONADOTROPIC ADENOMA	0.0035461	0.13303602034380776
CASTLEMAN DISEASE	0.0035461	0.13303602034380776
HYPOTONIA-CYSTINURIA SYNDROME	0.0035461	0.13303602034380776
CONGENITAL ANALBUMINEMIA	0.0035461	0.13303602034380776
MACROPHAGIC MYOFASCIITIS	0.0035461	0.13303602034380776
POLYMYOSITIS	0.0035461	0.13303602034380776
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.0035461	0.13303602034380776
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.0035461	0.13303602034380776
CRYPTOGENIC ORGANIZING PNEUMONIA	0.0035461	0.13303602034380776
LYME DISEASE	0.0035461	0.13303602034380776
ADULT-ONSET STILL DISEASE	0.0035461	0.13303602034380776
PRIMARY MYELOFIBROSIS	0.0035461	0.13303602034380776
AMYOTROPHIC LATERAL SCLEROSIS	0.0035461	0.13303602034380776
RELAPSING FEVER	0.0035461	0.13303602034380776
GAMMA-HEAVY CHAIN DISEASE	0.0035461	0.13303602034380776
AREGENERATIVE ANEMIA	0.0035461	0.13303602034380776
PRIMARY PARATHYROID HYPERPLASIA	0.0035461	0.13303602034380776
BABESIOSIS	0.0035461	0.13303602034380776
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.0035461	0.13303602034380776
MARBURG HEMORRHAGIC FEVER	0.0035461	0.13303602034380776
REYNOLDS SYNDROME	0.0035461	0.13303602034380776
X-LINKED SIDEROBLASTIC ANEMIA	0.0035461	0.13303602034380776
BLACKFAN-DIAMOND ANEMIA	0.0035461	0.13303602034380776
BOTULISM	0.0035461	0.13303602034380776
JUVENILE DERMATOMYOSITIS	0.0035461	0.13303602034380776
PRIMARY SCLEROSING CHOLANGITIS	0.0035461	0.13303602034380776
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 37	0.0035461	0.13303602034380776
COLD AGGLUTININ DISEASE	0.0035461	0.13303602034380776
ACUTE MONOBLASTIC LEUKEMIA	0.0035461	0.13303602034380776
KIKUCHI-FUJIMOTO DISEASE	0.0035461	0.13303602034380776
LEISHMANIASIS	0.0035461	0.13303602034380776
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.0035461	0.13303602034380776
CYSTINOSIS	0.0035461	0.13303602034380776
THYMOMA	0.0035461	0.13303602034380776
DERMATOMYOSITIS	0.0035461	0.13303602034380776
BECKER MUSCULAR DYSTROPHY	0.0035461	0.13303602034380776
CENTRAL CONGENITAL HYPOTHYROIDISM	0.0035461	0.13303602034380776
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.0035461	0.13303602034380776
HUGHES-STOVIN SYNDROME	0.0035461	0.13303602034380776
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, MYOPATHIC FORM	0.0035461	0.13303602034380776
AUTOIMMUNE HEMOLYTIC ANEMIA, COLD TYPE	0.0035461	0.13303602034380776
ISOLATED AGAMMAGLOBULINEMIA	0.0035461	0.13303602034380776
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.0035461	0.13303602034380776
ACUTE PROMYELOCYTIC LEUKEMIA	0.0035461	0.13303602034380776
CHRONIC MYELOID LEUKEMIA	0.0035461	0.13303602034380776
MANTLE CELL LYMPHOMA	0.0035461	0.13303602034380776
LEGIONELLOSIS	0.0035461	0.13303602034380776
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.0035461	0.13303602034380776
PULMONARY ARTERIAL HYPERTENSION	0.0035461	0.13303602034380776
ACUTE PANMYELOSIS WITH MYELOFIBROSIS	0.0035461	0.13303602034380776
PRIMARY BILIARY CHOLANGITIS	0.0035461	0.13303602034380776
SYSTEMIC CAPILLARY LEAK SYNDROME	0.0035461	0.13303602034380776
EBSTEIN MALFORMATION	0.0035461	0.13303602034380776
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.0035461	0.13303602034380776
MALT LYMPHOMA	0.0035461	0.13303602034380776
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.0035461	0.13303602034380776
FOLLICULAR LYMPHOMA	0.0035461	0.13303602034380776
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.0035461	0.13303602034380776
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.0035461	0.13303602034380776
EVANS SYNDROME	0.0035461	0.13303602034380776
TOXIC EPIDERMAL NECROLYSIS	0.0035461	0.13303602034380776
MASTOCYTOSIS	0.0035461	0.13303602034380776
KLATSKIN TUMOR	0.0035461	0.13303602034380776
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.0035461	0.13303602034380776
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.0035461	0.13303602034380776
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.0035461	0.13303602034380776
SATOYOSHI SYNDROME	0.0035461	0.13303602034380776
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.0035461	0.13303602034380776
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	0.0035461	0.13303602034380776
ADIPOSIS DOLOROSA	0.0035461	0.13303602034380776
HEMOCHROMATOSIS, TYPE 3; HFE3	0.0035461	0.13303602034380776
BARTH SYNDROME; BTHS	0.0035461	0.13303602034380776
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.0035461	0.13303602034380776
MYXEDEMA	0.0035461	0.13303602034380776
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0035461	0.13303602034380776
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.0035461	0.13303602034380776
CREATINE PHOSPHOKINASE, ELEVATED SERUM	0.0035461	0.13303602034380776
ANISOCORIA	0.0035461	0.13303602034380776
PEROXISOME BIOGENESIS DISORDER 10B	0.003532904	0.13254095722532355
DISTAL TRISOMY 6P	0.003532904	0.13254095722532355
KNOBLOCH SYNDROME	0.003528769	0.1323858279441071
OCULOCEREBRORENAL SYNDROME OF LOWE	0.0035287689999999997	0.1323858279441071
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.0035287689999999997	0.1323858279441071
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0035287689999999997	0.1323858279441071
ALG2-CDG	0.0035287689999999997	0.1323858279441071
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.0034786999999999995	0.13050743181805477
ERMINE PHENOTYPE	0.00346501	0.12999383572135512
APPARENT MINERALOCORTICOID EXCESS	0.00342466	0.12848005905942433
FAMILIAL PSEUDOHYPERKALEMIA	0.00342466	0.12848005905942433
%613944 IGA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.00342466	0.12848005905942433
NEPHRONOPHTHISIS 1	0.00342466	0.12848005905942433
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00342466	0.12848005905942433
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.00342466	0.12848005905942433
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00342466	0.12848005905942433
ACQUIRED GENERALIZED LIPODYSTROPHY	0.00342466	0.12848005905942433
GRANGE SYNDROME	0.00342466	0.12848005905942433
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00342466	0.12848005905942433
LCAT DEFICIENCY	0.00342466	0.12848005905942433
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.00342466	0.12848005905942433
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.00342466	0.12848005905942433
SICKLE CELL ANEMIA	0.00342466	0.12848005905942433
LONG QT SYNDROME 13; LQT13	0.00342466	0.12848005905942433
FIBRONECTIN GLOMERULOPATHY	0.00342466	0.12848005905942433
PARAGANGLIOMAS 6	0.00342466	0.12848005905942433
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2	0.00342466	0.12848005905942433
SECONDARY POLYCYTHEMIA	0.00342466	0.12848005905942433
ADRENOCORTICAL CARCINOMA	0.00342466	0.12848005905942433
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.00342466	0.12848005905942433
CONGENITAL ADRENAL HYPERPLASIA	0.00342466	0.12848005905942433
%161900 RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1;;NEPHROPATHY, FAMILIAL;;NEPHRITIS, FAMILIAL, WITHOUT DEAFNESS OR OCULAR DEFECT;;RENAL FAILURE, ADULT-ONSET; AORF	0.00342466	0.12848005905942433
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.00342466	0.12848005905942433
PLIN1-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00342466	0.12848005905942433
NAIL-PATELLA-LIKE RENAL DISEASE	0.00342466	0.12848005905942433
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.00342466	0.12848005905942433
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00342466	0.12848005905942433
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.00342466	0.12848005905942433
POSTERIOR URETHRAL VALVE	0.00342466	0.12848005905942433
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.00342466	0.12848005905942433
CYSTIC HAMARTOMA OF LUNG AND KIDNEY	0.00342466	0.12848005905942433
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.00342466	0.12848005905942433
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00342466	0.12848005905942433
NELSON SYNDROME	0.00342466	0.12848005905942433
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.00342466	0.12848005905942433
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.00342466	0.12848005905942433
POLYCYSTIC KIDNEY DISEASE 2	0.00342466	0.12848005905942433
CATECHOLAMINE-PRODUCING TUMOR	0.00342466	0.12848005905942433
PRIMARY MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS	0.00342466	0.12848005905942433
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.00342466	0.12848005905942433
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00342466	0.12848005905942433
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.00342466	0.12848005905942433
ALAGILLE SYNDROME 2	0.00342466	0.12848005905942433
RENAL AGENESIS	0.00342466	0.12848005905942433
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.00342466	0.12848005905942433
PRIMARY LIPODYSTROPHY	0.00342466	0.12848005905942433
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.00342466	0.12848005905942433
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.00342466	0.12848005905942433
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.00342466	0.12848005905942433
PREECLAMPSIA	0.00342466	0.12848005905942433
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00342466	0.12848005905942433
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00342466	0.12848005905942433
RHABDOID TUMOR	0.00342466	0.12848005905942433
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.00342466	0.12848005905942433
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00342466	0.12848005905942433
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.00342466	0.12848005905942433
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.00342466	0.12848005905942433
FAMILIAL PARTIAL LIPODYSTROPHY, KÃ–BBERLING TYPE	0.00342466	0.12848005905942433
AMYLOIDOSIS, FAMILIAL VISCERAL	0.00342466	0.12848005905942433
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.00342466	0.12848005905942433
PSEUDOHYPOALDOSTERONISM TYPE 2	0.00342466	0.12848005905942433
POLYCYSTIC KIDNEY DISEASE 3	0.00342466	0.12848005905942433
PSEUDOXANTHOMA ELASTICUM	0.00342466	0.12848005905942433
CIRRHOSIS, FAMILIAL	0.00342466	0.12848005905942433
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.00342466	0.12848005905942433
HYPERALDOSTERONISM, FAMILIAL, TYPE II; HALD2	0.00342466	0.12848005905942433
ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3	0.00342466	0.12848005905942433
MOYAMOYA DISEASE WITH EARLY-ONSET ACHALASIA	0.00342466	0.12848005905942433
MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	0.00342466	0.12848005905942433
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00342466	0.12848005905942433
POLYCYSTIC KIDNEYS	0.00342466	0.12848005905942433
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00342466	0.12848005905942433
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.00342466	0.12848005905942433
DENYS-DRASH SYNDROME	0.00342466	0.12848005905942433
PRIMARY PROGRESSIVE FREEZING GAIT	0.00342466	0.12848005905942433
X-LINKED HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00342466	0.12848005905942433
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00342466	0.12848005905942433
LIDDLE SYNDROME 1; LIDLS1	0.00342466	0.12848005905942433
GANGLIONEUROMA	0.00342466	0.12848005905942433
AORTA COARCTATION	0.00342466	0.12848005905942433
OCHOA SYNDROME	0.00342466	0.12848005905942433
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00342466	0.12848005905942433
NEPHROBLASTOMA	0.00342466	0.12848005905942433
ALAGILLE SYNDROME	0.00342466	0.12848005905942433
TETANUS	0.00342466	0.12848005905942433
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 3	0.00342466	0.12848005905942433
INFANT BOTULISM	0.00342466	0.12848005905942433
CAUDAL REGRESSION SEQUENCE	0.00342466	0.12848005905942433
INTRACRANIAL HYPERTENSION, IDIOPATHIC	0.00342466	0.12848005905942433
MELORHEOSTOSIS WITH OSTEOPOIKILOSIS	0.00342466	0.12848005905942433
FRASIER SYNDROME	0.00342466	0.12848005905942433
FAMILIAL BICUSPID AORTIC VALVE	0.00342466	0.12848005905942433
LIDDLE SYNDROME 3; LIDLS3	0.00342466	0.12848005905942433
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.00342466	0.12848005905942433
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.00342466	0.12848005905942433
PSEUDOHYPOALDOSTERONISM, TYPE II	0.00342466	0.12848005905942433
FAMILIAL HYPERALDOSTERONISM TYPE III	0.00342466	0.12848005905942433
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.00342466	0.12848005905942433
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.00342466	0.12848005905942433
ABDOMINAL OBESITY-METABOLIC SYNDROME 1	0.00342466	0.12848005905942433
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.00342466	0.12848005905942433
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00342466	0.12848005905942433
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	0.00342466	0.12848005905942433
ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2	0.00342466	0.12848005905942433
HYPERALDOSTERONISM, FAMILIAL, TYPE IV	0.00342466	0.12848005905942433
GLYCOGEN STORAGE DISEASE IA	0.00342466	0.12848005905942433
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00342466	0.12848005905942433
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.00342466	0.12848005905942433
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00342466	0.12848005905942433
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.00342466	0.12848005905942433
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00342466	0.12848005905942433
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00342466	0.12848005905942433
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.00342466	0.12848005905942433
LIDDLE SYNDROME 2; LIDLS2	0.00342466	0.12848005905942433
FAMILIAL HYPERALDOSTERONISM TYPE I	0.00342466	0.12848005905942433
STIFF-PERSON SYNDROME; SPS	0.00342466	0.12848005905942433
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00342466	0.12848005905942433
GLYCOGEN STORAGE DISEASE IB	0.00342466	0.12848005905942433
CONGENITAL PULMONARY VEINS ATRESIA OR STENOSIS	0.00342466	0.12848005905942433
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.00342466	0.12848005905942433
TRIMETHYLAMINURIA	0.00342466	0.12848005905942433
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.00342466	0.12848005905942433
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0033608530000000005	0.12608626606146117
DISTAL MONOSOMY 15Q	0.0033608530000000005	0.12608626606146117
COFFIN-SIRIS SYNDROME 4; CSS4	0.0033608530000000005	0.12608626606146117
KLEEFSTRA SYNDROME	0.0033608530000000005	0.12608626606146117
KABUKI SYNDROME 1	0.0033608530000000005	0.12608626606146117
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.0033608530000000005	0.12608626606146117
PHELAN-MCDERMID SYNDROME	0.0033608530000000005	0.12608626606146117
CHROMOSOME 1P35 DELETION SYNDROME	0.0033608530000000005	0.12608626606146117
COFFIN-SIRIS SYNDROME 3; CSS3	0.0033608530000000005	0.12608626606146117
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.0033608530000000005	0.12608626606146117
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.0033608530000000005	0.12608626606146117
EMANUEL SYNDROME	0.0033608530000000005	0.12608626606146117
ALG11-CDG	0.0033608530000000005	0.12608626606146117
22Q11.2 MICRODUPLICATION SYNDROME	0.0033608530000000005	0.12608626606146117
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.0033608530000000005	0.12608626606146117
RUBINSTEIN-TAYBI SYNDROME	0.0033608530000000005	0.12608626606146117
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.0033608530000000005	0.12608626606146117
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.003360853	0.12608626606146114
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0033471630000000002	0.1255726699647615
MONOSOMY 18Q	0.0033471630000000002	0.1255726699647615
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0033471630000000002	0.1255726699647615
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0033471630000000002	0.1255726699647615
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.0033471630000000002	0.1255726699647615
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.0033471630000000002	0.1255726699647615
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.0033471630000000002	0.1255726699647615
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0033471630000000002	0.1255726699647615
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.0033471630000000002	0.1255726699647615
CHROMOSOME 10Q26 DELETION SYNDROME	0.0033471630000000002	0.1255726699647615
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0033471630000000002	0.1255726699647615
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.0033471630000000002	0.1255726699647615
INFANTILE LIVER FAILURE SYNDROME 1	0.003347163	0.12557266996476146
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.003347163	0.12557266996476146
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.003347163	0.12557266996476146
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.003347163	0.12557266996476146
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.003347163	0.12557266996476146
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.00329998	0.12380254544828367
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00329998	0.12380254544828367
%300719 DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES	0.00329998	0.12380254544828367
NATHALIE SYNDROME	0.00329998	0.12380254544828367
AGEL AMYLOIDOSIS	0.00329998	0.12380254544828367
TOWNES-BROCKS SYNDROME	0.00329998	0.12380254544828367
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00329998	0.12380254544828367
BETA-THALASSEMIA MAJOR	0.00329998	0.12380254544828367
KNIEST DYSPLASIA	0.00329998	0.12380254544828367
SPASTIC PARAPARESIS AND DEAFNESS	0.00329998	0.12380254544828367
ACROOSTEOLYSIS DOMINANT TYPE	0.00329998	0.12380254544828367
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00329998	0.12380254544828367
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00328629	0.12328894935158399
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00328629	0.12328894935158399
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00328629	0.12328894935158399
DYSTONIA, JUVENILE-ONSET	0.00328629	0.12328894935158399
STICKLER SYNDROME	0.00328629	0.12328894935158399
STICKLER SYNDROME TYPE 2	0.00328629	0.12328894935158399
NATHALIE SYNDROME	0.00328629	0.12328894935158399
STICKLER SYNDROME TYPE 1	0.00328629	0.12328894935158399
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00328629	0.12328894935158399
NAIL-PATELLA SYNDROME	0.00328629	0.12328894935158399
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00328629	0.12328894935158399
VOGT-KOYANAGI-HARADA DISEASE	0.00328629	0.12328894935158399
DUANE-RADIAL RAY SYNDROME; DRRS	0.00328629	0.12328894935158399
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00328629	0.12328894935158399
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.00328629	0.12328894935158399
USHER SYNDROME TYPE 3	0.00328629	0.12328894935158399
NEUROFIBROMATOSIS TYPE 2	0.00328629	0.12328894935158399
STICKLER SYNDROME, TYPE II	0.00328629	0.12328894935158399
RELAPSING POLYCHONDRITIS	0.00328629	0.12328894935158399
SHORT SYNDROME	0.00328629	0.12328894935158399
STICKLER SYNDROME, TYPE I	0.00328629	0.12328894935158399
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.003267824	0.12259617612136804
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.003267824	0.12259617612136804
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.003267824	0.12259617612136804
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.003267824	0.12259617612136804
OCULOCEREBROCUTANEOUS SYNDROME	0.003263689	0.12244104684015161
16Q24.3 MICRODELETION SYNDROME	0.003263689	0.12244104684015161
ACROCALLOSAL SYNDROME; ACLS	0.003263689	0.12244104684015161
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.003263689	0.12244104684015161
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.003263689	0.12244104684015161
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.003263689	0.12244104684015161
KRABBE DISEASE	0.003263689	0.12244104684015161
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.0032636889999999997	0.12244104684015159
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.0032636889999999997	0.12244104684015159
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.0032541339999999997	0.12208258002466836
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.0032541339999999997	0.12208258002466836
PEROXISOME BIOGENESIS DISORDER 6B	0.0032541339999999997	0.12208258002466836
WAARDENBURG-SHAH SYNDROME	0.0032541339999999997	0.12208258002466836
PEROXISOME BIOGENESIS DISORDER 5B	0.0032541339999999997	0.12208258002466836
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.0032541339999999997	0.12208258002466836
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.0032541339999999997	0.12208258002466836
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.0032541339999999997	0.12208258002466836
WOLFRAM SYNDROME	0.003249999	0.12192745074345193
KALLMANN SYNDROME	0.003249999	0.12192745074345193
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.003249999	0.12192745074345193
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.003084514	0.11571909062202416
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.003084514	0.11571909062202416
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.003084514	0.11571909062202416
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.003084514	0.11571909062202416
CONGENITAL VARICELLA SYNDROME	0.003084514	0.11571909062202416
OCULO-PALATO-CEREBRAL SYNDROME	0.003084514	0.11571909062202416
3Q29 MICRODELETION SYNDROME	0.003084514	0.11571909062202416
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.0030803790000000003	0.11556396134080771
INCONTINENTIA PIGMENTI; IP	0.0030803790000000003	0.11556396134080771
PHENYLKETONURIA	0.0030803790000000003	0.11556396134080771
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.0030803790000000003	0.11556396134080771
ASPARTYLGLUCOSAMINURIA; AGU	0.0030803790000000003	0.11556396134080771
LATHOSTEROLOSIS	0.0030803790000000003	0.11556396134080771
HARROD SYNDROME	0.0030803790000000003	0.11556396134080771
NEVUS COMEDONICUS SYNDROME	0.003080379	0.11556396134080771
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.003080379	0.11556396134080771
8P11.2 DELETION SYNDROME	0.003048223	0.1143575920138921
CHROMOSOME 19P13.13 DELETION SYNDROME	0.003048223	0.1143575920138921
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.003048223	0.1143575920138921
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.003048223	0.1143575920138921
ADENYLOSUCCINASE DEFICIENCY	0.003048223	0.1143575920138921
MONOSOMY 9P	0.003048223	0.1143575920138921
20Q11.2 MICRODUPLICATION SYNDROME	0.003048223	0.1143575920138921
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.003048223	0.1143575920138921
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.003048223	0.1143575920138921
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.003048223	0.1143575920138921
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.003048223	0.1143575920138921
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.003048223	0.1143575920138921
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.003048223	0.1143575920138921
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.003048223	0.1143575920138921
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.003048223	0.1143575920138921
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.003048223	0.1143575920138921
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.003048223	0.1143575920138921
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.0030482229999999996	0.11435759201389208
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.0030482229999999996	0.11435759201389208
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.0030482229999999996	0.11435759201389208
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.0030482229999999996	0.11435759201389208
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.0030482229999999996	0.11435759201389208
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.0030482229999999996	0.11435759201389208
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00302121	0.11334416824762851
DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	0.00302121	0.11334416824762851
COWCHOCK SYNDROME; COWCK	0.00302121	0.11334416824762851
DEAFNESS, AUTOSOMAL RECESSIVE 29	0.00302121	0.11334416824762851
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.0029873499999999997	0.11207387140071462
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.0029873499999999997	0.11207387140071462
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.0029873499999999997	0.11207387140071462
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.0029873499999999997	0.11207387140071462
ISOLATED ANIRIDIA	0.0029873499999999997	0.11207387140071462
ANIRIDIA	0.0029873499999999997	0.11207387140071462
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.0029873499999999997	0.11207387140071462
ANTERIOR SEGMENT DYSGENESIS 2; ASGD2	0.0029873499999999997	0.11207387140071462
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.0029873499999999997	0.11207387140071462
SPONDYLO-OCULAR SYNDROME	0.0029873499999999997	0.11207387140071462
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.0029873499999999997	0.11207387140071462
X-LINKED IMMUNONEUROLOGIC DISORDER	0.0029873499999999997	0.11207387140071462
LEBER CONGENITAL AMAUROSIS 16	0.0029873499999999997	0.11207387140071462
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.0029873499999999997	0.11207387140071462
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.0029873499999999997	0.11207387140071462
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.0029873499999999997	0.11207387140071462
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.0029873499999999997	0.11207387140071462
MORNING GLORY DISC ANOMALY	0.0029873499999999997	0.11207387140071462
NANCE-HORAN SYNDROME	0.0029873499999999997	0.11207387140071462
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.0029873499999999997	0.11207387140071462
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.0029873499999999997	0.11207387140071462
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.0029873499999999997	0.11207387140071462
CATARACT-MICROCORNEA SYNDROME	0.0029873499999999997	0.11207387140071462
MEND SYNDROME; MEND	0.0028695030000000002	0.10765270564412098
MONOSOMY 9Q22.3	0.0028695030000000002	0.10765270564412098
MEND SYNDROME	0.0028695030000000002	0.10765270564412098
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.0028695030000000002	0.10765270564412098
JACOBSEN SYNDROME	0.0028695030000000002	0.10765270564412098
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.0028695030000000002	0.10765270564412098
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.0028695030000000002	0.10765270564412098
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.0028695030000000002	0.10765270564412098
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.0028695030000000002	0.10765270564412098
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.002819434	0.10577430951806868
BRESEK SYNDROME	0.002819434	0.10577430951806868
WARSAW BREAKAGE SYNDROME; WABS	0.002819434	0.10577430951806868
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.002819434	0.10577430951806868
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.002819434	0.10577430951806868
OPTIC ATROPHY 11; OPA11	0.002819434	0.10577430951806868
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.002819434	0.10577430951806868
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.002819434	0.10577430951806868
17P11.2 MICRODUPLICATION SYNDROME	0.002819434	0.10577430951806868
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.002819434	0.10577430951806868
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.0028152990000000003	0.10561918023685223
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.0028152990000000003	0.10561918023685223
DISTAL MONOSOMY 3P	0.0028152990000000003	0.10561918023685223
MENTAL RETARDATION, X-LINKED 102	0.0028152990000000003	0.10561918023685223
CYCLIC VOMITING SYNDROME	0.0028152990000000003	0.10561918023685223
KLEEFSTRA SYNDROME	0.0028152990000000003	0.10561918023685223
XP22.13P22.2 DUPLICATION SYNDROME	0.0028152990000000003	0.10561918023685223
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.0028152990000000003	0.10561918023685223
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.002815299	0.10561918023685221
XYLOSIDASE DEFICIENCY	0.002815299	0.10561918023685221
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.002815299	0.10561918023685221
MICROPHTHALMIA, SYNDROMIC 3	0.0028057439999999998	0.10526071342136897
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.0028057439999999998	0.10526071342136897
BRAIN-LUNG-THYROID SYNDROME	0.0028057439999999998	0.10526071342136897
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.0028057439999999998	0.10526071342136897
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0028057439999999998	0.10526071342136897
TOWNES-BROCKS SYNDROME 1; TBS1	0.0028057439999999998	0.10526071342136897
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0028057439999999998	0.10526071342136897
CRANIOSYNOSTOSIS 6; CRS6	0.0028057439999999998	0.10526071342136897
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0028057439999999998	0.10526071342136897
MOYNAHAN SYNDROME	0.002801609	0.10510558414015254
KEARNS-SAYRE SYNDROME; KSS	0.002801609	0.10510558414015254
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.002801609	0.10510558414015254
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.002801609	0.10510558414015254
COFFIN-LOWRY SYNDROME; CLS	0.002801609	0.10510558414015254
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.002801609	0.10510558414015254
RENIER-GABREELS-JASPER SYNDROME	0.002801609	0.10510558414015254
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.002801609	0.10510558414015254
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.002801609	0.10510558414015254
WORSTER-DROUGHT SYNDROME	0.002801609	0.10510558414015254
TRIPLE A SYNDROME	0.002801609	0.10510558414015254
SCLEROSTEOSIS 1; SOST1	0.0027222699999999997	0.10212909029675914
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.0027222699999999997	0.10212909029675914
GAPO SYNDROME	0.0027222699999999997	0.10212909029675914
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.0027222699999999997	0.10212909029675914
RENAL COLOBOMA SYNDROME	0.0027222699999999997	0.10212909029675914
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.0027222699999999997	0.10212909029675914
FRIEDREICH ATAXIA	0.0027222699999999997	0.10212909029675914
SPINOCEREBELLAR ATAXIA TYPE 31	0.0027222699999999997	0.10212909029675914
DYSOSTEOSCLEROSIS	0.0027222699999999997	0.10212909029675914
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.0027222699999999997	0.10212909029675914
OSTEOPETROSIS AND RELATED DISORDERS	0.0027222699999999997	0.10212909029675914
45,X/46,XY MIXED GONADAL DYSGENESIS	0.0027222699999999997	0.10212909029675914
SPINOCEREBELLAR ATAXIA TYPE 18	0.0027222699999999997	0.10212909029675914
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.0027222699999999997	0.10212909029675914
SPINOCEREBELLAR ATAXIA 13	0.0027222699999999997	0.10212909029675914
CHIARI MALFORMATION TYPE I	0.0027222699999999997	0.10212909029675914
RICHARDS-RUNDLE SYNDROME	0.0027222699999999997	0.10212909029675914
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.0027222699999999997	0.10212909029675914
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00270858	0.10161549420005946
CHANARIN-DORFMAN SYNDROME	0.00270858	0.10161549420005946
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00270858	0.10161549420005946
NOONAN SYNDROME	0.00270858	0.10161549420005946
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00270858	0.10161549420005946
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00270858	0.10161549420005946
ENDOSTEAL HYPEROSTOSIS, WORTH TYPE	0.00270858	0.10161549420005946
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.00270858	0.10161549420005946
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.00270858	0.10161549420005946
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00270858	0.10161549420005946
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00270858	0.10161549420005946
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00270858	0.10161549420005946
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00270858	0.10161549420005946
FETAL IODINE SYNDROME	0.00270858	0.10161549420005946
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00270858	0.10161549420005946
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00270858	0.10161549420005946
MONOSOMY 22Q13.3	0.0026044230000000002	0.0977079245401655
17Q12 MICRODELETION SYNDROME	0.0026044230000000002	0.0977079245401655
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.0026044230000000002	0.0977079245401655
TARP SYNDROME	0.0026044230000000002	0.0977079245401655
TAY-SACHS DISEASE	0.0026044230000000002	0.0977079245401655
SEVERE CANAVAN DISEASE	0.0026044230000000002	0.0977079245401655
CRANIOPHARYNGIOMA	0.0026044230000000002	0.0977079245401655
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.0026044230000000002	0.0977079245401655
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.0026044230000000002	0.0977079245401655
MULTIPLE CARBOXYLASE DEFICIENCY	0.0026044230000000002	0.0977079245401655
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.0026044230000000002	0.0977079245401655
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.0026044230000000002	0.0977079245401655
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.0026044230000000002	0.0977079245401655
FUCOSIDOSIS	0.0026044230000000002	0.0977079245401655
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.0026044230000000002	0.0977079245401655
SMITH-MAGENIS SYNDROME; SMS	0.0026044230000000002	0.0977079245401655
KEUTEL SYNDROME	0.0026044230000000002	0.0977079245401655
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0026044230000000002	0.0977079245401655
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.002590733	0.09719432844346582
EAST SYNDROME	0.002590733	0.09719432844346582
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.002590733	0.09719432844346582
DONNAI-BARROW SYNDROME	0.002590733	0.09719432844346582
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.002590733	0.09719432844346582
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.002590733	0.09719432844346582
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.002590733	0.09719432844346582
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.002590733	0.09719432844346582
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.002590733	0.09719432844346582
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.002590733	0.09719432844346582
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.002590733	0.09719432844346582
CHROMOSOME 2Q37 DELETION SYNDROME	0.002590733	0.09719432844346582
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.002590733	0.09719432844346582
DISTAL MONOSOMY 19P13.3	0.002590733	0.09719432844346582
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.002590733	0.09719432844346582
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.002590733	0.09719432844346582
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.002590733	0.09719432844346582
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00253896	0.09525200479741523
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00253896	0.09525200479741523
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00253896	0.09525200479741523
MECKEL SYNDROME	0.00253896	0.09525200479741523
MONOSOMY 13Q14	0.00253896	0.09525200479741523
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.00253896	0.09525200479741523
STROMME SYNDROME; STROMS	0.00253896	0.09525200479741523
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00253896	0.09525200479741523
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00253896	0.09525200479741523
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00253896	0.09525200479741523
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00253896	0.09525200479741523
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00253896	0.09525200479741523
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00253896	0.09525200479741523
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00253896	0.09525200479741523
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00253896	0.09525200479741523
MARTSOLF SYNDROME	0.00253896	0.09525200479741523
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00253896	0.09525200479741523
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0025068039999999996	0.0940456354704996
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.0025068039999999996	0.0940456354704996
AICARDI-GOUTIERES SYNDROME 6	0.0025068039999999996	0.0940456354704996
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.0025068039999999996	0.0940456354704996
6Q16 MICRODELETION SYNDROME	0.0025068039999999996	0.0940456354704996
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0025068039999999996	0.0940456354704996
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0025068039999999996	0.0940456354704996
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0025068039999999996	0.0940456354704996
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0025068039999999996	0.0940456354704996
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.0025068039999999996	0.0940456354704996
MENTAL RETARDATION, X-LINKED 106; MRX106	0.0025068039999999996	0.0940456354704996
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.002502669	0.09389050618928317
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.002502669	0.09389050618928317
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.002502669	0.09389050618928317
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.002502669	0.09389050618928317
MEHMO SYNDROME	0.002502669	0.09389050618928317
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.002502669	0.09389050618928317
TYROSINEMIA TYPE 2	0.002502669	0.09389050618928317
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.002502669	0.09389050618928317
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.002502669	0.09389050618928317
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.002502669	0.09389050618928317
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.002502669	0.09389050618928317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.002502669	0.09389050618928317
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.002502669	0.09389050618928317
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.0023280840000000002	0.08734074910072852
PELLAGRA-LIKE SYNDROME	0.0023280840000000002	0.08734074910072852
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.0023280840000000002	0.08734074910072852
SAUL-WILSON SYNDROME; SWILS	0.0023280840000000002	0.08734074910072852
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.0023280840000000002	0.08734074910072852
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.0023280840000000002	0.08734074910072852
ELSAHY-WATERS SYNDROME; ESWS	0.0023280840000000002	0.08734074910072852
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.0023280840000000002	0.08734074910072852
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.0023280840000000002	0.08734074910072852
ALDH18A1-RELATED DE BARSY SYNDROME	0.0023280840000000002	0.08734074910072852
TREACHER-COLLINS SYNDROME	0.0023280840000000002	0.08734074910072852
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.0023280840000000002	0.08734074910072852
GALACTOSE EPIMERASE DEFICIENCY	0.0023280840000000002	0.08734074910072852
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.002323949	0.08718561981951206
ADAMS-OLIVER SYNDROME	0.002323949	0.08718561981951206
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.002323949	0.08718561981951206
DYSEQUILIBRIUM SYNDROME	0.002323949	0.08718561981951206
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.002323949	0.08718561981951206
PROTEUS SYNDROME	0.002323949	0.08718561981951206
FLYNN-AIRD SYNDROME	0.002323949	0.08718561981951206
MUSCLE-EYE-BRAIN DISEASE	0.002323949	0.08718561981951206
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.002323949	0.08718561981951206
LINEAR VERRUCOUS NEVUS SYNDROME	0.002323949	0.08718561981951206
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.002323949	0.08718561981951206
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.002323949	0.08718561981951206
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.002323949	0.08718561981951206
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.002323949	0.08718561981951206
ECTODERMAL DYSPLASIA SYNDROME	0.002323949	0.08718561981951206
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.002323949	0.08718561981951206
CEREBROTENDINOUS XANTHOMATOSIS	0.002323949	0.08718561981951206
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.002323949	0.08718561981951206
HEREDITARY FRUCTOSE INTOLERANCE	0.002323949	0.08718561981951206
JOUBERT SYNDROME WITH RENAL DEFECT	0.002291793	0.08597925049259644
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.002291793	0.08597925049259644
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.002291793	0.08597925049259644
GRISCELLI SYNDROME	0.002291793	0.08597925049259644
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.002291793	0.08597925049259644
CHÃ‰DIAK-HIGASHI SYNDROME	0.002291793	0.08597925049259644
SCHINDLER DISEASE, TYPE I	0.002291793	0.08597925049259644
19P13.13 MICRODELETION SYNDROME	0.002291793	0.08597925049259644
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.002291793	0.08597925049259644
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.002291793	0.08597925049259644
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.002291793	0.08597925049259644
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.002291793	0.08597925049259644
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.002291793	0.08597925049259644
OCULOECTODERMAL SYNDROME; OES	0.002291793	0.08597925049259644
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.002291793	0.08597925049259644
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.002291793	0.08597925049259644
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.002291793	0.08597925049259644
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.002291793	0.08597925049259644
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.002291793	0.08597925049259644
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.002291793	0.08597925049259644
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.002291793	0.08597925049259644
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.002291793	0.08597925049259644
JOUBERT SYNDROME WITH OCULAR DEFECT	0.002291793	0.08597925049259644
OPTIC PATHWAY GLIOMA	0.002291793	0.08597925049259644
6Q TERMINAL DELETION SYNDROME	0.002291793	0.08597925049259644
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.002291793	0.08597925049259644
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.002291793	0.08597925049259644
ELEJALDE DISEASE	0.002291793	0.08597925049259644
FREE SIALIC ACID STORAGE DISEASE	0.002291793	0.08597925049259644
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.002291793	0.08597925049259644
OROFACIODIGITAL SYNDROME TYPE 6	0.002291793	0.08597925049259644
INFANTILE SIALIC ACID STORAGE DISEASE	0.002291793	0.08597925049259644
SALLA DISEASE	0.002291793	0.08597925049259644
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.002291793	0.08597925049259644
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.002291793	0.08597925049259644
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.002291793	0.08597925049259644
JOUBERT SYNDROME	0.002291793	0.08597925049259644
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.002291793	0.08597925049259644
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.002291793	0.08597925049259644
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.002291793	0.08597925049259644
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.002291793	0.08597925049259644
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.002291793	0.08597925049259644
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.002291793	0.08597925049259644
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.002291793	0.08597925049259644
48,XXYY SYNDROME	0.002291793	0.08597925049259644
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.002291793	0.08597925049259644
MENTAL RETARDATION, X-LINKED 104; MRX104	0.002291793	0.08597925049259644
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.002291793	0.08597925049259644
HARTNUP DISEASE	0.002291793	0.08597925049259644
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.002291793	0.08597925049259644
46,XX GONADAL DYSGENESIS	0.00227388	0.08530722369345974
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00227388	0.08530722369345974
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00227388	0.08530722369345974
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00227388	0.08530722369345974
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00227388	0.08530722369345974
DISTAL MONOSOMY 10P	0.00227388	0.08530722369345974
FETAL METHYLMERCURY SYNDROME	0.00227388	0.08530722369345974
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00227388	0.08530722369345974
DIABETIC EMBRYOPATHY	0.00227388	0.08530722369345974
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00227388	0.08530722369345974
FANCONI ANEMIA	0.00227388	0.08530722369345974
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00227388	0.08530722369345974
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00227388	0.08530722369345974
FEINGOLD SYNDROME 1; FGLDS1	0.00227388	0.08530722369345974
MICROTRIPLICATION 11Q24.1	0.00227388	0.08530722369345974
PIEBALDISM	0.00227388	0.08530722369345974
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00227388	0.08530722369345974
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00227388	0.08530722369345974
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00227388	0.08530722369345974
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00227388	0.08530722369345974
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00227388	0.08530722369345974
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00227388	0.08530722369345974
OTOMANDIBULAR SYNDROME	0.00226019	0.08479362759676007
FEINGOLD SYNDROME	0.00226019	0.08479362759676007
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00226019	0.08479362759676007
ACROOTOOCULAR SYNDROME	0.00226019	0.08479362759676007
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00226019	0.08479362759676007
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00226019	0.08479362759676007
ACROCRANIOFACIAL DYSOSTOSIS	0.00226019	0.08479362759676007
SEVERE COMBINED IMMUNODEFICIENCY	0.00226019	0.08479362759676007
JOHANSON-BLIZZARD SYNDROME; JBS	0.00226019	0.08479362759676007
JOHANSON-BLIZZARD SYNDROME	0.00226019	0.08479362759676007
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00226019	0.08479362759676007
DE SANCTIS-CACCHIONE SYNDROME	0.00226019	0.08479362759676007
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00226019	0.08479362759676007
3MC SYNDROME 2	0.0020630040000000002	0.07739596799677304
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0020630040000000002	0.07739596799677304
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.0020630040000000002	0.07739596799677304
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.0020630040000000002	0.07739596799677304
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0020630040000000002	0.07739596799677304
BARDET-BIEDL SYNDROME 16; BBS16	0.0020630040000000002	0.07739596799677304
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.0020630040000000002	0.07739596799677304
FRIED SYNDROME	0.0020630040000000002	0.07739596799677304
ISOLATED PLAGIOCEPHALY	0.0020630040000000002	0.07739596799677304
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.0020630040000000002	0.07739596799677304
COFFIN-SIRIS SYNDROME 7; CSS7	0.0020630040000000002	0.07739596799677304
AURICULOCONDYLAR SYNDROME	0.0020630040000000002	0.07739596799677304
DISTAL MONOSOMY 6P	0.0020630040000000002	0.07739596799677304
SWEENEY-COX SYNDROME; SWCOS	0.0020630040000000002	0.07739596799677304
8P23.1 DUPLICATION SYNDROME	0.0020630040000000002	0.07739596799677304
CHAR SYNDROME	0.0020630040000000002	0.07739596799677304
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.0020630040000000002	0.07739596799677304
LYMPHEDEMA, HEREDITARY, III	0.0020630040000000002	0.07739596799677304
14Q22Q23 MICRODELETION SYNDROME	0.0020630040000000002	0.07739596799677304
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.0020630040000000002	0.07739596799677304
THANATOPHORIC DYSPLASIA	0.002058869	0.07724083871555656
CHIME SYNDROME	0.002058869	0.07724083871555656
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.002058869	0.07724083871555656
GALACTOSIALIDOSIS	0.002058869	0.07724083871555656
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.002058869	0.07724083871555656
BETA-MANNOSIDOSIS	0.002058869	0.07724083871555656
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.002058869	0.07724083871555656
RAMON SYNDROME	0.002058869	0.07724083871555656
THANATOPHORIC DYSPLASIA TYPE 1	0.002058869	0.07724083871555656
MYASTHENIA GRAVIS	0.002058869	0.07724083871555656
OHDO SYNDROME	0.002058869	0.07724083871555656
7Q11.23 MICRODUPLICATION SYNDROME	0.002058869	0.07724083871555656
CRIGLER-NAJJAR SYNDROME	0.002058869	0.07724083871555656
THANATOPHORIC DYSPLASIA TYPE 2	0.002058869	0.07724083871555656
NEUROFIBROMATOSIS, TYPE II	0.002058869	0.07724083871555656
CRIGLER-NAJJAR SYNDROME TYPE 1	0.002058869	0.07724083871555656
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.002058869	0.07724083871555656
PFEIFFER SYNDROME TYPE 3	0.002058869	0.07724083871555656
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.002058869	0.07724083871555656
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.002058869	0.07724083871555656
4Q21 MICRODELETION SYNDROME	0.002058869	0.07724083871555656
PITT-HOPKINS-LIKE SYNDROME	0.002058869	0.07724083871555656
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.002058869	0.07724083871555656
DYSOSTEOSCLEROSIS	0.002058869	0.07724083871555656
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.002058869	0.07724083871555656
ACQUIRED PARTIAL LIPODYSTROPHY	0.002058869	0.07724083871555656
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.002058869	0.07724083871555656
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.002058869	0.07724083871555656
GYRATE ATROPHY OF CHOROID AND RETINA	0.002058869	0.07724083871555656
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.002058869	0.07724083871555656
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.002058869	0.07724083871555656
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.002058869	0.07724083871555656
ADRENOLEUKODYSTROPHY	0.002058869	0.07724083871555656
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.002049314	0.07688237190007334
OPITZ G/BBB SYNDROME	0.002049314	0.07688237190007334
PEROXISOME BIOGENESIS DISORDER 3B	0.002049314	0.07688237190007334
LATERAL MENINGOCELE SYNDROME	0.002049314	0.07688237190007334
GALACTOSE EPIMERASE DEFICIENCY	0.002049314	0.07688237190007334
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.002049314	0.07688237190007334
STEEL SYNDROME; STLS	0.002049314	0.07688237190007334
8Q12 MICRODUPLICATION SYNDROME	0.002049314	0.07688237190007334
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.002049314	0.07688237190007334
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.002049314	0.07688237190007334
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.002049314	0.07688237190007334
NOONAN SYNDROME 11; NS11	0.002049314	0.07688237190007334
CDAGS SYNDROME	0.002049314	0.07688237190007334
THAUVIN-ROBINET-FAIVRE SYNDROME	0.002049314	0.07688237190007334
JOUBERT SYNDROME 21	0.002049314	0.07688237190007334
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.002049314	0.07688237190007334
NOONAN SYNDROME 6; NS6	0.002049314	0.07688237190007334
IMMUNODEFICIENCY 23; IMD23	0.002049314	0.07688237190007334
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.002049314	0.07688237190007334
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.002049314	0.07688237190007334
RETINITIS PIGMENTOSA 59; RP59	0.0020451790000000003	0.0767272426188569
HADDAD SYNDROME	0.0020451790000000003	0.0767272426188569
FOUNTAIN SYNDROME	0.0020451790000000003	0.0767272426188569
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.0020451790000000003	0.0767272426188569
FOUNTAIN SYNDROME	0.0020451790000000003	0.0767272426188569
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.0020451790000000003	0.0767272426188569
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.0020451790000000003	0.0767272426188569
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.0020451790000000003	0.0767272426188569
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.0020451790000000003	0.0767272426188569
CONGENITAL HYDROCEPHALUS	0.0020451790000000003	0.0767272426188569
ACUTE BILIRUBIN ENCEPHALOPATHY	0.0020451790000000003	0.0767272426188569
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.0020451790000000003	0.0767272426188569
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.0020451790000000003	0.0767272426188569
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.0020451790000000003	0.0767272426188569
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.0020451790000000003	0.0767272426188569
RAMON SYNDROME	0.0020451790000000003	0.0767272426188569
THYROCEREBRORETINAL SYNDROME	0.0020451790000000003	0.0767272426188569
SAETHRE-CHOTZEN SYNDROME	0.0020451790000000003	0.0767272426188569
HYPERLEUCINE-ISOLEUCINEMIA	0.0020451790000000003	0.0767272426188569
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.0020451790000000003	0.0767272426188569
IMMUNODEFICIENCY 47	0.0020451790000000003	0.0767272426188569
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.0020451790000000003	0.0767272426188569
THYROCEREBRORENAL SYNDROME	0.0020451790000000003	0.0767272426188569
LOWRY-WOOD SYNDROME	0.00196125	0.07357854964589068
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00196125	0.07357854964589068
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00196125	0.07357854964589068
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00196125	0.07357854964589068
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00196125	0.07357854964589068
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00196125	0.07357854964589068
FOCAL DERMAL HYPOPLASIA; FDH	0.00196125	0.07357854964589068
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00196125	0.07357854964589068
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00196125	0.07357854964589068
ATAXIA-PANCYTOPENIA SYNDROME	0.00196125	0.07357854964589068
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00196125	0.07357854964589068
MUCOLIPIDOSIS TYPE IV	0.00196125	0.07357854964589068
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00196125	0.07357854964589068
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001843403	0.06915738388929706
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001843403	0.06915738388929706
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.001843403	0.06915738388929706
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001843403	0.06915738388929706
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.001843403	0.06915738388929706
HOLOPROSENCEPHALY 1; HPE1	0.001843403	0.06915738388929706
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001843403	0.06915738388929706
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001843403	0.06915738388929706
LISSENCEPHALY 4	0.001843403	0.06915738388929706
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001843403	0.06915738388929706
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.001843403	0.06915738388929706
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001843403	0.06915738388929706
SMITH-MAGENIS SYNDROME	0.001843403	0.06915738388929706
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001843403	0.06915738388929706
15Q14 MICRODELETION SYNDROME	0.001843403	0.06915738388929706
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001843403	0.06915738388929706
KBG SYNDROME	0.001843403	0.06915738388929706
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001843403	0.06915738388929706
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001843403	0.06915738388929706
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001843403	0.06915738388929706
KLEEFSTRA SYNDROME 2; KLEFS2	0.001843403	0.06915738388929706
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.001843403	0.06915738388929706
HOLOPROSENCEPHALY 2; HPE2	0.001843403	0.06915738388929706
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001843403	0.06915738388929706
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001843403	0.06915738388929706
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001843403	0.06915738388929706
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001843403	0.06915738388929706
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001843403	0.06915738388929706
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.001843403	0.06915738388929706
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001843403	0.06915738388929706
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001843403	0.06915738388929706
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001843403	0.06915738388929706
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.001843403	0.06915738388929706
DPAGT1-CDG	0.001843403	0.06915738388929706
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.001843403	0.06915738388929706
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001843403	0.06915738388929706
CK SYNDROME	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001843403	0.06915738388929706
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001843403	0.06915738388929706
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001843403	0.06915738388929706
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001843403	0.06915738388929706
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001843403	0.06915738388929706
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001843403	0.06915738388929706
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001843403	0.06915738388929706
XQ28 (MECP2) DUPLICATION	0.001843403	0.06915738388929706
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.001843403	0.06915738388929706
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001843403	0.06915738388929706
RUVALCABA SYNDROME	0.001843403	0.06915738388929706
COFFIN-SIRIS SYNDROME 5	0.001843403	0.06915738388929706
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001843403	0.06915738388929706
PITT-HOPKINS SYNDROME	0.001843403	0.06915738388929706
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001843403	0.06915738388929706
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001843403	0.06915738388929706
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001843403	0.06915738388929706
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.001843403	0.06915738388929706
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001843403	0.06915738388929706
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001843403	0.06915738388929706
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001843403	0.06915738388929706
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001843403	0.06915738388929706
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001843403	0.06915738388929706
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.001843403	0.06915738388929706
DISTAL MONOSOMY 10Q	0.001843403	0.06915738388929706
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001843403	0.06915738388929706
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.001843403	0.06915738388929706
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001843403	0.06915738388929706
10Q22.3Q23.3 MICRODELETION SYNDROME	0.001843403	0.06915738388929706
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001843403	0.06915738388929706
FILIPPI SYNDROME	0.001843403	0.06915738388929706
8P23.1 MICRODELETION SYNDROME	0.001843403	0.06915738388929706
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.001843403	0.06915738388929706
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001843403	0.06915738388929706
SSR4-CDG	0.001843403	0.06915738388929706
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.001843403	0.06915738388929706
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001843403	0.06915738388929706
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.001843403	0.06915738388929706
ALG3-CDG	0.001843403	0.06915738388929706
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001843403	0.06915738388929706
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001843403	0.06915738388929706
STT3A-CDG	0.001843403	0.06915738388929706
STT3B-CDG	0.001843403	0.06915738388929706
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001843403	0.06915738388929706
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001843403	0.06915738388929706
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001843403	0.06915738388929706
KBG SYNDROME	0.001843403	0.06915738388929706
MATERNAL PHENYLKETONURIA	0.001843403	0.06915738388929706
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001843403	0.06915738388929706
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.001843403	0.06915738388929706
2Q37 MICRODELETION SYNDROME	0.001843403	0.06915738388929706
C SYNDROME	0.001843403	0.06915738388929706
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001843403	0.06915738388929706
ALG1-CDG	0.001843403	0.06915738388929706
HOLOPROSENCEPHALY	0.001843403	0.06915738388929706
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001843403	0.06915738388929706
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001843403	0.06915738388929706
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001843403	0.06915738388929706
RING CHROMOSOME 22 SYNDROME	0.001843403	0.06915738388929706
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001843403	0.06915738388929706
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001843403	0.06915738388929706
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.001843403	0.06915738388929706
17Q11.2 MICRODUPLICATION SYNDROME	0.001843403	0.06915738388929706
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001843403	0.06915738388929706
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001843403	0.06915738388929706
CHROMOSOME 16P13.3 DELETION SYNDROME	0.001843403	0.06915738388929706
DISTAL MONOSOMY 1Q	0.001843403	0.06915738388929706
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001843403	0.06915738388929706
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001843403	0.06915738388929706
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001843403	0.06915738388929706
MEHMO SYNDROME; MEHMO	0.001843403	0.06915738388929706
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.001843403	0.06915738388929706
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00178253	0.06687366327611959
OTODENTAL SYNDROME	0.00178253	0.06687366327611959
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00178253	0.06687366327611959
MEGALOCORNEA	0.00178253	0.06687366327611959
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.00178253	0.06687366327611959
MICROPHTHALMIA, ISOLATED 5	0.00178253	0.06687366327611959
IDIOPATHIC PANUVEITIS	0.00178253	0.06687366327611959
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.00178253	0.06687366327611959
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.00178253	0.06687366327611959
ROTHMUND-THOMSON SYNDROME TYPE 2	0.00178253	0.06687366327611959
ROTHMUND-THOMSON SYNDROME TYPE 1	0.00178253	0.06687366327611959
PROTEUS-LIKE SYNDROME	0.00178253	0.06687366327611959
DERMATITIS, ATOPIC	0.00178253	0.06687366327611959
ENHANCED S-CONE SYNDROME	0.00178253	0.06687366327611959
POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS	0.00178253	0.06687366327611959
MUSCULAR DYSTROPHY, CONGENITAL, WITH INFANTILE CATARACT AND HYPOGONADISM	0.00178253	0.06687366327611959
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.00178253	0.06687366327611959
PACHYONYCHIA CONGENITA	0.00178253	0.06687366327611959
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00178253	0.06687366327611959
%609376 CATARACT 35; CTRCT35;;CATARACT, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE 1; CATCN1	0.00178253	0.06687366327611959
COENZYME Q10 DEFICIENCY	0.00178253	0.06687366327611959
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.00178253	0.06687366327611959
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00178253	0.06687366327611959
COATS DISEASE	0.00178253	0.06687366327611959
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00178253	0.06687366327611959
WEILL-MARCHESANI SYNDROME	0.00178253	0.06687366327611959
HYPERGONADOTROPIC HYPOGONADISM-CATARACT SYNDROME	0.00178253	0.06687366327611959
HIDROTIC ECTODERMAL DYSPLASIA	0.00178253	0.06687366327611959
TRIPLOIDY	0.00178253	0.06687366327611959
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00178253	0.06687366327611959
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.00178253	0.06687366327611959
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.00178253	0.06687366327611959
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00178253	0.06687366327611959
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00178253	0.06687366327611959
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	0.00178253	0.06687366327611959
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00178253	0.06687366327611959
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00178253	0.06687366327611959
STEINERT MYOTONIC DYSTROPHY	0.00178253	0.06687366327611959
WERNER SYNDROME; WRN	0.00178253	0.06687366327611959
GORLIN SYNDROME	0.00178253	0.06687366327611959
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00178253	0.06687366327611959
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.00178253	0.06687366327611959
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.00178253	0.06687366327611959
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00178253	0.06687366327611959
INTERMEDIATE UVEITIS	0.00178253	0.06687366327611959
FRONTOFACIONASAL DYSPLASIA	0.00178253	0.06687366327611959
HYPERTROPHIC NEUROPATHY AND CATARACT	0.00178253	0.06687366327611959
MYOTONIC DYSTROPHY 1	0.00178253	0.06687366327611959
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00178253	0.06687366327611959
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00178253	0.06687366327611959
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00178253	0.06687366327611959
AUTOSOMAL RECESSIVE PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.00178253	0.06687366327611959
AMOEBIC KERATITIS	0.00178253	0.06687366327611959
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.00178253	0.06687366327611959
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.00178253	0.06687366327611959
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.00178253	0.06687366327611959
ANIRIDIA 3	0.00178253	0.06687366327611959
ANIRIDIA 2	0.00178253	0.06687366327611959
DOWN SYNDROME	0.00178253	0.06687366327611959
ALAGILLE SYNDROME 1; ALGS1	0.00178253	0.06687366327611959
DENT DISEASE	0.00178253	0.06687366327611959
EXFOLIATION SYNDROME; XFS	0.00178253	0.06687366327611959
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.00178253	0.06687366327611959
GROENOUW TYPE I CORNEAL DYSTROPHY	0.00178253	0.06687366327611959
BARDET-BIEDL SYNDROME 18; BBS18	0.00178253	0.06687366327611959
116100 CATARACT, MEMBRANOUS	0.00178253	0.06687366327611959
PROXIMAL MYOTONIC MYOPATHY	0.00178253	0.06687366327611959
GALACTOSEMIA	0.00178253	0.06687366327611959
IRIS PIGMENT LAYER, CLEAVAGE OF	0.00178253	0.06687366327611959
GALACTOKINASE DEFICIENCY	0.00178253	0.06687366327611959
MONILETHRIX	0.00178253	0.06687366327611959
DAHLBERG-BORER-NEWCOMER SYNDROME	0.00178253	0.06687366327611959
ANTERIOR SEGMENT DYSGENESIS 8	0.00178253	0.06687366327611959
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.00178253	0.06687366327611959
127200 DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES;;MOORE-FEDERMAN SYNDROME	0.00178253	0.06687366327611959
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.00178253	0.06687366327611959
SPONASTRIME DYSPLASIA	0.00178253	0.06687366327611959
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00178253	0.06687366327611959
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00178253	0.06687366327611959
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00178253	0.06687366327611959
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.00178253	0.06687366327611959
CONE-ROD DYSTROPHY 16	0.00178253	0.06687366327611959
%225200 ECTOPIA LENTIS ET PUPILLAE;;ECTOPIA LENTIS WITH ECTOPIA OF PUPIL	0.00178253	0.06687366327611959
MULTIPLE EPIPHYSEAL DYSPLASIA, BEIGHTON TYPE	0.00178253	0.06687366327611959
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.00178253	0.06687366327611959
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00178253	0.06687366327611959
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00178253	0.06687366327611959
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00178253	0.06687366327611959
ANIRIDIA, MICROCORNEA, AND SPONTANEOUSLY REABSORBED CATARACT	0.00178253	0.06687366327611959
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00178253	0.06687366327611959
ALG8-CDG	0.00178253	0.06687366327611959
SPINAL MUSCULAR ATROPHY-DANDY-WALKER MALFORMATION-CATARACTS SYNDROME	0.00178253	0.06687366327611959
ANIRIDIA-INTELLECTUAL DISABILITY SYNDROME	0.00178253	0.06687366327611959
LEBER CONGENITAL AMAUROSIS, TYPE II	0.00178253	0.06687366327611959
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00178253	0.06687366327611959
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00178253	0.06687366327611959
BIRDSHOT CHORIORETINOPATHY	0.00178253	0.06687366327611959
CLASSIC GALACTOSEMIA	0.00178253	0.06687366327611959
WOOLLY HAIR	0.00178253	0.06687366327611959
ANIRIDIA AND ABSENT PATELLA	0.00178253	0.06687366327611959
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.00178253	0.06687366327611959
VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD	0.00178253	0.06687366327611959
BASAL CELL NEVUS SYNDROME	0.00178253	0.06687366327611959
TRICHOMEGALY; TCMGLY	0.00178253	0.06687366327611959
BRANCHIO-OCULO-FACIAL SYNDROME	0.00178253	0.06687366327611959
RETINITIS PIGMENTOSA 84; RP84	0.00178253	0.06687366327611959
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.00178253	0.06687366327611959
CATARACT AND CONGENITAL ICHTHYOSIS	0.00178253	0.06687366327611959
HYPOGONADISM-CATARACT SYNDROME	0.00178253	0.06687366327611959
CATARACT, CRYSTALLINE CORALLIFORM	0.00178253	0.06687366327611959
GALACTOKINASE DEFICIENCY	0.00178253	0.06687366327611959
RETINITIS PIGMENTOSA 4; RP4	0.00178253	0.06687366327611959
OROFACIODIGITAL SYNDROME VI	0.0017503739999999999	0.06566729394920395
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.0017503739999999999	0.06566729394920395
REVESZ SYNDROME	0.0017503739999999999	0.06566729394920395
NAVAJO NEUROHEPATOPATHY	0.0017503739999999999	0.06566729394920395
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.0017503739999999999	0.06566729394920395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.0017503739999999999	0.06566729394920395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.0017503739999999999	0.06566729394920395
SPINOCEREBELLAR ATAXIA TYPE 29	0.0017503739999999999	0.06566729394920395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.0017503739999999999	0.06566729394920395
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.0017503739999999999	0.06566729394920395
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.0017503739999999999	0.06566729394920395
JOUBERT SYNDROME 32; JBTS32	0.0017503739999999999	0.06566729394920395
JOUBERT SYNDROME 31; JBTS31	0.0017503739999999999	0.06566729394920395
JOUBERT SYNDROME 7	0.0017503739999999999	0.06566729394920395
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.0017503739999999999	0.06566729394920395
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0017503739999999999	0.06566729394920395
JOUBERT SYNDROME 2	0.0017503739999999999	0.06566729394920395
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.0017503739999999999	0.06566729394920395
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.0017503739999999999	0.06566729394920395
CARDIOFACIOCUTANEOUS SYNDROME	0.0017503739999999999	0.06566729394920395
BAKER-GORDON SYNDROME; BAGOS	0.0017503739999999999	0.06566729394920395
SPINOCEREBELLAR ATAXIA TYPE 7	0.0017503739999999999	0.06566729394920395
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.0017503739999999999	0.06566729394920395
CEREBELLAR ATAXIA, CAYMAN TYPE	0.0017503739999999999	0.06566729394920395
FARBER DISEASE	0.0017503739999999999	0.06566729394920395
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.0017503739999999999	0.06566729394920395
JOUBERT SYNDROME 27	0.0017503739999999999	0.06566729394920395
NEPHRONOPHTHISIS 11; NPHP11	0.0017503739999999999	0.06566729394920395
JOUBERT SYNDROME 26	0.0017503739999999999	0.06566729394920395
JOUBERT SYNDROME 24	0.0017503739999999999	0.06566729394920395
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.0017503739999999999	0.06566729394920395
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.0017503739999999999	0.06566729394920395
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.0017503739999999999	0.06566729394920395
SENIOR-LOKEN SYNDROME 9	0.0017503739999999999	0.06566729394920395
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.0017503739999999999	0.06566729394920395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0017503739999999999	0.06566729394920395
CRANIOFRONTONASAL SYNDROME; CFNS	0.0017503739999999999	0.06566729394920395
JOUBERT SYNDROME 28	0.0017503739999999999	0.06566729394920395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.0017503739999999999	0.06566729394920395
ARIMA SYNDROME	0.0017503739999999999	0.06566729394920395
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.0017503739999999999	0.06566729394920395
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.001746239	0.06551216466798751
INFANTILE NEUROAXONAL DYSTROPHY	0.001746239	0.06551216466798751
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.001746239	0.06551216466798751
LISSENCEPHALY, X-LINKED, 1; LISX1	0.001746239	0.06551216466798751
OCULOCEREBROCUTANEOUS SYNDROME	0.001746239	0.06551216466798751
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.001746239	0.06551216466798751
ATAXIA-TELANGIECTASIA	0.001746239	0.06551216466798751
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.001746239	0.06551216466798751
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.001746239	0.06551216466798751
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.001746239	0.06551216466798751
MOMO SYNDROME	0.001746239	0.06551216466798751
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.001746239	0.06551216466798751
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.001746239	0.06551216466798751
METACHROMATIC LEUKODYSTROPHY	0.001746239	0.06551216466798751
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.001746239	0.06551216466798751
EPISODIC ATAXIA TYPE 3	0.001746239	0.06551216466798751
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.001746239	0.06551216466798751
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.001746239	0.06551216466798751
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.001746239	0.06551216466798751
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.001746239	0.06551216466798751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.001746239	0.06551216466798751
GAPO SYNDROME; GAPOS	0.001746239	0.06551216466798751
MALAN OVERGROWTH SYNDROME	0.001746239	0.06551216466798751
EPISODIC ATAXIA, TYPE 6	0.001746239	0.06551216466798751
PERRAULT SYNDROME 5; PRLTS5	0.001746239	0.06551216466798751
SECONDARY SYRINGOMYELIA	0.001746239	0.06551216466798751
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.001746239	0.06551216466798751
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.001746239	0.06551216466798751
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.001746239	0.06551216466798751
HUNTINGTON DISEASE-LIKE 1	0.001746239	0.06551216466798751
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.001746239	0.06551216466798751
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.001746239	0.06551216466798751
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.001746239	0.06551216466798751
MESOMELIA-SYNOSTOSES SYNDROME	0.00151745	0.056928882172164096
184705 STEINFELD SYNDROME	0.00151745	0.056928882172164096
BROOKE-SPIEGLER SYNDROME	0.00151745	0.056928882172164096
%615654 DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58	0.00151745	0.056928882172164096
AUROCEPHALOSYNDACTYLY	0.00151745	0.056928882172164096
TUNE DEAFNESS	0.00151745	0.056928882172164096
DEAFNESS, X-LINKED 5; DFNX5	0.00151745	0.056928882172164096
%615649 DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54	0.00151745	0.056928882172164096
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00151745	0.056928882172164096
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00151745	0.056928882172164096
PILI TORTI	0.00151745	0.056928882172164096
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00151745	0.056928882172164096
MELNICK-NEEDLES SYNDROME	0.00151745	0.056928882172164096
ANUS, IMPERFORATE	0.00151745	0.056928882172164096
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00151745	0.056928882172164096
NAGER SYNDROME	0.00151745	0.056928882172164096
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.00151745	0.056928882172164096
PITUITARY CARCINOMA	0.00151745	0.056928882172164096
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00151745	0.056928882172164096
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00151745	0.056928882172164096
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00151745	0.056928882172164096
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00151745	0.056928882172164096
USHER SYNDROME, TYPE ID	0.00151745	0.056928882172164096
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.00151745	0.056928882172164096
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00151745	0.056928882172164096
DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65	0.00151745	0.056928882172164096
TURCOT SYNDROME WITH POLYPOSIS	0.00151745	0.056928882172164096
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.00151745	0.056928882172164096
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.00151745	0.056928882172164096
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.00151745	0.056928882172164096
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.00151745	0.056928882172164096
DEAFNESS, AUTOSOMAL RECESSIVE 47	0.00151745	0.056928882172164096
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00151745	0.056928882172164096
CONE-ROD DYSTROPHY 1; CORD1	0.00151745	0.056928882172164096
3MC SYNDROME	0.00151745	0.056928882172164096
ISOLATED KLIPPEL-FEIL SYNDROME	0.00151745	0.056928882172164096
BARBER-SAY SYNDROME; BBRSAY	0.00151745	0.056928882172164096
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.00151745	0.056928882172164096
ABCD SYNDROME	0.00151745	0.056928882172164096
CAMPOMELIC DYSPLASIA	0.00151745	0.056928882172164096
LOCKED-IN SYNDROME	0.00151745	0.056928882172164096
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA	0.00151745	0.056928882172164096
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 2	0.00151745	0.056928882172164096
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.00151745	0.056928882172164096
DEAFNESS, AUTOSOMAL RECESSIVE 55	0.00151745	0.056928882172164096
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00151745	0.056928882172164096
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.00151745	0.056928882172164096
WILDERVANCK SYNDROME	0.00151745	0.056928882172164096
PAGET DISEASE OF BONE 4; PDB4	0.00151745	0.056928882172164096
CARNEY-STRATAKIS SYNDROME	0.00151745	0.056928882172164096
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00151745	0.056928882172164096
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00151745	0.056928882172164096
DEAFNESS, AUTOSOMAL RECESSIVE 33	0.00151745	0.056928882172164096
RETICULAR DYSGENESIS	0.00151745	0.056928882172164096
DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OFFINGERS AND TOES	0.00151745	0.056928882172164096
CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS	0.00151745	0.056928882172164096
KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	0.00151745	0.056928882172164096
KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	0.00151745	0.056928882172164096
THALIDOMIDE EMBRYOPATHY	0.00151745	0.056928882172164096
DEAFNESS-CRANIOFACIAL SYNDROME	0.00151745	0.056928882172164096
DEAFNESS, X-LINKED 7; DFNX7	0.00151745	0.056928882172164096
DEAFNESS, AUTOSOMAL DOMINANT 24	0.00151745	0.056928882172164096
EAR EXOSTOSES	0.00151745	0.056928882172164096
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00151745	0.056928882172164096
PFEIFFER SYNDROME TYPE 1	0.00151745	0.056928882172164096
IVIC SYNDROME	0.00151745	0.056928882172164096
DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73	0.00151745	0.056928882172164096
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.00151745	0.056928882172164096
CAMURATI-ENGELMANN DISEASE	0.00151745	0.056928882172164096
DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107	0.00151745	0.056928882172164096
DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106	0.00151745	0.056928882172164096
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.00151745	0.056928882172164096
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00151745	0.056928882172164096
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00151745	0.056928882172164096
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00151745	0.056928882172164096
SPINOCEREBELLAR ATAXIA TYPE 36	0.00151745	0.056928882172164096
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.00151745	0.056928882172164096
CHARGE-LIKE SYNDROME, X-LINKED	0.00151745	0.056928882172164096
ACRODYSOSTOSIS	0.00151745	0.056928882172164096
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00151745	0.056928882172164096
MENIERE DISEASE	0.00151745	0.056928882172164096
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.00151745	0.056928882172164096
OTOSCLEROSIS 3; OTSC3	0.00151745	0.056928882172164096
DEMENTIA, FAMILIAL DANISH	0.00151745	0.056928882172164096
RETINAL VENOUS BEADING	0.00151745	0.056928882172164096
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.00151745	0.056928882172164096
PULMONIC STENOSIS AND DEAFNESS	0.00151745	0.056928882172164096
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00151745	0.056928882172164096
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00151745	0.056928882172164096
ISOLATED BRACHYCEPHALY	0.00151745	0.056928882172164096
CORNEODERMATOOSSEOUS SYNDROME	0.00151745	0.056928882172164096
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.00151745	0.056928882172164096
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.00151745	0.056928882172164096
DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74	0.00151745	0.056928882172164096
CLEIDOCRANIAL DYSPLASIA; CCD	0.00151745	0.056928882172164096
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.00151745	0.056928882172164096
PAGET DISEASE OF BONE 3; PDB3	0.00151745	0.056928882172164096
BRANCHIOOTIC SYNDROME 2	0.00151745	0.056928882172164096
COXOAURICULAR SYNDROME	0.00151745	0.056928882172164096
OSTEOGENESIS IMPERFECTA, TYPE IV	0.00151745	0.056928882172164096
OSTEOGENESIS IMPERFECTA, TYPE I	0.00151745	0.056928882172164096
MAYER-ROKITANSKY-KÃœSTER-HAUSER SYNDROME TYPE 2	0.00151745	0.056928882172164096
DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41	0.00151745	0.056928882172164096
WAARDENBURG-SHAH SYNDROME	0.00151745	0.056928882172164096
121450 CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS;;BAND KERATOPATHY WITH DEAFNESS	0.00151745	0.056928882172164096
%607683 DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52;;DEAFNESS, AUTOSOMAL DOMINANT 42; DFNA42	0.00151745	0.056928882172164096
X-LINKED HYPOPHOSPHATEMIA	0.00151745	0.056928882172164096
SIFRIM-HITZ-WEISS SYNDROME	0.00151745	0.056928882172164096
OROFACIODIGITAL SYNDROME XVII	0.00151745	0.056928882172164096
N SYNDROME	0.00151745	0.056928882172164096
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.00151745	0.056928882172164096
OTOPALATODIGITAL SYNDROME TYPE 1	0.00151745	0.056928882172164096
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00151745	0.056928882172164096
DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32	0.00151745	0.056928882172164096
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00151745	0.056928882172164096
BRITTLE CORNEA SYNDROME 2; BCS2	0.00151745	0.056928882172164096
ESOPHAGEAL ATRESIA	0.00151745	0.056928882172164096
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00151745	0.056928882172164096
COXOAURICULAR SYNDROME	0.00151745	0.056928882172164096
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.00151745	0.056928882172164096
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00151745	0.056928882172164096
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00151745	0.056928882172164096
CAMPOMELIC DYSPLASIA	0.00151745	0.056928882172164096
%613916 DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89	0.00151745	0.056928882172164096
RAPADILINO SYNDROME	0.00151745	0.056928882172164096
DISTAL TRISOMY 14Q	0.00151745	0.056928882172164096
MORQUIO SYNDROME A	0.00151745	0.056928882172164096
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.00151745	0.056928882172164096
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00151745	0.056928882172164096
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.00151745	0.056928882172164096
SCLEROSTEOSIS 2; SOST2	0.00151745	0.056928882172164096
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.00151745	0.056928882172164096
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00151745	0.056928882172164096
ISOLATED ANORECTAL MALFORMATION	0.00151745	0.056928882172164096
PROLIDASE DEFICIENCY	0.00151745	0.056928882172164096
USHER SYNDROME, TYPE IID; USH2D	0.00151745	0.056928882172164096
KEARNS-SAYRE SYNDROME	0.00151745	0.056928882172164096
SENSORINEURAL DEAFNESS WITH DILATED CARDIOMYOPATHY	0.00151745	0.056928882172164096
GRACILE SYNDROME	0.00151745	0.056928882172164096
ALBERS-SCHÃ–NBERG OSTEOPETROSIS	0.00151745	0.056928882172164096
BARBER-SAY SYNDROME	0.00151745	0.056928882172164096
NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS	0.00151745	0.056928882172164096
TIETZ SYNDROME	0.00151745	0.056928882172164096
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.00151745	0.056928882172164096
RENAL, GENITAL, AND MIDDLE EAR ANOMALIES	0.00151745	0.056928882172164096
CAMURATI-ENGELMANN DISEASE	0.00151745	0.056928882172164096
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00151745	0.056928882172164096
CAT-EYE SYNDROME	0.00151745	0.056928882172164096
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00151745	0.056928882172164096
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00151745	0.056928882172164096
HARDIKAR SYNDROME	0.00151745	0.056928882172164096
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00151745	0.056928882172164096
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00151745	0.056928882172164096
GLYCOGEN STORAGE DISEASE II	0.00151745	0.056928882172164096
%614414 DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96	0.00151745	0.056928882172164096
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.00151745	0.056928882172164096
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.00151745	0.056928882172164096
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00151745	0.056928882172164096
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00151745	0.056928882172164096
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00151745	0.056928882172164096
OTOSCLEROSIS 8; OTSC8	0.00151745	0.056928882172164096
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00151745	0.056928882172164096
3MC SYNDROME 3	0.00151745	0.056928882172164096
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.00151745	0.056928882172164096
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.00151745	0.056928882172164096
CONGENITAL VELOPHARYNGEAL INCOMPETENCE	0.00151745	0.056928882172164096
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.00151745	0.056928882172164096
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.00151745	0.056928882172164096
BOR SYNDROME	0.00151745	0.056928882172164096
%614617 DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86	0.00151745	0.056928882172164096
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.00151745	0.056928882172164096
FETAL IODINE DEFICIENCY DISORDER	0.00151745	0.056928882172164096
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.00151745	0.056928882172164096
IVIC SYNDROME	0.00151745	0.056928882172164096
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.00151745	0.056928882172164096
BRITTLE CORNEA SYNDROME	0.00151745	0.056928882172164096
OPTICOCOCHLEODENTATE DEGENERATION	0.00151745	0.056928882172164096
BONE MARROW FAILURE SYNDROME 1; BMFS1	0.00151745	0.056928882172164096
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00151745	0.056928882172164096
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00151745	0.056928882172164096
RHYNS SYNDROME	0.00151745	0.056928882172164096
AXENFELD-RIEGER SYNDROME	0.00151745	0.056928882172164096
CLEIDOCRANIAL DYSPLASIA	0.00151745	0.056928882172164096
OSTEOGENESIS IMPERFECTA	0.00151745	0.056928882172164096
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.00150376	0.056415286075464414
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.00150376	0.056415286075464414
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL RECESSIVE 26	0.00150376	0.056415286075464414
CARDIOMYOPATHY, DILATED, 1J; CMD1J	0.00150376	0.056415286075464414
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00150376	0.056415286075464414
STICKLER SYNDROME, TYPE V; STL5	0.00150376	0.056415286075464414
PANHYPOPHYSITIS	0.00150376	0.056415286075464414
DEAFNESS, X-LINKED 1	0.00150376	0.056415286075464414
NASODIGITOACOUSTIC SYNDROME	0.00150376	0.056415286075464414
ADENOHYPOPHYSITIS	0.00150376	0.056415286075464414
GINGIVAL FIBROMATOSIS-PROGRESSIVE DEAFNESS SYNDROME	0.00150376	0.056415286075464414
FAMILIAL ISOLATED DILATED CARDIOMYOPATHY	0.00150376	0.056415286075464414
%605818 DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27	0.00150376	0.056415286075464414
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00150376	0.056415286075464414
KEIPERT SYNDROME	0.00150376	0.056415286075464414
ABRUZZO-ERICKSON SYNDROME	0.00150376	0.056415286075464414
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00150376	0.056415286075464414
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.00150376	0.056415286075464414
%607017 DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT 27	0.00150376	0.056415286075464414
ERMINE PHENOTYPE	0.00150376	0.056415286075464414
USHER SYNDROME, TYPE IG	0.00150376	0.056415286075464414
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.00150376	0.056415286075464414
GEMIGNANI SYNDROME	0.00150376	0.056415286075464414
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00150376	0.056415286075464414
COGAN SYNDROME	0.00150376	0.056415286075464414
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00150376	0.056415286075464414
SCHEIE SYNDROME	0.00150376	0.056415286075464414
KEIPERT SYNDROME; KPTS	0.00150376	0.056415286075464414
HURLER-SCHEIE SYNDROME	0.00150376	0.056415286075464414
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00150376	0.056415286075464414
NEPHROPATHY-DEAFNESS-HYPERPARATHYROIDISM SYNDROME	0.00150376	0.056415286075464414
DEAFNESS-CRANIOFACIAL SYNDROME	0.00150376	0.056415286075464414
FACIOSCAPULOHUMERAL DYSTROPHY	0.00150376	0.056415286075464414
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.00150376	0.056415286075464414
KNUCKLE PADS-LEUKONYCHIA-SENSORINEURAL DEAFNESS-PALMOPLANTAR HYPERKERATOSIS SYNDROME	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71	0.00150376	0.056415286075464414
JUBERG-MARSIDI SYNDROME	0.00150376	0.056415286075464414
DEAFNESS-INFERTILITY SYNDROME	0.00150376	0.056415286075464414
CRANIOMETAPHYSEAL DYSPLASIA	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT 25	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT 59	0.00150376	0.056415286075464414
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.00150376	0.056415286075464414
256120 NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM	0.00150376	0.056415286075464414
WOLFRAM SYNDROME 2; WFS2	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL RECESSIVE 68	0.00150376	0.056415286075464414
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.00150376	0.056415286075464414
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT 69	0.00150376	0.056415286075464414
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 13	0.00150376	0.056415286075464414
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00150376	0.056415286075464414
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00150376	0.056415286075464414
NEUTRAL LIPID STORAGE MYOPATHY	0.00150376	0.056415286075464414
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 18	0.00150376	0.056415286075464414
KERATODERMA HEREDITARIUM MUTILANS	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT 66	0.00150376	0.056415286075464414
SCLEROSTEOSIS	0.00150376	0.056415286075464414
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 2	0.00150376	0.056415286075464414
SHORT SYNDROME	0.00150376	0.056415286075464414
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00150376	0.056415286075464414
OPTIC ATROPHY 8	0.00150376	0.056415286075464414
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00150376	0.056415286075464414
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL RECESSIVE 97	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT 68	0.00150376	0.056415286075464414
SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP	0.00150376	0.056415286075464414
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00150376	0.056415286075464414
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 10	0.00150376	0.056415286075464414
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.00150376	0.056415286075464414
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.00150376	0.056415286075464414
DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8	0.00150376	0.056415286075464414
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL RECESSIVE 9	0.00150376	0.056415286075464414
MYH9-RELATED DISEASE	0.00150376	0.056415286075464414
FETAL CYTOMEGALOVIRUS SYNDROME	0.00150376	0.056415286075464414
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 12	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 3	0.00150376	0.056415286075464414
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 7	0.00150376	0.056415286075464414
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 5	0.00150376	0.056415286075464414
ENLARGED VESTIBULAR AQUEDUCT	0.00150376	0.056415286075464414
ALBINISM-DEAFNESS SYNDROME	0.00150376	0.056415286075464414
DEAFNESS, Y-LINKED 2; DFNY2	0.00150376	0.056415286075464414
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00150376	0.056415286075464414
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.00150376	0.056415286075464414
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.00150376	0.056415286075464414
KID SYNDROME	0.00150376	0.056415286075464414
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00150376	0.056415286075464414
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.00150376	0.056415286075464414
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64	0.00150376	0.056415286075464414
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT 50	0.00150376	0.056415286075464414
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00150376	0.056415286075464414
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00150376	0.056415286075464414
DEAFNESS, MID-TONE NEURAL	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT 1	0.00150376	0.056415286075464414
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00150376	0.056415286075464414
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.00150376	0.056415286075464414
%614211 DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33	0.00150376	0.056415286075464414
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00150376	0.056415286075464414
DEAFNESS-OLIGODONTIA SYNDROME	0.00150376	0.056415286075464414
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00150376	0.056415286075464414
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL RECESSIVE 13	0.00150376	0.056415286075464414
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.00150376	0.056415286075464414
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE	0.00150376	0.056415286075464414
BRANCHIOOTIC SYNDROME	0.00150376	0.056415286075464414
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.00150376	0.056415286075464414
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00150376	0.056415286075464414
115250 COLLAGENOMA, FAMILIAL CUTANEOUS	0.00150376	0.056415286075464414
DEAFNESS, Y-LINKED 1	0.00150376	0.056415286075464414
WOODHOUSE-SAKATI SYNDROME	0.00150376	0.056415286075464414
EEC SYNDROME	0.00150376	0.056415286075464414
WAARDENBURG SYNDROME, TYPE 4B; WS4B	0.00150376	0.056415286075464414
AUTOSOMAL DOMINANT OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00150376	0.056415286075464414
NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL RECESSIVE 14	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16	0.00150376	0.056415286075464414
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.00150376	0.056415286075464414
RENAL CALICEAL DIVERTICULI-DEAFNESS SYNDROME	0.00150376	0.056415286075464414
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT 30	0.00150376	0.056415286075464414
ACROCRANIOFACIAL DYSOSTOSIS	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 49	0.00150376	0.056415286075464414
HAMAMY SYNDROME; HMMS	0.00150376	0.056415286075464414
PALMOPLANTAR KERATODERMA-DEAFNESS SYNDROME	0.00150376	0.056415286075464414
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.00150376	0.056415286075464414
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.00150376	0.056415286075464414
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00150376	0.056415286075464414
DEAFNESS, NEURAL, CONGENITAL MODERATE	0.00150376	0.056415286075464414
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00150376	0.056415286075464414
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT 47	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL RECESSIVE 113	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 28	0.00150376	0.056415286075464414
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.00150376	0.056415286075464414
SPONDYLOPERIPHERAL DYSPLASIA	0.00150376	0.056415286075464414
ACROCALLOSAL SYNDROME	0.00150376	0.056415286075464414
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00150376	0.056415286075464414
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00150376	0.056415286075464414
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.00150376	0.056415286075464414
MIDDLE EAR NEUROENDOCRINE TUMOR	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL RECESSIVE 51	0.00150376	0.056415286075464414
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT 43	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL RECESSIVE 99	0.00150376	0.056415286075464414
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 42	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL RECESSIVE 115; DFNB115	0.00150376	0.056415286075464414
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00150376	0.056415286075464414
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00150376	0.056415286075464414
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00150376	0.056415286075464414
ISOLATED SPLIT HAND-SPLIT FOOT MALFORMATION	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL RECESSIVE 100; DFNB100	0.00150376	0.056415286075464414
KERATODERMA HEREDITARIUM MUTILANS WITH ICHTHYOSIS	0.00150376	0.056415286075464414
PERRAULT SYNDROME 2; PRLTS2	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL DOMINANT 53	0.00150376	0.056415286075464414
PENDRED SYNDROME	0.00150376	0.056415286075464414
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00150376	0.056415286075464414
DEAFNESS, X-LINKED 4	0.00150376	0.056415286075464414
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.00150376	0.056415286075464414
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00150376	0.056415286075464414
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.00150376	0.056415286075464414
BRACHYDACTYLY, TYPE B2	0.00150376	0.056415286075464414
LOWE-KOHN-COHEN SYNDROME	0.00150376	0.056415286075464414
AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL RECESSIVE 114; DFNB114	0.00150376	0.056415286075464414
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00150376	0.056415286075464414
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00150376	0.056415286075464414
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.056415286075464414
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.00150376	0.056415286075464414
DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS	0.00150376	0.056415286075464414
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00150376	0.056415286075464414
HYPEROSTOSIS CORTICALIS GENERALISATA	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL RECESSIVE 57; DFNB57	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL RECESSIVE 110; DFNB110	0.00150376	0.056415286075464414
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00150376	0.056415286075464414
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.00150376	0.056415286075464414
USHER SYNDROME, TYPE IIIA	0.00150376	0.056415286075464414
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00150376	0.056415286075464414
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00150376	0.056415286075464414
HEMIFACIAL MICROSOMIA	0.00150376	0.056415286075464414
FAMILIAL LONG QT SYNDROME	0.00150376	0.056415286075464414
MADRAS MOTOR NEURON DISEASE	0.00150376	0.056415286075464414
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.00150376	0.056415286075464414
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00150376	0.056415286075464414
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 24	0.00150376	0.056415286075464414
BJÃ–RNSTAD SYNDROME	0.00150376	0.056415286075464414
HIRSCHSPRUNG DISEASE	0.00150376	0.056415286075464414
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00150376	0.056415286075464414
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 27	0.00150376	0.056415286075464414
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.00150376	0.056415286075464414
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.00150376	0.056415286075464414
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103	0.00150376	0.056415286075464414
MENTAL RETARDATION, X-LINKED 46	0.00150376	0.056415286075464414
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00150376	0.056415286075464414
SENSORINEURAL HEARING LOSS-EARLY GRAYING-ESSENTIAL TREMOR SYNDROME	0.00150376	0.056415286075464414
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.00150376	0.056415286075464414
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00150376	0.056415286075464414
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00150376	0.056415286075464414
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL RECESSIVE 23	0.00150376	0.056415286075464414
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00150376	0.056415286075464414
DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66	0.00150376	0.056415286075464414
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00150376	0.056415286075464414
OTODENTAL DYSPLASIA	0.00150376	0.056415286075464414
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.00150376	0.056415286075464414
221745 DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE	0.00150376	0.056415286075464414
HIRSCHSPRUNG DISEASE-DEAFNESS-POLYDACTYLY SYNDROME	0.00150376	0.056415286075464414
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.00150376	0.056415286075464414
RADIO-ULNAR SYNOSTOSIS-AMEGAKARYOCYTIC THROMBOCYTOPENIA SYNDROME	0.00150376	0.056415286075464414
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00150376	0.056415286075464414
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00150376	0.056415286075464414
WAARDENBURG SYNDROME TYPE 2	0.00150376	0.056415286075464414
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00150376	0.056415286075464414
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.001301984	0.04884542734590457
FETAL TRIMETHADIONE SYNDROME	0.001301984	0.04884542734590457
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.001301984	0.04884542734590457
ALAZAMI-YUAN SYNDROME	0.001301984	0.04884542734590457
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.001301984	0.04884542734590457
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.001301984	0.04884542734590457
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.001301984	0.04884542734590457
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001301984	0.04884542734590457
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.001301984	0.04884542734590457
TOLUENE EMBRYOPATHY	0.001301984	0.04884542734590457
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.001301984	0.04884542734590457
PHENOBARBITAL EMBRYOPATHY	0.001301984	0.04884542734590457
FETAL ALCOHOL SYNDROME	0.001301984	0.04884542734590457
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.001301984	0.04884542734590457
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.001301984	0.04884542734590457
ALAZAMI SYNDROME; ALAZS	0.001301984	0.04884542734590457
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.001301984	0.04884542734590457
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001301984	0.04884542734590457
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.001301984	0.04884542734590457
LIG4 SYNDROME	0.001301984	0.04884542734590457
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.001301984	0.04884542734590457
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.001301984	0.04884542734590457
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.001301984	0.04884542734590457
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.001301984	0.04884542734590457
12Q14 MICRODELETION SYNDROME	0.001301984	0.04884542734590457
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.001301984	0.04884542734590457
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.001301984	0.04884542734590457
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.001301984	0.04884542734590457
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.001301984	0.04884542734590457
SECKEL SYNDROME 9; SCKL9	0.001301984	0.04884542734590457
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.001301984	0.04884542734590457
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.001301984	0.04884542734590457
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.001301984	0.04884542734590457
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.001301984	0.04884542734590457
TURNPENNY-FRY SYNDROME; TPFS	0.001301984	0.04884542734590457
TRISOMY 9P	0.001301984	0.04884542734590457
FORSYTHE-WAKELING SYNDROME; FWS	0.001301984	0.04884542734590457
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.001301984	0.04884542734590457
LOWRY-MACLEAN SYNDROME	0.001301984	0.04884542734590457
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.001301984	0.04884542734590457
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.001301984	0.04884542734590457
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.001301984	0.04884542734590457
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.001301984	0.04884542734590457
HARTSFIELD SYNDROME; HRTFDS	0.001301984	0.04884542734590457
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.001301984	0.04884542734590457
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.001301984	0.04884542734590457
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001301984	0.04884542734590457
HOLOPROSENCEPHALY 5; HPE5	0.001301984	0.04884542734590457
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.001301984	0.04884542734590457
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.001301984	0.04884542734590457
RIDDLE SYNDROME	0.001301984	0.04884542734590457
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.001301984	0.04884542734590457
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.001301984	0.04884542734590457
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.001301984	0.04884542734590457
17Q21.31 MICRODUPLICATION SYNDROME	0.001301984	0.04884542734590457
OKAMOTO SYNDROME	0.001301984	0.04884542734590457
CRANIOTELENCEPHALIC DYSPLASIA	0.001301984	0.04884542734590457
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.001301984	0.04884542734590457
OGDEN SYNDROME; OGDNS	0.001301984	0.04884542734590457
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.001301984	0.04884542734590457
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.001301984	0.04884542734590457
CEREBELLOFACIODENTAL SYNDROME	0.001301984	0.04884542734590457
ADAMS-OLIVER SYNDROME 3; AOS3	0.001301984	0.04884542734590457
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.001301984	0.04884542734590457
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.001301984	0.04884542734590457
%300712 CRANIOFACIOSKELETAL SYNDROME	0.001301984	0.04884542734590457
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001301984	0.04884542734590457
HOLMES-GANG SYNDROME	0.001301984	0.04884542734590457
BARATELA-SCOTT SYNDROME	0.001301984	0.04884542734590457
HOLOPROSENCEPHALY 11	0.001301984	0.04884542734590457
HOYERAAL-HREIDARSSON SYNDROME	0.001301984	0.04884542734590457
TONNE-KALSCHEUER SYNDROME; TOKAS	0.001301984	0.04884542734590457
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.001301984	0.04884542734590457
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.001301984	0.04884542734590457
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.001301984	0.04884542734590457
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.001301984	0.04884542734590457
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.001301984	0.04884542734590457
RING CHROMOSOME 12 SYNDROME	0.001301984	0.04884542734590457
LIG4 SYNDROME	0.001301984	0.04884542734590457
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.001301984	0.04884542734590457
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.001301984	0.04884542734590457
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.001301984	0.04884542734590457
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001301984	0.04884542734590457
OROFACIODIGITAL SYNDROME XIV; OFD14	0.001301984	0.04884542734590457
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.001301984	0.04884542734590457
OROFACIODIGITAL SYNDROME TYPE 14	0.001301984	0.04884542734590457
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.001301984	0.04884542734590457
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001301984	0.04884542734590457
HOLOPROSENCEPHALY 3; HPE3	0.001301984	0.04884542734590457
GOLDBERG-SHPRINTZEN SYNDROME	0.001301984	0.04884542734590457
HYPERTRICHOSIS CUBITI	0.001301984	0.04884542734590457
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.001301984	0.04884542734590457
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.001301984	0.04884542734590457
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.001301984	0.04884542734590457
MONOSOMY 13Q34	0.001301984	0.04884542734590457
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.001301984	0.04884542734590457
DESBUQUOIS DYSPLASIA 2; DBQD2	0.001301984	0.04884542734590457
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.001301984	0.04884542734590457
SECKEL SYNDROME 8; SCKL8	0.001301984	0.04884542734590457
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.001301984	0.04884542734590457
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.001301984	0.04884542734590457
AL-RAQAD SYNDROME; ARS	0.001301984	0.04884542734590457
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.001301984	0.04884542734590457
2Q32Q33 MICRODELETION SYNDROME	0.001301984	0.04884542734590457
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.001301984	0.04884542734590457
MUCOLIPIDOSIS IV; ML4	0.001301984	0.04884542734590457
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.001301984	0.04884542734590457
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.001301984	0.04884542734590457
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.001301984	0.04884542734590457
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.001301984	0.04884542734590457
HADZISELIMOVIC SYNDROME	0.001301984	0.04884542734590457
ANGELMAN SYNDROME (TYPE 2)	0.001297849	0.04869029806468812
DUPLICATION/INVERSION 15Q11	0.001297849	0.04869029806468812
WIEDEMANN-STEINER SYNDROME	0.001297849	0.04869029806468812
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.001297849	0.04869029806468812
ANGELMAN SYNDROME (TYPE 1)	0.001297849	0.04869029806468812
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.001297849	0.04869029806468812
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.001297849	0.04869029806468812
TETRASOMY 18P	0.001297849	0.04869029806468812
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.001297849	0.04869029806468812
ANGELMAN SYNDROME	0.001297849	0.04869029806468812
SJÃ–GREN-LARSSON SYNDROME	0.001297849	0.04869029806468812
CAMOS SYNDROME	0.001297849	0.04869029806468812
HEREDITARY METHEMOGLOBINEMIA	0.001297849	0.04869029806468812
ADENYLOSUCCINATE LYASE DEFICIENCY	0.001297849	0.04869029806468812
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.001297849	0.04869029806468812
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.001297849	0.04869029806468812
3-HYDROXYISOBUTYRIC ACIDURIA	0.001297849	0.04869029806468812
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.001297849	0.04869029806468812
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.001297849	0.04869029806468812
SUPRABULBAR PARESIS, CONGENITAL	0.001297849	0.04869029806468812
COHEN SYNDROME	0.001297849	0.04869029806468812
DPM1-CDG	0.001297849	0.04869029806468812
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.001297849	0.04869029806468812
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.001297849	0.04869029806468812
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.001297849	0.04869029806468812
9Q33.3Q34.11 MICRODELETION SYNDROME	0.001297849	0.04869029806468812
20P13 MICRODELETION SYNDROME	0.001297849	0.04869029806468812
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.001297849	0.04869029806468812
TEMPLE-BARAITSER SYNDROME	0.001297849	0.04869029806468812
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.001297849	0.04869029806468812
ADNP SYNDROME	0.001297849	0.04869029806468812
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.001297849	0.04869029806468812
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.001297849	0.04869029806468812
FILIPPI SYNDROME; FLPIS	0.001297849	0.04869029806468812
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.001297849	0.04869029806468812
BANGSTAD SYNDROME	0.001297849	0.04869029806468812
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.001297849	0.04869029806468812
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.001297849	0.04869029806468812
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.001297849	0.04869029806468812
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.001297849	0.04869029806468812
WOLF-HIRSCHHORN SYNDROME	0.001297849	0.04869029806468812
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.001297849	0.04869029806468812
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.001297849	0.04869029806468812
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.001297849	0.04869029806468812
PSEUDO-TORCH SYNDROME 2	0.001297849	0.04869029806468812
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.001297849	0.04869029806468812
5Q35 MICRODUPLICATION SYNDROME	0.001297849	0.04869029806468812
2Q23.1 MICRODELETION SYNDROME	0.001297849	0.04869029806468812
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.001297849	0.04869029806468812
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.001297849	0.04869029806468812
HALL-RIGGS SYNDROME	0.001297849	0.04869029806468812
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.001297849	0.04869029806468812
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.001297849	0.04869029806468812
PITT-HOPKINS SYNDROME	0.001297849	0.04869029806468812
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.001297849	0.04869029806468812
DISTAL MONOSOMY 7Q36	0.001297849	0.04869029806468812
14Q12 MICRODELETION SYNDROME	0.001297849	0.04869029806468812
SYMMETRICAL THALAMIC CALCIFICATIONS	0.001297849	0.04869029806468812
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.001297849	0.04869029806468812
MICROFORM HOLOPROSENCEPHALY	0.001297849	0.04869029806468812
C SYNDROME	0.001297849	0.04869029806468812
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.001297849	0.04869029806468812
PERRAULT SYNDROME 3	0.001297849	0.04869029806468812
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.001297849	0.04869029806468812
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.001297849	0.04869029806468812
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.001297849	0.04869029806468812
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.001297849	0.04869029806468812
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.001297849	0.04869029806468812
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.001297849	0.04869029806468812
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.001297849	0.04869029806468812
BRANCHIOSKELETOGENITAL SYNDROME	0.001297849	0.04869029806468812
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.001297849	0.04869029806468812
LISSENCEPHALY 3; LIS3	0.001297849	0.04869029806468812
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.001297849	0.04869029806468812
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.001297849	0.04869029806468812
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.001297849	0.04869029806468812
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.001297849	0.04869029806468812
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.001297849	0.04869029806468812
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.001297849	0.04869029806468812
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.001297849	0.04869029806468812
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.001297849	0.04869029806468812
LOWRY-MACLEAN SYNDROME	0.001297849	0.04869029806468812
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.001297849	0.04869029806468812
LEUKOCYTE ADHESION DEFICIENCY	0.001297849	0.04869029806468812
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.001297849	0.04869029806468812
SANJAD-SAKATI SYNDROME	0.001297849	0.04869029806468812
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.001297849	0.04869029806468812
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.001297849	0.04869029806468812
SECKEL SYNDROME 7; SCKL7	0.001297849	0.04869029806468812
WOLCOTT-RALLISON SYNDROME	0.001297849	0.04869029806468812
OCULOCUTANEOUS ALBINISM TYPE 4	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00120482	0.045200208124595034
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00120482	0.045200208124595034
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00120482	0.045200208124595034
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.00120482	0.045200208124595034
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00120482	0.045200208124595034
COLOBOMA, OCULAR	0.00120482	0.045200208124595034
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 18	0.00120482	0.045200208124595034
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00120482	0.045200208124595034
JOUBERT SYNDROME 5	0.00120482	0.045200208124595034
EXUDATIVE VITREORETINOPATHY 7; EVR7	0.00120482	0.045200208124595034
OCULOCUTANEOUS ALBINISM TYPE 3	0.00120482	0.045200208124595034
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.00120482	0.045200208124595034
X-LINKED RECESSIVE OCULAR ALBINISM	0.00120482	0.045200208124595034
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 60	0.00120482	0.045200208124595034
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 59	0.00120482	0.045200208124595034
OCULOCUTANEOUS ALBINISM	0.00120482	0.045200208124595034
SENIOR-LOKEN SYNDROME 3	0.00120482	0.045200208124595034
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.00120482	0.045200208124595034
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 14	0.00120482	0.045200208124595034
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.00120482	0.045200208124595034
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.00120482	0.045200208124595034
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00120482	0.045200208124595034
OCULOCUTANEOUS ALBINISM TYPE 5	0.00120482	0.045200208124595034
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00120482	0.045200208124595034
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00120482	0.045200208124595034
ARNOLD-CHIARI MALFORMATION TYPE I	0.00120482	0.045200208124595034
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00120482	0.045200208124595034
TREMOR, NYSTAGMUS, AND DUODENAL ULCER	0.00120482	0.045200208124595034
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00120482	0.045200208124595034
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.00120482	0.045200208124595034
GILLESPIE SYNDROME; GLSP	0.00120482	0.045200208124595034
245800 LAURENCE-MOON SYNDROME	0.00120482	0.045200208124595034
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00120482	0.045200208124595034
OCULOCUTANEOUS ALBINISM TYPE 6	0.00120482	0.045200208124595034
LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	0.00120482	0.045200208124595034
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.00120482	0.045200208124595034
VITREORETINOCHOROIDOPATHY; VRCP	0.00120482	0.045200208124595034
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00120482	0.045200208124595034
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00120482	0.045200208124595034
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00120482	0.045200208124595034
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.00120482	0.045200208124595034
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00120482	0.045200208124595034
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.00120482	0.045200208124595034
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00120482	0.045200208124595034
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00120482	0.045200208124595034
BENIGN PAROXYSMAL TONIC UPGAZE OF CHILDHOOD WITH ATAXIA	0.00120482	0.045200208124595034
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00120482	0.045200208124595034
LEBER CONGENITAL AMAUROSIS 12; LCA12	0.00120482	0.045200208124595034
FOVEAL HYPOPLASIA 2; FVH2	0.00120482	0.045200208124595034
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00120482	0.045200208124595034
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00120482	0.045200208124595034
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00120482	0.045200208124595034
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 8	0.00120482	0.045200208124595034
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 26	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 3	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 2	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 1	0.00120482	0.045200208124595034
OCULOCUTANEOUS ALBINISM TYPE 2	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00120482	0.045200208124595034
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00120482	0.045200208124595034
BALLER-GEROLD SYNDROME	0.00120482	0.045200208124595034
CONE-ROD DYSTROPHY, X-LINKED, 3	0.00120482	0.045200208124595034
JOUBERT SYNDROME 4	0.00120482	0.045200208124595034
MELKERSSON-ROSENTHAL SYNDROME	0.00120482	0.045200208124595034
OLIVER-MCFARLANE SYNDROME	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 21	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00120482	0.045200208124595034
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00120482	0.045200208124595034
ACHROMATOPSIA 7; ACHM7	0.00120482	0.045200208124595034
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00120482	0.045200208124595034
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.00120482	0.045200208124595034
BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 38; SCA38	0.00120482	0.045200208124595034
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.00120482	0.045200208124595034
JOUBERT SYNDROME 3; JBTS3	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 20	0.00120482	0.045200208124595034
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.00120482	0.045200208124595034
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00120482	0.045200208124595034
TERATOMA, PINEAL	0.00120482	0.045200208124595034
OPHTHALMOPLEGIA, FAMILIAL STATIC	0.00120482	0.045200208124595034
CRANIOECTODERMAL DYSPLASIA 1	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 38	0.00120482	0.045200208124595034
NYSTAGMUS, VOLUNTARY	0.00120482	0.045200208124595034
RETINITIS PIGMENTOSA 20	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00120482	0.045200208124595034
CONE-ROD DYSTROPHY 20; CORD20	0.00120482	0.045200208124595034
FAMILIAL PAROXYSMAL ATAXIA	0.00120482	0.045200208124595034
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00120482	0.045200208124595034
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00120482	0.045200208124595034
CHIARI MALFORMATION TYPE II	0.00120482	0.045200208124595034
ALAND ISLAND EYE DISEASE	0.00120482	0.045200208124595034
SPASTIC PARAPLEGIA TYPE 7	0.00120482	0.045200208124595034
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.00120482	0.045200208124595034
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00120482	0.045200208124595034
RETINITIS PIGMENTOSA 12; RP12	0.00120482	0.045200208124595034
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.00120482	0.045200208124595034
X-LINKED RETINAL DYSPLASIA	0.00120482	0.045200208124595034
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00120482	0.045200208124595034
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00120482	0.045200208124595034
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00120482	0.045200208124595034
DANDY-WALKER SYNDROME	0.00120482	0.045200208124595034
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 34; SCA34	0.00120482	0.045200208124595034
GORLIN-CHAUDHRY-MOSS SYNDROME	0.00120482	0.045200208124595034
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.00120482	0.045200208124595034
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00120482	0.045200208124595034
EPISODIC ATAXIA TYPE 7	0.00120482	0.045200208124595034
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00120482	0.045200208124595034
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.00120482	0.045200208124595034
OCULAR ALBINISM	0.00120482	0.045200208124595034
SPASTIC PARAPLEGIA TYPE 2	0.00120482	0.045200208124595034
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00120482	0.045200208124595034
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00120482	0.045200208124595034
CATARACT 19, MULTIPLE TYPES; CTRCT19	0.00120482	0.045200208124595034
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.00120482	0.045200208124595034
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00120482	0.045200208124595034
NYSTAGMUS, MYOCLONIC	0.00120482	0.045200208124595034
PETERS ANOMALY	0.00120482	0.045200208124595034
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00120482	0.045200208124595034
RETINITIS PIGMENTOSA 14	0.00120482	0.045200208124595034
MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES	0.00120482	0.045200208124595034
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00120482	0.045200208124595034
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00120482	0.045200208124595034
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00120482	0.045200208124595034
SOTOS SYNDROME 2	0.00120482	0.045200208124595034
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00120482	0.045200208124595034
CONE DYSTROPHY 4	0.00120482	0.045200208124595034
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00120482	0.045200208124595034
LENTIGINES	0.00120482	0.045200208124595034
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00120482	0.045200208124595034
CEREBELLAR HYPOPLASIA	0.00120482	0.045200208124595034
YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME	0.00120482	0.045200208124595034
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00120482	0.045200208124595034
CONE-ROD DYSTROPHY 6; CORD6	0.00120482	0.045200208124595034
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 28	0.00120482	0.045200208124595034
X-LINKED ENDOTHELIAL CORNEAL DYSTROPHY	0.00120482	0.045200208124595034
EPISODIC ATAXIA, TYPE 8	0.00120482	0.045200208124595034
JALILI SYNDROME	0.00120482	0.045200208124595034
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00120482	0.045200208124595034
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.00120482	0.045200208124595034
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 46; SCA46	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA 45; SCA45	0.00120482	0.045200208124595034
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 26	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA TYPE 25	0.00120482	0.045200208124595034
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.00120482	0.045200208124595034
ATAXIA WITH VITAMIN E DEFICIENCY	0.00120482	0.045200208124595034
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.00120482	0.045200208124595034
CRANIOFACIAL DYSSYNOSTOSIS	0.00120482	0.045200208124595034
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00120482	0.045200208124595034
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00120482	0.045200208124595034
CRANIOECTODERMAL DYSPLASIA	0.00120482	0.045200208124595034
%615312 ALBINISM, OCULOCUTANEOUS, TYPE V; OCA5	0.00120482	0.045200208124595034
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00120482	0.045200208124595034
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00120482	0.045200208124595034
PETERS ANOMALY	0.00120482	0.045200208124595034
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00120482	0.045200208124595034
AMYOTROPHIC DYSTONIC PARAPLEGIA	0.00120482	0.045200208124595034
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.00120482	0.045200208124595034
SYRINGOMYELIA, ISOLATED	0.00120482	0.045200208124595034
Ã…LAND ISLANDS EYE DISEASE	0.00120482	0.045200208124595034
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00120482	0.045200208124595034
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00120482	0.045200208124595034
SPASMUS NUTANS	0.00120482	0.045200208124595034
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00120482	0.045200208124595034
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00120482	0.045200208124595034
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00120482	0.045200208124595034
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001086973	0.040779042368001395
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.001086973	0.040779042368001395
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.001086973	0.040779042368001395
DYSTONIA-APHONIA SYNDROME	0.001086973	0.040779042368001395
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.040779042368001395
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.040779042368001395
15Q11Q13 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
LANDAU-KLEFFNER SYNDROME	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.040779042368001395
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001086973	0.040779042368001395
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.040779042368001395
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.040779042368001395
ARGININOSUCCINIC ACIDURIA	0.001086973	0.040779042368001395
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.040779042368001395
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.040779042368001395
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.040779042368001395
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001086973	0.040779042368001395
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.040779042368001395
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.040779042368001395
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001086973	0.040779042368001395
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.001086973	0.040779042368001395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.040779042368001395
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.040779042368001395
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.040779042368001395
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.001086973	0.040779042368001395
XQ25 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.040779042368001395
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.040779042368001395
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001086973	0.040779042368001395
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001086973	0.040779042368001395
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.001086973	0.040779042368001395
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001086973	0.040779042368001395
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 7	0.001086973	0.040779042368001395
SULFOCYSTEINURIA	0.001086973	0.040779042368001395
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.040779042368001395
11Q22.2Q22.3 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.040779042368001395
KETOADIPICACIDURIA	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.040779042368001395
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
MAPLE SYRUP URINE DISEASE	0.001086973	0.040779042368001395
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001086973	0.040779042368001395
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.040779042368001395
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.040779042368001395
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.040779042368001395
SOTOS SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001086973	0.040779042368001395
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.040779042368001395
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
HERNÃNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.040779042368001395
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.040779042368001395
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001086973	0.040779042368001395
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.040779042368001395
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
CITRULLINEMIA, CLASSIC	0.001086973	0.040779042368001395
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.040779042368001395
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.040779042368001395
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.040779042368001395
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.040779042368001395
48,XXXY SYNDROME	0.001086973	0.040779042368001395
MAN1B1-CDG	0.001086973	0.040779042368001395
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.001086973	0.040779042368001395
49,XXXXY SYNDROME	0.001086973	0.040779042368001395
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.040779042368001395
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.040779042368001395
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.040779042368001395
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.040779042368001395
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001086973	0.040779042368001395
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.040779042368001395
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.040779042368001395
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.040779042368001395
L1 SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001086973	0.040779042368001395
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.040779042368001395
ISOVALERIC ACIDEMIA	0.001086973	0.040779042368001395
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001086973	0.040779042368001395
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.040779042368001395
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001086973	0.040779042368001395
WIEDEMANN-STEINER SYNDROME; WDSTS	0.001086973	0.040779042368001395
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.040779042368001395
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.040779042368001395
DIGEORGE SYNDROME; DGS	0.001086973	0.040779042368001395
PROPIONIC ACIDEMIA	0.001086973	0.040779042368001395
GAUCHER DISEASE, TYPE II	0.001086973	0.040779042368001395
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.040779042368001395
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.001086973	0.040779042368001395
XP21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.001086973	0.040779042368001395
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.040779042368001395
SHUKLA-VERNON SYNDROME; SHUVER	0.001086973	0.040779042368001395
TEMTAMY SYNDROME; TEMTYS	0.001086973	0.040779042368001395
TETRASOMY 5P	0.001086973	0.040779042368001395
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.001086973	0.040779042368001395
HARTNUP DISORDER	0.001086973	0.040779042368001395
NIEMANN-PICK DISEASE TYPE C	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001086973	0.040779042368001395
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.040779042368001395
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.040779042368001395
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.001086973	0.040779042368001395
FOLATE MALABSORPTION, HEREDITARY	0.001086973	0.040779042368001395
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.040779042368001395
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001086973	0.040779042368001395
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001086973	0.040779042368001395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.040779042368001395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.040779042368001395
WAISMAN SYNDROME; WSMN	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.001086973	0.040779042368001395
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.040779042368001395
SIALURIA	0.001086973	0.040779042368001395
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001086973	0.040779042368001395
CHROMOSOME 16P13.2 DELETION SYNDROME	0.001086973	0.040779042368001395
LUSCAN-LUMISH SYNDROME; LLS	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.040779042368001395
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001086973	0.040779042368001395
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.001086973	0.040779042368001395
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.040779042368001395
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.040779042368001395
NETHERTON SYNDROME	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.001086973	0.040779042368001395
PFEIFFER SYNDROME TYPE 2	0.001086973	0.040779042368001395
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.040779042368001395
20P12.3 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.040779042368001395
XQ25 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
PRADER-WILLI SYNDROME; PWS	0.001086973	0.040779042368001395
SCHIZENCEPHALY	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001086973	0.040779042368001395
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.040779042368001395
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.040779042368001395
CITRULLINEMIA TYPE II	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.040779042368001395
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001086973	0.040779042368001395
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 90	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.040779042368001395
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.040779042368001395
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.040779042368001395
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.040779042368001395
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.040779042368001395
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001086973	0.040779042368001395
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.040779042368001395
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001086973	0.040779042368001395
ARGININEMIA	0.001086973	0.040779042368001395
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.040779042368001395
HELSMOORTEL-VAN DER AA SYNDROME	0.001086973	0.040779042368001395
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.040779042368001395
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001086973	0.040779042368001395
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.040779042368001395
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.040779042368001395
PALLISTER-HALL SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.040779042368001395
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001086973	0.040779042368001395
NIEMANN-PICK DISEASE, TYPE C2	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.040779042368001395
DISTAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.001086973	0.040779042368001395
MIRAGE SYNDROME; MIRAGE	0.001086973	0.040779042368001395
WILSON-TURNER SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.040779042368001395
TIMOTHY SYNDROME; TS	0.001086973	0.040779042368001395
COFFIN-SIRIS SYNDROME 2; CSS2	0.001086973	0.040779042368001395
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.040779042368001395
2P21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.040779042368001395
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.040779042368001395
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.001086973	0.040779042368001395
TRISOMY X	0.001086973	0.040779042368001395
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001086973	0.040779042368001395
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00075643	0.028378341521295647
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00075643	0.028378341521295647
CHARGE SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00075643	0.028378341521295647
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00075643	0.028378341521295647
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00075643	0.028378341521295647
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00075643	0.028378341521295647
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.028378341521295647
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00075643	0.028378341521295647
MICROCEPHALY-CARDIOMYOPATHY	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00075643	0.028378341521295647
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00075643	0.028378341521295647
IMMUNODEFICIENCY 55; IMD55	0.00075643	0.028378341521295647
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.00075643	0.028378341521295647
SCHISIS ASSOCIATION	0.00075643	0.028378341521295647
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
FRONTONASAL DYSPLASIA 2; FND2	0.00075643	0.028378341521295647
ENCEPHALOMALACIA, MULTILOCULAR	0.00075643	0.028378341521295647
CEREBROCOSTOMANDIBULAR SYNDROME	0.00075643	0.028378341521295647
DUBOWITZ SYNDROME	0.00075643	0.028378341521295647
NEU-LAXOVA SYNDROME 2; NLS2	0.00075643	0.028378341521295647
CERNUNNOS-XLF DEFICIENCY	0.00075643	0.028378341521295647
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.00075643	0.028378341521295647
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00075643	0.028378341521295647
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00075643	0.028378341521295647
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00075643	0.028378341521295647
DISTAL MONOSOMY 17Q	0.00075643	0.028378341521295647
HYPERREFLEXIA	0.00075643	0.028378341521295647
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00075643	0.028378341521295647
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00075643	0.028378341521295647
TRISOMY 18P	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00075643	0.028378341521295647
MEIER-GORLIN SYNDROME 3; MGORS3	0.00075643	0.028378341521295647
MEIER-GORLIN SYNDROME 5; MGORS5	0.00075643	0.028378341521295647
RING CHROMOSOME 1 SYNDROME	0.00075643	0.028378341521295647
SECKEL SYNDROME 5; SCKL5	0.00075643	0.028378341521295647
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00075643	0.028378341521295647
BARTSOCAS-PAPAS SYNDROME	0.00075643	0.028378341521295647
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00075643	0.028378341521295647
ISOLATED OSTEOPOIKILOSIS	0.00075643	0.028378341521295647
NON-DISTAL TRISOMY 13Q	0.00075643	0.028378341521295647
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00075643	0.028378341521295647
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00075643	0.028378341521295647
NON-DISTAL TRISOMY 10Q	0.00075643	0.028378341521295647
MEIER-GORLIN SYNDROME 8; MGORS8	0.00075643	0.028378341521295647
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00075643	0.028378341521295647
DISTAL MONOSOMY 13Q	0.00075643	0.028378341521295647
SECKEL SYNDROME 4	0.00075643	0.028378341521295647
BLOOM SYNDROME	0.00075643	0.028378341521295647
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00075643	0.028378341521295647
RING CHROMOSOME 6 SYNDROME	0.00075643	0.028378341521295647
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00075643	0.028378341521295647
LARYNGEAL ABDUCTOR PARALYSIS	0.00075643	0.028378341521295647
RING CHROMOSOME 7 SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00075643	0.028378341521295647
MECKEL SYNDROME, TYPE 1; MKS1	0.00075643	0.028378341521295647
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00075643	0.028378341521295647
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00075643	0.028378341521295647
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00075643	0.028378341521295647
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00075643	0.028378341521295647
DYSOSTOSIS, STANESCU TYPE	0.00075643	0.028378341521295647
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00075643	0.028378341521295647
FEINGOLD SYNDROME 2; FGLDS2	0.00075643	0.028378341521295647
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.028378341521295647
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.028378341521295647
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00075643	0.028378341521295647
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00075643	0.028378341521295647
BONNEMANN-MEINECKE-REICH SYNDROME	0.00075643	0.028378341521295647
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00075643	0.028378341521295647
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00075643	0.028378341521295647
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00075643	0.028378341521295647
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00075643	0.028378341521295647
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00075643	0.028378341521295647
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.028378341521295647
SECKEL SYNDROME 2; SCKL2	0.00075643	0.028378341521295647
MMEP SYNDROME	0.00075643	0.028378341521295647
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00075643	0.028378341521295647
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00075643	0.028378341521295647
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00075643	0.028378341521295647
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.00075643	0.028378341521295647
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00075643	0.028378341521295647
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00075643	0.028378341521295647
TETRAPLOIDY	0.00075643	0.028378341521295647
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00075643	0.028378341521295647
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00075643	0.028378341521295647
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00075643	0.028378341521295647
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO ZNF335 DEFICIENCY	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00075643	0.028378341521295647
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00075643	0.028378341521295647
HUMERO-RADIAL SYNOSTOSIS	0.00075643	0.028378341521295647
MASA SYNDROME	0.00075643	0.028378341521295647
PAGOD SYNDROME	0.00075643	0.028378341521295647
WEAVER-WILLIAMS SYNDROME	0.00075643	0.028378341521295647
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00075643	0.028378341521295647
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00075643	0.028378341521295647
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.028378341521295647
VERVERI-BRADY SYNDROME; VERBRAS	0.00075643	0.028378341521295647
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00075643	0.028378341521295647
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00075643	0.028378341521295647
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00075643	0.028378341521295647
MENTAL RETARDATION, X-LINKED 63	0.00075643	0.028378341521295647
MÃœLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00075643	0.028378341521295647
CHROMOSOME XP11.3 DELETION SYNDROME	0.00075643	0.028378341521295647
BARDET-BIEDL SYNDROME 20	0.00075643	0.028378341521295647
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
SECKEL SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00075643	0.028378341521295647
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00075643	0.028378341521295647
ANONYCHIA-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00075643	0.028378341521295647
XK APROSENCEPHALY SYNDROME	0.00075643	0.028378341521295647
DIAMOND-BLACKFAN ANEMIA 1	0.00075643	0.028378341521295647
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00075643	0.028378341521295647
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00075643	0.028378341521295647
SATOYOSHI SYNDROME	0.00075643	0.028378341521295647
9Q SUBTELOMERIC DELETION SYNDROME	0.00075643	0.028378341521295647
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.00075643	0.028378341521295647
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00075643	0.028378341521295647
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00075643	0.028378341521295647
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00075643	0.028378341521295647
RHIZOMELIC SYNDROME, URBACH TYPE	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00075643	0.028378341521295647
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00075643	0.028378341521295647
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00075643	0.028378341521295647
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00075643	0.028378341521295647
601453 TRICHODENTAL DYSPLASIA	0.00075643	0.028378341521295647
PSEUDOPROGERIA SYNDROME	0.00075643	0.028378341521295647
MILLER-DIEKER SYNDROME (MDS)	0.00075643	0.028378341521295647
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00075643	0.028378341521295647
CRI DU CHAT SYNDROME (5P DELETION)	0.00075643	0.028378341521295647
RENAL TUBULAR DYSGENESIS	0.00075643	0.028378341521295647
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00075643	0.028378341521295647
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00075643	0.028378341521295647
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00075643	0.028378341521295647
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00075643	0.028378341521295647
1Q21.1 RECURRENT MICRODELETION (SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00075643	0.028378341521295647
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00075643	0.028378341521295647
MONOSOMY 5P	0.00075643	0.028378341521295647
STIMMLER SYNDROME	0.00075643	0.028378341521295647
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00075643	0.028378341521295647
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.028378341521295647
DISTAL 17P13.1 MICRODELETION SYNDROME	0.00075643	0.028378341521295647
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00075643	0.028378341521295647
MEIER-GORLIN SYNDROME 6; MGORS6	0.00075643	0.028378341521295647
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00075643	0.028378341521295647
POLAND SYNDROME	0.00075643	0.028378341521295647
SAY SYNDROME	0.00075643	0.028378341521295647
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00075643	0.028378341521295647
RUVALCABA SYNDROME	0.00075643	0.028378341521295647
OROFACIODIGITAL SYNDROME TYPE 5	0.00075643	0.028378341521295647
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00075643	0.028378341521295647
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00075643	0.028378341521295647
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00075643	0.028378341521295647
KLIPPEL-TRÃ‰NAUNAY SYNDROME	0.00075643	0.028378341521295647
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
BOWEN-CONRADI SYNDROME	0.00075643	0.028378341521295647
DISTAL TRISOMY 5Q	0.00075643	0.028378341521295647
PSEUDOTRISOMY 13 SYNDROME	0.00075643	0.028378341521295647
BLOOM SYNDROME	0.00075643	0.028378341521295647
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00075643	0.028378341521295647
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00075643	0.028378341521295647
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00075643	0.028378341521295647
RING CHROMOSOME 13 SYNDROME	0.00075643	0.028378341521295647
RHIZOMELIC SYNDROME	0.00075643	0.028378341521295647
FONTAINE PROGEROID SYNDROME; FPS	0.00075643	0.028378341521295647
GMS SYNDROME	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00075643	0.028378341521295647
CARDIAC LIPIDOSIS, FAMILIAL	0.00075643	0.028378341521295647
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00075643	0.028378341521295647
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00075643	0.028378341521295647
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00075643	0.028378341521295647
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
FACIOCARDIOMELIC SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00075643	0.028378341521295647
FRASER SYNDROME	0.00075643	0.028378341521295647
FRYNS-SMEETS-THIRY SYNDROME	0.00075643	0.028378341521295647
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
GENITOPALATOCARDIAC SYNDROME	0.00075643	0.028378341521295647
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00075643	0.028378341521295647
OCULOPALATOCEREBRAL SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00075643	0.028378341521295647
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.00075643	0.028378341521295647
COFFIN-SIRIS SYNDROME 10; CSS10	0.00075643	0.028378341521295647
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00075643	0.028378341521295647
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00075643	0.028378341521295647
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00075643	0.028378341521295647
KERATOSIS FOLLICULARIS-DWARFISM-CEREBRAL ATROPHY SYNDROME	0.00075643	0.028378341521295647
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00075643	0.028378341521295647
JUBERG-HAYWARD SYNDROME	0.00075643	0.028378341521295647
JOHNSON NEUROECTODERMAL SYNDROME	0.00075643	0.028378341521295647
PRIMARY PULMONARY HYPOPLASIA	0.00075643	0.028378341521295647
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00075643	0.028378341521295647
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00075643	0.028378341521295647
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00075643	0.028378341521295647
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00075643	0.028378341521295647
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00075643	0.028378341521295647
MECKEL SYNDROME, TYPE 4; MKS4	0.00075643	0.028378341521295647
JUNG SYNDROME	0.00075643	0.028378341521295647
XYLT1-CDG	0.00075643	0.028378341521295647
OCULOAURICULOFRONTONASAL SYNDROME	0.00075643	0.028378341521295647
CULLER-JONES SYNDROME; CJS	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.020467085824608922
TRANSALDOLASE DEFICIENCY	0.000545554	0.020467085824608922
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000545554	0.020467085824608922
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.020467085824608922
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.020467085824608922
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.020467085824608922
AUSTRALIA ANTIGEN	0.000545554	0.020467085824608922
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.020467085824608922
CURRARINO SYNDROME	0.000545554	0.020467085824608922
RABSON-MENDENHALL SYNDROME	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.020467085824608922
JOUBERT SYNDROME 1	0.000545554	0.020467085824608922
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.020467085824608922
TYSHCHENKO SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.020467085824608922
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.020467085824608922
COFFIN-SIRIS SYNDROME 6; CSS6	0.000545554	0.020467085824608922
TETRASOMY X	0.000545554	0.020467085824608922
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.020467085824608922
CHROMOSOME 9P DELETION SYNDROME	0.000545554	0.020467085824608922
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 2	0.000545554	0.020467085824608922
SEPTOOPTIC DYSPLASIA	0.000545554	0.020467085824608922
3C SYNDROME	0.000545554	0.020467085824608922
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.020467085824608922
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.020467085824608922
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.020467085824608922
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020467085824608922
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.020467085824608922
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.020467085824608922
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.020467085824608922
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.020467085824608922
SYNDROMIC DIARRHEA	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000545554	0.020467085824608922
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.020467085824608922
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.020467085824608922
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000545554	0.020467085824608922
WOLMAN DISEASE	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.020467085824608922
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.020467085824608922
CHAR SYNDROME	0.000545554	0.020467085824608922
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.020467085824608922
XIA-GIBBS SYNDROME	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.020467085824608922
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.020467085824608922
HYDROXYKYNURENINURIA	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.020467085824608922
ALG6-CDG	0.000545554	0.020467085824608922
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.020467085824608922
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.020467085824608922
AU-KLINE SYNDROME; AUKS	0.000545554	0.020467085824608922
FRIAS SYNDROME	0.000545554	0.020467085824608922
300270 ADRENOMYODYSTROPHY	0.000545554	0.020467085824608922
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.020467085824608922
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.020467085824608922
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.020467085824608922
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.020467085824608922
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.020467085824608922
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.020467085824608922
NOONAN SYNDROME 9; NS9	0.000545554	0.020467085824608922
JOUBERT SYNDROME 10	0.000545554	0.020467085824608922
NOONAN SYNDROME 3; NS3	0.000545554	0.020467085824608922
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.020467085824608922
PROPIONIC ACIDEMIA	0.000545554	0.020467085824608922
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.020467085824608922
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
LARSEN-LIKE SYNDROME	0.000545554	0.020467085824608922
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.020467085824608922
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.020467085824608922
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.020467085824608922
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.020467085824608922
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.020467085824608922
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.020467085824608922
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.020467085824608922
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
NOONAN SYNDROME 5; NS5	0.000545554	0.020467085824608922
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.020467085824608922
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.020467085824608922
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.020467085824608922
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.020467085824608922
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.020467085824608922
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.020467085824608922
ICF SYNDROME	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.020467085824608922
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.020467085824608922
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.020467085824608922
JOUBERT SYNDROME 6	0.000545554	0.020467085824608922
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.000545554	0.020467085824608922
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.020467085824608922
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.020467085824608922
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000545554	0.020467085824608922
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.020467085824608922
MICROVILLUS INCLUSION DISEASE	0.000545554	0.020467085824608922
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.020467085824608922
ZEBRA BODY MYOPATHY	0.000545554	0.020467085824608922
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.020467085824608922
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.020467085824608922
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.020467085824608922
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.020467085824608922
2Q23.1 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.020467085824608922
EVEN-PLUS SYNDROME	0.000545554	0.020467085824608922
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.020467085824608922
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.020467085824608922
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.020467085824608922
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.020467085824608922
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.020467085824608922
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.020467085824608922
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.020467085824608922
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.020467085824608922
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.020467085824608922
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.020467085824608922
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.020467085824608922
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.020467085824608922
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.020467085824608922
1P21.3 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
CURRY-JONES SYNDROME	0.000545554	0.020467085824608922
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000545554	0.020467085824608922
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.020467085824608922
JOUBERT SYNDROME 25	0.000545554	0.020467085824608922
HEREDITARY OROTIC ACIDURIA	0.000545554	0.020467085824608922
LAMB-SHAFFER SYNDROME	0.000545554	0.020467085824608922
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000545554	0.020467085824608922
TARP SYNDROME; TARPS	0.000545554	0.020467085824608922
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.020467085824608922
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.020467085824608922
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.020467085824608922
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.020467085824608922
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.020467085824608922
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.020467085824608922
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.020467085824608922
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.020467085824608922
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.020467085824608922
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.020467085824608922
FRONTOOCULAR SYNDROME	0.000545554	0.020467085824608922
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.020467085824608922
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.020467085824608922
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.020467085824608922
ABETAL34V AMYLOIDOSIS	0.000545554	0.020467085824608922
OGDEN SYNDROME	0.000545554	0.020467085824608922
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.020467085824608922
48,XYYY SYNDROME	0.000545554	0.020467085824608922
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.020467085824608922
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.020467085824608922
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.020467085824608922
OTOFACIOCERVICAL SYNDROME	0.000545554	0.020467085824608922
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.020467085824608922
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.020467085824608922
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.020467085824608922
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.020467085824608922
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.020467085824608922
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.020467085824608922
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.020467085824608922
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.020467085824608922
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.020467085824608922
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.020467085824608922
ATELOSTEOGENESIS TYPE III	0.000545554	0.020467085824608922
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.020467085824608922
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.020467085824608922
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.020467085824608922
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020467085824608922
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.020467085824608922
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.020467085824608922
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.000545554	0.020467085824608922
OCCIPITAL HORN SYNDROME	0.000545554	0.020467085824608922
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.020467085824608922
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.020467085824608922
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.020467085824608922
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.020467085824608922
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.020467085824608922
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.020467085824608922
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.020467085824608922
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.020467085824608922
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000545554	0.020467085824608922
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.020467085824608922
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.000545554	0.020467085824608922
DISTAL MONOSOMY 9P	0.000545554	0.020467085824608922
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.000545554	0.020467085824608922
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.020467085824608922
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.000545554	0.020467085824608922
DEXTROCARDIA	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.020467085824608922
TRISOMY 12P	0.000545554	0.020467085824608922
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.020467085824608922
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.020467085824608922
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.020467085824608922
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000545554	0.020467085824608922
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.020467085824608922
TEMTAMY SYNDROME	0.000545554	0.020467085824608922
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.020467085824608922
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.020467085824608922
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.020467085824608922
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.020467085824608922
THYROID ECTOPIA	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.020467085824608922
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.020467085824608922
JOUBERT SYNDROME 8	0.000545554	0.020467085824608922
JOUBERT SYNDROME 15	0.000545554	0.020467085824608922
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.020467085824608922
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.020467085824608922
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.020467085824608922
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.020467085824608922
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.020467085824608922
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.020467085824608922
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.020467085824608922
CUTIS LAXA	0.000545554	0.020467085824608922
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.020467085824608922
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.020467085824608922
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000545554	0.020467085824608922
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.020467085824608922
ZECHI-CEIDE SYNDROME	0.000545554	0.020467085824608922
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.020467085824608922
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.020467085824608922
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.020467085824608922
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.020467085824608922
OROTIC ACIDURIA	0.000545554	0.020467085824608922
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.020467085824608922
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.020467085824608922
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.020467085824608922
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.020467085824608922
COLE-CARPENTER SYNDROME	0.000545554	0.020467085824608922
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.020467085824608922
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.020467085824608922
GERODERMA OSTEODYSPLASTICA	0.000545554	0.020467085824608922
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.020467085824608922
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.020467085824608922
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.020467085824608922
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.020467085824608922
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.020467085824608922
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.020467085824608922
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.020467085824608922
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.020311956543392476
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020311956543392476
1P36 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
PARIETAL FORAMINA	0.000541419	0.020311956543392476
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.020311956543392476
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.000541419	0.020311956543392476
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020311956543392476
ASPARTYLGLUCOSAMINURIA	0.000541419	0.020311956543392476
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.020311956543392476
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392476
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020311956543392476
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.020311956543392476
2Q33.1 DELETION SYNDROME	0.000541419	0.020311956543392476
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.020311956543392476
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.020311956543392476
DERMOTRICHIC SYNDROME	0.000541419	0.020311956543392476
ADRENOMYODYSTROPHY	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.020311956543392476
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020311956543392476
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020311956543392476
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020311956543392476
CROUZON SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020311956543392476
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020311956543392476
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.020311956543392476
DARIER-WHITE DISEASE; DAR	0.000541419	0.020311956543392476
EPILEPSY, READING	0.000541419	0.020311956543392476
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020311956543392476
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392476
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020311956543392476
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020311956543392476
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392476
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020311956543392476
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.020311956543392476
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020311956543392476
PARTINGTON SYNDROME	0.000541419	0.020311956543392476
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020311956543392476
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.020311956543392476
FRAGILE X SYNDROME	0.000541419	0.020311956543392476
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020311956543392476
SMITH-KINGSMORE SYNDROME; SKS	0.000541419	0.020311956543392476
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392476
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020311956543392476
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.020311956543392476
TENORIO SYNDROME; TNORS	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392476
QAZI-MARKOUIZOS SYNDROME	0.000541419	0.020311956543392476
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.020311956543392476
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020311956543392476
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020311956543392476
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.020311956543392476
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020311956543392476
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020311956543392476
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020311956543392476
THREONINEMIA	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020311956543392476
CLARK-BARAITSER SYNDROME	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.020311956543392476
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020311956543392476
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392476
AICA-RIBOSIDURIA	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.020311956543392476
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020311956543392476
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020311956543392476
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.020311956543392476
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392476
CITRULLINEMIA TYPE I	0.000541419	0.020311956543392476
ATKIN-FLAITZ SYNDROME	0.000541419	0.020311956543392476
TAY-SACHS DISEASE; TSD	0.000541419	0.020311956543392476
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.000541419	0.020311956543392476
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392476
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.020311956543392476
CYSTATHIONINURIA	0.000541419	0.020311956543392476
PGM3-CDG	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020311956543392476
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.020311956543392476
FRYNS SYNDROME	0.000541419	0.020311956543392476
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020311956543392476
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.020311956543392476
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.020311956543392476
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.020311956543392476
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392476
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392476
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA	0.000541419	0.020311956543392476
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392476
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020311956543392476
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.020311956543392476
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.020311956543392476
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020311956543392476
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.020311956543392476
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.020311956543392476
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.020311956543392476
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392476
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020311956543392476
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.020311956543392476
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.020311956543392476
HEREDITARY HYPEREKPLEXIA	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.020311956543392476
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.020311956543392476
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.020311956543392476
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS 2	0.000541419	0.020311956543392476
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392476
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.020311956543392476
NASU-HAKOLA DISEASE	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020311956543392476
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020311956543392476
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.020311956543392476
EPENDYMOMA	0.000541419	0.020311956543392476
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.020311956543392476
ISOLATED BILIARY ATRESIA	0.000541419	0.020311956543392476
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020311956543392476
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020311956543392476
GURRIERI SYNDROME	0.000541419	0.020311956543392476
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020311956543392476
PORENCEPHALY	0.000541419	0.020311956543392476
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020311956543392476
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.020311956543392476
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020311956543392476
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020311956543392476
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392476
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.020311956543392476
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392476
ALZHEIMER DISEASE 3; AD	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.020311956543392476
MOYAMOYA DISEASE	0.000541419	0.020311956543392476
MICROSPORIDIOSIS	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.020311956543392476
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.020311956543392476
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020311956543392476
PINEOBLASTOMA	0.000541419	0.020311956543392476
SUBEPENDYMOMA	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020311956543392476
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020311956543392476
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020311956543392476
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.000541419	0.020311956543392476
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.020311956543392476
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020311956543392476
KUFOR-RAKEB SYNDROME	0.000541419	0.020311956543392476
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020311956543392476
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020311956543392476
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.020311956543392476
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.020311956543392476
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.020311956543392476
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.020311956543392476
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020311956543392476
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.020311956543392476
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.020311956543392476
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.020311956543392476
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.020311956543392476
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020311956543392476
ROMANO-WARD SYNDROME	0.000541419	0.020311956543392476
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020311956543392476
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.020311956543392476
DEND SYNDROME	0.000541419	0.020311956543392476
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020311956543392476
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020311956543392476
RABIES	0.000541419	0.020311956543392476
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.020311956543392476
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.020311956543392476
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.020311956543392476
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.020311956543392476
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000541419	0.020311956543392476
FAMILIAL THROMBOCYTOSIS	0.000541419	0.020311956543392476
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020311956543392476
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392476
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020311956543392476
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.020311956543392476
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.020311956543392476
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020311956543392476
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392476
HEREDITARY COPROPORPHYRIA	0.000541419	0.020311956543392476
AUTISM	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.020311956543392476
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020311956543392476
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020311956543392476
SCRUB TYPHUS	0.000541419	0.020311956543392476
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020311956543392476
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.020311956543392476
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020311956543392476
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.020311956543392476
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.020311956543392476
ISOLATED SPINA BIFIDA	0.000541419	0.020311956543392476
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.020311956543392476
47,XYY SYNDROME	0.000541419	0.020311956543392476
ALEXANDER DISEASE	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020311956543392476
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.020311956543392476
PORPHYRIA VARIEGATA	0.000541419	0.020311956543392476
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020311956543392476
MOGS-CDG	0.000541419	0.020311956543392476
ALG9-CDG	0.000541419	0.020311956543392476
MPDU1-CDG	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020311956543392476
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020311956543392476
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020311956543392476
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.020311956543392476
KIFAFA SEIZURE DISORDER	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.020311956543392476
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020311956543392476
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.020311956543392476
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392476
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.020311956543392476
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.020311956543392476
17Q24.2 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020311956543392476
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
NOONAN SYNDROME 7; NS7	0.000541419	0.020311956543392476
CENTRAL DIABETES INSIPIDUS	0.000541419	0.020311956543392476
DIAMINOPENTANURIA	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020311956543392476
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020311956543392476
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020311956543392476
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392476
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.020311956543392476
FRONTAL ENCEPHALOCELE	0.000541419	0.020311956543392476
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392476
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392476
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020311956543392476
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.020311956543392476
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.020311956543392476
HYPERPROLINEMIA, TYPE II	0.000541419	0.020311956543392476
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020311956543392476
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020311956543392476
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020311956543392476
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.020311956543392476
RING CHROMOSOME 10 SYNDROME	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392476
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.020311956543392476
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392476
EPILEPSY-TELANGIECTASIA	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020311956543392476
HYPER-BETA-ALANINEMIA	0.000541419	0.020311956543392476
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.020311956543392476
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020311956543392476
RECURRENT ACUTE PANCREATITIS	0.000541419	0.020311956543392476
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
LHERMITTE-DUCLOS DISEASE	0.000541419	0.020311956543392476
ONDINE SYNDROME	0.000541419	0.020311956543392476
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020311956543392476
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392476
CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392476
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020311956543392476
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
BERNARD-SOULIER SYNDROME	0.000541419	0.020311956543392476
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.020311956543392476
CRYPTOCOCCOSIS	0.000541419	0.020311956543392476
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020311956543392476
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020311956543392476
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.020311956543392476
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020311956543392476
ROSAÃ-DORFMAN DISEASE	0.000541419	0.020311956543392476
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
HYPERLYSINEMIA, TYPE I	0.000541419	0.020311956543392476
